CN105848626A - Transparent composition containing oil and microcapsules - Google Patents
Transparent composition containing oil and microcapsules Download PDFInfo
- Publication number
- CN105848626A CN105848626A CN201480070567.4A CN201480070567A CN105848626A CN 105848626 A CN105848626 A CN 105848626A CN 201480070567 A CN201480070567 A CN 201480070567A CN 105848626 A CN105848626 A CN 105848626A
- Authority
- CN
- China
- Prior art keywords
- weight
- compositions
- microcapsules
- oil
- core
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
纳米乳液或微乳液形式的透明组合物包含含有可释放的着色剂的微胶囊。所述组合物包含至少一个脂肪相、至少一种非离子表面活性剂、至少一种包含可释放的着色剂的微胶囊,和水。这种组合物提供高化妆性如润肤性和高滑溜感,同时在剪切时给予消费者变色感觉。Transparent compositions in the form of nanoemulsions or microemulsions comprise microcapsules containing releasable colorants. The composition comprises at least one fatty phase, at least one nonionic surfactant, at least one microcapsule comprising a releasable colorant, and water. Such compositions provide high cosmetic properties such as emolliency and high slippery feel while giving the consumer a discoloration sensation upon shearing.
Description
技术领域technical field
本发明涉及包含油和微胶囊的组合物。更特别地,本发明涉及微乳液或纳米乳液形式的组合物,其包括包含可释放的着色剂的微胶囊。The present invention relates to compositions comprising oil and microcapsules. More particularly, the present invention relates to compositions in the form of microemulsions or nanoemulsions comprising microcapsules comprising releasable colorants.
背景技术Background technique
化妆品组合物通常被用于赋予皮肤美观的色彩,而且隐藏皮肤缺陷如发红(redness)和/或斑点。迄今为止已开发了许多配方。此外,对响应外部刺激如剪切力而提供颜色变化的化妆产品的兴趣日益增强。Cosmetic compositions are generally used to impart an aesthetically pleasing color to the skin and to conceal skin imperfections such as redness and/or blemishes. Many formulations have been developed to date. Furthermore, there is growing interest in cosmetic products that provide color changes in response to external stimuli such as shear forces.
通常,通过在组合物中包含微胶囊化的着色剂来实现这种目的,其中在施用到皮肤上后,组合物提供颜色变化。更特别地,通过含着色剂的微胶囊提供颜色变化,所述微胶囊在通过施加机械力而破裂后释放包埋的着色剂到组合物中,从而改变其颜色。机械作用如摩擦将局部组合物铺展开并促进其渗透进入皮肤。组合物颜色的立即改变提供了视觉上的美观效果。Typically, this is achieved by including microencapsulated colorants in the composition, wherein the composition provides a color change after application to the skin. More particularly, the color change is provided by colorant-containing microcapsules which upon rupture by application of mechanical force release the entrapped colorant into the composition, thereby changing its color. Mechanical action such as friction spreads the topical composition and facilitates its penetration into the skin. The immediate change in color of the composition provides a visually pleasing effect.
本领域中已经知道将颜料引入化妆品组合物中,特别是包含大量水的用于皮肤护理或用于化妆皮肤的组合物。预期这些组合物在施用后具有清爽的(fresh)感官效果且赋予皮肤合适的色泽(color shade)。此外,它们包含大量活性成分的能力获得高度赞赏。It is known in the art to incorporate pigments into cosmetic compositions, especially compositions for skin care or for making up the skin which contain large amounts of water. These compositions are expected to have a fresh sensory effect after application and impart a suitable color shade to the skin. Furthermore, their ability to contain a large number of active ingredients is highly appreciated.
这种清爽的感官和光学效果例如在“快速打破(quick break)型”配方中、在面部精华素(face serum)中、在眼部精华素(eye serum)中和在粉底中是需要的。This refreshing sensory and optical effect is desired, for example, in "quick break" formulations, in face serums, in eye serums and in foundations.
然而,引入大量颜料可损害清爽效果:颜料倾向于吸收水,导致组合物更快速地干掉,因此使得组合物更难以均匀地施用在皮肤上。However, introducing large amounts of pigments can impair the cooling effect: pigments tend to absorb water, causing the composition to dry out more quickly, thus making it more difficult to apply the composition evenly on the skin.
从而,在施用到皮肤后这种组合物的颜色关于均一性没有达到期望的要求。此外,一旦组合物已经在皮肤上形成干膜,并不总是可能补救这种问题。Thus, the color of such compositions after application to the skin does not meet the desired requirements with regard to uniformity. Furthermore, it is not always possible to remedy the problem once the composition has formed a dry film on the skin.
为了提供透明的化妆品,迄今为止已使用以下技术。这是化妆品或皮肤学领域中已知的实践:使用水包油(O/W)乳液。这些乳液(其由分散在水相中的油相(或亲油相)组成)具有外部水相。因此,所述产品由于它们提供的清爽感使用起来更令人愉悦。然而,当大量油存在时它们相对缺少稳定性。就一些应用而言,有利的是具有大量油,因为油提供皮肤以舒适,滋养它,并当这些油具有卸妆性质时也可从皮肤卸妆。In order to provide transparent cosmetics, the following techniques have been used so far. This is a known practice in the field of cosmetics or dermatology: the use of oil-in-water (O/W) emulsions. These emulsions, which consist of an oil phase (or lipophilic phase) dispersed in an aqueous phase, have an external aqueous phase. Thus, the products are more pleasant to use due to the refreshing sensation they provide. However, they lack relative stability when large amounts of oil are present. For some applications, it is advantageous to have a large amount of oils, as the oils provide the skin with comfort, nourish it, and when these oils have makeup-removing properties, also remove makeup from the skin.
此外,有利的是具有细乳液,即其中油相为非常小的液滴即不到4μm尺寸的液滴的形式的乳液,因为这些细乳液具有令人愉悦的化妆感并且通常比粗乳液更稳定。Furthermore, it is advantageous to have miniemulsions, i.e. emulsions in which the oil phase is in the form of very small droplets, i.e. droplets less than 4 μm in size, as these have a pleasing cosmetic feel and are generally more stable than macroemulsions .
这些乳液可尤其通过相变型温度技术制备(PIT乳液),其中构成油相的小球的平均尺寸在给定限度内,即0.1μm至4μm(100nm至4000nm)。相变型温度(或PIT)乳化的原理,就理论上而言,对于本领域技术人员而言是众所周知的;其于1968年由K.Shinoda描述(J.Chem.Soc.Jpn.,1968,89,435)。已经显示这种乳化技术使得可能获得稳定的细乳液(K.Shinoda和H.Saito,J.Colloid Interface Sci.,1969,30,258)。早在1972年Mitsui等人就将这种技术应用在了化妆品中(“相变型温度方法在化妆品乳化中的应用”(“Application of the phase-inversion-temperature method to theemulsification of cosmetics”);T.Mitsui,Y.Machida和F.Harusawa,美国.Cosmet.Perfum.,1972,87,33)。These emulsions can be prepared especially by phase transition type temperature techniques (PIT emulsions), in which the average size of the globules constituting the oil phase is within given limits, namely 0.1 μm to 4 μm (100 nm to 4000 nm). The principle of phase change temperature (or PIT) emulsification is well known to those skilled in the art in theory; it was described by K.Shinoda in 1968 (J.Chem.Soc.Jpn., 1968, 89,435). It has been shown that this emulsification technique makes it possible to obtain stable miniemulsions (K. Shinoda and H. Saito, J. Colloid Interface Sci., 1969, 30, 258). As early as 1972, Mitsui et al applied this technology to cosmetics ("Application of the phase-inversion-temperature method to the emulsification of cosmetics"); T . Mitsui, Y. Machida and F. Harusawa, USA. Cosmet. Perfum., 1972, 87, 33).
这种技术的原理如下:在超过体系的相变型温度(即所用乳化剂的亲水性和亲油性之间达到平衡的温度)的温度下制备O/W乳液(将水相引入油相中);在更高的温度下,即高于相变型温度(>PIT),乳液为油包水型的,并且当其冷却时,该乳液在相变型温度下反转以变为水包油型乳液,预先经历微乳液状态。这种方法使得可能容易地获得直径通常小于4μm的乳液。通常使用的水包油型的乳化表面活性剂具有在8至18范围内的HLB(亲水性亲油性平衡)。这些乳化剂,由于它们的两亲结构,位于油相/水相界面,并且因此使分散的油滴稳定。The principle of this technique is as follows: an O/W emulsion (introduction of the water phase into the oil phase) is prepared at a temperature exceeding the phase transition type temperature of the system (i.e. the temperature at which equilibrium is reached between the hydrophilic and lipophilic properties of the emulsifier used) ; at higher temperatures, i.e. above the phase transition temperature (>PIT), the emulsion is water-in-oil and when it cools, the emulsion inverts at the phase transition temperature to become oil-in-water type emulsions, previously undergoing a microemulsion state. This method makes it possible to easily obtain emulsions with diameters typically smaller than 4 μm. Commonly used emulsifying surfactants of the oil-in-water type have an HLB (Hydrophile-Lipophile Balance) in the range of 8 to 18. These emulsifiers, due to their amphiphilic structure, are located at the oil/water phase interface and thus stabilize the dispersed oil droplets.
然而,难以生产包含大量油相的细O/W乳液,因为这种乳液具有不稳定化的趋势,这种不稳定化导致水相和油相聚结和分离,释放出油。为了改善这些乳液的稳定性,可提高乳化剂的浓度;然而,高浓度的乳化剂可导致粗糙、发粘的(clingy或sticky)感觉,并对皮肤、眼睛和头皮而言导致无害性问题。However, it is difficult to produce fine O/W emulsions containing a large amount of oil phase because of the tendency of such emulsions to destabilize leading to coalescence and separation of the water and oil phases, releasing the oil. To improve the stability of these emulsions, the concentration of emulsifiers can be increased; however, high concentrations of emulsifiers can lead to a rough, sticky (clingy or sticky) feel and cause harmless problems to the skin, eyes and scalp .
特别地,细乳液如O/W纳米乳液或微乳液由于其透明或稍微半透明的外观而在化妆产品中引起特别的兴趣。In particular, miniemulsions such as O/W nanoemulsions or microemulsions are of particular interest in cosmetic products due to their transparent or slightly translucent appearance.
例如,JP-A-H09-110635公开了一种细乳液,其通过使用聚甘油脂肪酸酯(作为表面活性剂)和C10-C22 2-羟基脂肪酸的组合而形成。此外,JP-A-H11-71256公开了一种细乳液,其通过使用聚甘油脂肪酸酯和甜菜碱的组合而形成。For example, JP-A-H09-110635 discloses a miniemulsion formed by using a combination of polyglycerol fatty acid ester (as a surfactant) and C 10 -C 22 2-hydroxy fatty acid. Furthermore, JP-A-H11-71256 discloses a miniemulsion formed by using a combination of polyglyceryl fatty acid ester and betaine.
发明内容Contents of the invention
技术问题technical problem
本发明的目的是提供具有大量油的组合物,其具有乳液的透明或稍微半透明的,优选透明的外观,具有变色效果并具有对许多消费者而言可接受的高度化妆性(cosmeticity)。The object of the present invention is to provide a composition with a high amount of oil, which has the transparent or slightly translucent, preferably transparent appearance of an emulsion, has a color changing effect and has a high cosmeticity acceptable to many consumers.
问题的解决方案problem solution
本发明的以上目的可通过纳米乳液或微乳液形式的组合物实现,所述组合物包含(a)至少一个脂肪相,(b)至少一种非离子表面活性剂,(c)包含可释放的着色剂的至少一种微胶囊,和(d)水相。The above objects of the present invention can be achieved by a composition in the form of a nanoemulsion or microemulsion comprising (a) at least one fatty phase, (b) at least one nonionic surfactant, (c) comprising a releasable at least one microcapsule of colorant, and (d) an aqueous phase.
附图简述Brief description of the drawings
如下将描述意欲以非限定的方式说明本发明的附图,其代表将引入根据本发明的化妆品组合物中的微胶囊的实例。The accompanying drawings intended to illustrate the invention in a non-limiting manner and representing examples of microcapsules to be incorporated into the cosmetic composition according to the invention will be described below.
[图1]图1是说明本发明的第一实施方案的变色微胶囊的典型结构的示意图,其中A1代表核并且B1、C1、D1和E1是同心(concentrically)包围所述核的不同层。[ Fig. 1] Fig. 1 is a schematic diagram illustrating a typical structure of a color-changing microcapsule of the first embodiment of the present invention, wherein A1 represents a core and B1, C1, D1, and E1 are different layers concentrically surrounding the core.
[图2]图2是显示如下述实施例1中所用的变色微胶囊B的核-壳结构的微胶囊的第一实施方案的示意图。[ Fig. 2] Fig. 2 is a schematic diagram showing a first embodiment of a microcapsule of a core-shell structure of a color-changing microcapsule B as used in Example 1 described below.
[图3]图3是说明本发明的第二实施方案的微胶囊的典型结构的示意图,其中A2代表着色核,B2、C2、D2和E2是同心包围核A2的不同层,这些包围层中的至少一个是必须的并优选包括二氧化钛颗粒,而其它层是任选的。[Fig. 3] Fig. 3 is a schematic view illustrating a typical structure of a microcapsule according to a second embodiment of the present invention, wherein A2 represents a colored core, and B2, C2, D2, and E2 are different layers concentrically surrounding the core A2, and among these surrounding layers At least one of the layers is required and preferably includes titanium dioxide particles, while the other layers are optional.
[图4]图4是显示包含3层:着色核–内部颜色层(inner color layer)–TiO2颗粒层的微胶囊的第二实施方案的变色微胶囊的核-壳结构的示意图。包含在图4的右边颗粒中的颜料核对应于左边颗粒,所述颜料核包括颜料/卵磷脂层(内部颜色层)和内部颜料粉末(内部着色核)。[ Fig. 4] Fig. 4 is a schematic diagram showing the core-shell structure of the color-changing microcapsule of the second embodiment of the microcapsule comprising 3 layers: colored core-inner color layer-TiO 2 particle layer. The pigment core contained in the right particle of FIG. 4 corresponds to the left particle, and the pigment core includes a pigment/lecithin layer (inner color layer) and an inner pigment powder (inner coloring core).
[图5]图5是显示包含2层:着色核–TiO2颗粒层的微胶囊的第二实施方案的变色微胶囊的核-壳结构的示意图。[ Fig. 5] Fig. 5 is a schematic diagram showing the core-shell structure of the color-changing microcapsule of the second embodiment of the microcapsule comprising 2 layers: colored core-TiO 2 particle layer.
实施方案描述Implementation Description
由于本发明的组合物可为透明或稍微半透明的,该组合物可优选用于洗液(lotion)等。由于分散相是细分散的,本发明的组合物可提供润肤质地(emollienttexture)以及滑溜感(slipperiness)。此外,由于本发明的组合物含有包含可释放的着色剂的微胶囊,该组合物在被消费者同时施加剪切或压力后提供变色感觉。Since the composition of the present invention may be transparent or slightly translucent, the composition may be preferably used for lotions and the like. Since the dispersed phase is finely divided, the compositions of the present invention provide an emollient texture as well as slipperiness. Furthermore, since the composition of the present invention contains microcapsules comprising a releasable colorant, the composition provides a color change sensation upon simultaneous application of shear or pressure by the consumer.
本发明的组合物具有分散相,其由于包含可释放的着色剂的至少一种微胶囊的存在而具有较小的直径。因此,该组合物可为透明或稍微半透明的纳米乳液或微乳液形式。The composition of the invention has a dispersed phase which has a smaller diameter due to the presence of at least one microcapsule comprising a releasable colorant. Thus, the composition may be in the form of a clear or slightly translucent nanoemulsion or microemulsion.
在下文中将以更详细的方式对本发明的组合物进行解释。Hereinafter, the composition of the present invention will be explained in a more detailed manner.
1-1.脂肪相1-1. Fat phase
本发明的组合物包含主要由油组成的至少一个脂肪相。这里,“油”意指在室温(25℃)、大气压(760mmHg)下呈液体形式的脂肪化合物或物质。化妆品中通常使用的那些油可单独使用或以其组合使用。这些油可为挥发性的或非挥发性的,优选非挥发性的。该油可为极性油或非极性油。The compositions of the invention comprise at least one fatty phase consisting essentially of oil. Here, "oil" means a fatty compound or substance in liquid form at room temperature (25° C.) and atmospheric pressure (760 mmHg). Those oils commonly used in cosmetics may be used alone or in combination thereof. These oils may be volatile or nonvolatile, preferably nonvolatile. The oil can be polar or non-polar.
该油可为合成油或天然产生的油,如植物油和动物油。The oil may be a synthetic oil or a naturally occurring oil, such as vegetable and animal oils.
植物油可包括,例如,亚麻籽油、山茶油、澳洲坚果油、玉米油、貂油、橄榄油、鳄梨油、山茶花油(sasanqua oil)、蓖麻油、红花油、霍霍巴油、向日葵油、杏仁油、菜籽油、芝麻油、大豆油和花生油。Vegetable oils can include, for example, linseed oil, camellia oil, macadamia oil, corn oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, jojoba oil, sunflower oil , Almond Oil, Canola Oil, Sesame Oil, Soybean Oil, and Peanut Oil.
动物油可包括例如角鲨烯和角鲨烷。Animal oils may include, for example, squalene and squalane.
该油可为烃油、硅油或氟油(fluoro oil)。烃油可包括烷烃油、酯油、醚油和甘油三酯油。The oil may be hydrocarbon oil, silicone oil or fluoro oil. Hydrocarbon oils may include paraffin oils, ester oils, ether oils and triglyceride oils.
酯油优选是饱和的或不饱和的、直链或支链C1-C26脂族一元酸或多元酸和饱和的或不饱和的、直链或支链C1-C26脂族一元醇或多元醇的液体酯,所述酯的碳原子的总数大于或等于10。优选地,对于一元醇的酯,酯的醇部分和酸部分中的至少一种为支链的。在一元酸和一元醇的单酯中,可提及棕榈酸乙酯、棕榈酸乙基己酯、棕榈酸异丙酯、碳酸二辛酯、肉豆蔻酸烷基酯如肉豆蔻酸异丙酯或肉豆蔻酸乙酯、硬脂酸异鲸蜡酯、异壬酸2-乙基己酯、异壬酸异壬酯、新戊酸异癸酯和新戊酸异硬脂酯。也可使用C4-C22二羧酸或三羧酸和C1-C22醇的酯,以及单羧酸、二羧酸或三羧酸和非糖C4-C26二羟基、三羟基、四羟基或五羟基醇的酯。可特别提及:癸二酸二乙酯;月桂酰肌氨酸异丙酯;癸二酸二异丙酯;癸二酸双(2-乙基己基)酯;己二酸二异丙酯;己二酸二正丙酯;己二酸二辛酯;己二酸双(2-乙基己基)酯;己二酸二异硬脂酯;马来酸双(2-乙基己基)酯;柠檬酸三异丙酯;柠檬酸三异鲸蜡酯;柠檬酸三异硬脂酯;三乳酸甘油酯;三辛酸甘油酯;三(辛基十二烷醇)柠檬酸酯;三油醇柠檬酸酯;新戊二醇二庚酸酯;二甘醇二异壬酸酯。作为酯油,人们可使用C6-C30且优选C12-C22脂肪酸的糖酯和糖二酯。术语“糖”意指含有若干个醇官能团、具有或没有醛或酮官能团并且包含至少4个碳原子的携带氧的基于烃的化合物。这些糖可为单糖、寡糖或多糖。可提及的合适的糖的实例包括蔗糖(sucrose)(或蔗糖,saccharose)、葡萄糖、半乳糖、核糖、岩藻糖、麦芽糖、果糖、甘露糖、阿拉伯糖、木糖和乳糖,及其衍生物,尤其是烷基衍生物,例如甲基衍生物,例如甲基葡萄糖。脂肪酸的糖酯可尤其选自先前描述的糖和直链或支链、饱和或不饱和的C6-C30且优选C12-C22脂肪酸的酯或酯的混合物。如果它们是不饱和的,这些化合物可具有一至三个共轭或非共轭的碳-碳双键。该酯也可选自单酯、二酯、三酯、四酯和聚酯及其混合物。这些酯可为,例如,油酸酯、月桂酸酯、棕榈酸酯、肉豆蔻酸酯、山萮酸酯、椰油酸酯、硬脂酸酯、亚油酸酯、亚麻酸酯、癸酸酯和花生四烯酸酯,或其混合物例如,尤其是油棕榈酸酯(oleopalmitate)、油硬脂酸酯(oleostearate)和棕榈酸硬脂酸酯(palmitostearate)混合酯,以及季戊四醇四(乙基己酸)酯。更特别地,使用的是单酯和二酯,并且尤其是蔗糖、葡萄糖或甲基葡萄糖单油酸酯或二油酸酯、硬脂酸酯、山萮酸酯、油棕榈酸酯、亚油酸酯、亚麻酸酯和油硬脂酸酯。可提及的实例是由Amerchol公司以名称出售的产品,其是甲基葡萄糖二油酸酯。作为优选的酯油的实例,可提及,例如己二酸二异丙酯、己二酸二辛酯、己酸2-乙基己酯、月桂酸乙酯、辛酸鲸蜡酯、辛酸辛基十二烷基酯、新戊酸异癸酯、丙酸肉豆蔻酯、2-乙基己酸2-乙基己酯、辛酸2-乙基己酯、辛酸/癸酸2-乙基己酯、棕榈酸甲酯、棕榈酸乙酯、棕榈酸异丙酯、棕榈酸乙基己酯、月桂酸异己酯、月桂酸己酯、硬脂酸异鲸蜡酯、异硬脂酸异丙酯、肉豆蔻酸异丙酯、油酸异癸酯、三(2-乙基己酸)甘油酯、四(2-乙基己酸)季戊四醇酯、琥珀酸2-乙基己酯、癸二酸二乙酯、及其混合物。Ester oils are preferably saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monobasic or polyacids and saturated or unsaturated, linear or branched C 1 -C 26 aliphatic monohydric alcohols Or a liquid ester of a polyol having a total number of carbon atoms greater than or equal to 10. Preferably, for esters of monohydric alcohols, at least one of the alcohol portion and the acid portion of the ester is branched. Among the monoesters of monobasic acids and monohydric alcohols, mention may be made of ethyl palmitate, ethylhexyl palmitate, isopropyl palmitate, dioctyl carbonate, alkyl myristates such as isopropyl myristate Or ethyl myristate, isocetyl stearate, 2-ethylhexyl isononanoate, isononyl isononanoate, isodecyl neopentanoate and isostearyl neopentanoate. Esters of C 4 -C 22 dicarboxylic or tricarboxylic acids and C 1 -C 22 alcohols can also be used, as well as monocarboxylic, dicarboxylic or tricarboxylic acids and non-sugar C 4 -C 26 dihydroxy, trihydroxy , esters of tetrahydric or pentahydric alcohols. Particular mention may be made of: diethyl sebacate; isopropyl lauroyl sarcosinate; diisopropyl sebacate; bis(2-ethylhexyl) sebacate; diisopropyl adipate; Di-n-propyl adipate; Dioctyl adipate; Bis(2-ethylhexyl) adipate; Diisostearyl adipate; Bis(2-ethylhexyl) maleate; Triisopropyl Citrate; Triisocetyl Citrate; Triisostearyl Citrate; Triglyceryl Triglyceride; Glyceryl Tricaprylate; Ester; Neopentyl Glycol Diheptanoate; Diethylene Glycol Diisononanoate. As ester oils one can use sugar esters and diesters of C 6 -C 30 and preferably C 12 -C 22 fatty acids. The term "sugar" means an oxygen-bearing hydrocarbon-based compound containing several alcohol functions, with or without aldehyde or ketone functions, and comprising at least 4 carbon atoms. These sugars may be monosaccharides, oligosaccharides or polysaccharides. Examples of suitable sugars that may be mentioned include sucrose (or sucrose), glucose, galactose, ribose, fucose, maltose, fructose, mannose, arabinose, xylose and lactose, and derivatives thereof substances, especially alkyl derivatives, such as methyl derivatives, such as methylglucose. Sugar esters of fatty acids may especially be selected from the previously described esters or mixtures of sugars and linear or branched, saturated or unsaturated C 6 -C 30 and preferably C 12 -C 22 fatty acids. If they are unsaturated, these compounds may have from one to three conjugated or nonconjugated carbon-carbon double bonds. The esters may also be selected from monoesters, diesters, triesters, tetraesters and polyesters and mixtures thereof. These esters may be, for example, oleate, laurate, palmitate, myristate, behenate, cocoate, stearate, linoleate, linolenate, capric acid esters and arachidonic acid esters, or mixtures thereof such as, inter alia, mixed esters of oleopalmitate, oleostearate and palmitostearate, and pentaerythritol tetrakis(ethyl caproic acid) ester. More particularly mono- and diesters are used, and especially sucrose, glucose or methyl glucose mono- or di-oleate, stearate, behenate, oleyl palmitate, linoleic acid Esters, Linolenates and Oleostearates. An example that may be mentioned is the company Amerchol under the name The product sold, which is methyl glucose dioleate. As examples of preferred ester oils, mention may be made, for example, of diisopropyl adipate, dioctyl adipate, 2-ethylhexyl caproate, ethyl laurate, cetyl caprylate, octyl caprylate Lauryl Ester, Isodecyl Neopentanoate, Myristyl Propionate, 2-Ethylhexyl 2-Ethylhexanoate, 2-Ethylhexyl Octanoate, 2-Ethylhexyl Caprylate/Caprate , methyl palmitate, ethyl palmitate, isopropyl palmitate, ethylhexyl palmitate, isohexyl laurate, hexyl laurate, isocetyl stearate, isopropyl isostearate, Isopropyl myristate, Isodecyl Oleate, Glyceryl Tris(2-Ethylhexanoate), Pentaerythritol Tetrakis(2-Ethylhexanoate), 2-Ethylhexyl Succinate, Disebacate Ethyl esters, and mixtures thereof.
甘油三酯可包括人工甘油三酯,例如,甘油三肉豆蔻酸酯、甘油三棕榈酸酯、甘油三亚麻酸酯、甘油三月桂酸酯、甘油三癸酸酯、甘油三辛酸酯、甘油三(癸酸酯/辛酸酯)和甘油三(癸酸酯/辛酸酯/亚麻酸酯)。Triglycerides may include artificial triglycerides such as, trimyristyl, tripalmitin, trilinolenate, trilaurin, tricaprin, tricaprylycerin, glycerin Tris(caprate/caprylate) and triglycerides(caprate/caprylate/linolenate).
作为硅油,可提及,例如直链有机聚硅氧烷如二甲基聚硅氧烷、甲基苯基聚硅氧烷、甲基氢聚硅氧烷等等;环状有机聚硅氧烷如八甲基环四硅氧烷、十甲基环五硅氧烷、十二甲基环六硅氧烷等等;及其混合物。优选地,硅油选自液体聚二烷基硅氧烷,尤其是液体聚二甲基硅氧烷(PDMS)和包含至少一个芳基的液体聚有机硅氧烷。这些硅油还可以是有机改性的。按照本发明可使用的有机改性的硅酮是如上定义且在它们的结构中包括一个或更多个经由基于烃的基团连接的有机官能团的硅油。有机聚硅氧烷被更详细地定义于Walter Noll的硅氧烷化学和技术(Chemistry and Technology of Silicones)(1968),Academic Press中。它们可为挥发性的或非挥发性的。可使用挥发性的或非挥发性的硅油,如在环境温度下为液体或糊状的包含直链或环状硅酮链的挥发性的或非挥发性的聚二甲基硅氧烷(PDMS),特别是环聚二甲基硅氧烷(cyclopolydimethylsiloxane)(环聚二甲基硅氧烷,cyclomethicone)如环己硅氧烷;包含烷基、烷氧基或苯基的聚二甲基硅氧烷,所述烷基、烷氧基或苯基在硅酮链的侧链上或末端,所述基团具有2至24个碳原子;苯基硅氧烷如苯基三甲基聚硅氧烷(phenyl trimethicone)、苯基二甲基聚硅氧烷(phenyl dimethicone)、苯基三甲基甲硅烷氧基二苯基硅氧烷、二苯基二甲基聚硅氧烷、二苯基甲基二苯基三硅氧烷、2-苯基乙基三甲基甲硅烷氧基硅酸酯和聚甲基苯基硅氧烷。As the silicone oil, there may be mentioned, for example, linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane and the like; cyclic organopolysiloxanes Such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, etc.; and mixtures thereof. Preferably, the silicone oil is selected from liquid polydialkylsiloxanes, especially liquid polydimethylsiloxanes (PDMS) and liquid polyorganosiloxanes comprising at least one aromatic group. These silicone oils may also be organomodified. Organomodified silicones usable according to the invention are silicone oils as defined above and comprising in their structure one or more organofunctional groups linked via hydrocarbon-based groups. Organopolysiloxanes are defined in more detail in Walter Noll, Chemistry and Technology of Silicones (1968), Academic Press. They can be volatile or nonvolatile. Volatile or non-volatile silicone oils can be used, such as volatile or non-volatile polydimethylsiloxane (PDMS) containing linear or cyclic silicone chains, which are liquid or pasty at ambient temperature. ), especially cyclopolydimethylsiloxane (cyclopolydimethylsiloxane, cyclomethicone) such as cyclohexasiloxane; polydimethylsiloxane containing alkyl, alkoxy or phenyl Oxane, the alkyl, alkoxy or phenyl group is on the side chain or terminal of the silicone chain, said group has 2 to 24 carbon atoms; phenylsiloxane such as phenyltrimethicone Phenyl trimethicone, phenyl dimethicone, phenyl trimethylsiloxy diphenyl siloxane, diphenyl dimethyl polysiloxane, diphenyl phenylmethyldiphenyltrisiloxane, 2-phenylethyltrimethylsiloxysilicate and polymethylphenylsiloxane.
烷烃油可选自:Paraffinic oils may be selected from:
-直链或支链的,任选地环状的,C6-C16低级烷烃。可提及的实例包括己烷、十一烷、十二烷、十三烷和异链烷烃,例如异十六烷、异十二烷和异癸烷;和- Linear or branched, optionally cyclic, C 6 -C 16 lower alkanes. Examples that may be mentioned include hexane, undecane, dodecane, tridecane and isoparaffins such as isohexadecane, isododecane and isodecane; and
-含有多于16个碳原子的直链或支链烃,例如液体石蜡、液体石油膏(petroleum jelly)、聚癸烯和氢化聚异丁烯如和角鲨烷。- straight-chain or branched-chain hydrocarbons containing more than 16 carbon atoms, such as liquid paraffin, liquid petroleum jelly, polydecene and hydrogenated polyisobutene such as and squalane.
优选地,烷烃油可包括直链或支链烃如矿物油(例如,液体石蜡)、石蜡、凡士林或矿脂(petrolatum)、萘等等;氢化聚异丁烯、异二十烷和癸烯/丁烯共聚物;及其混合物。优选地,该油可选自在室温、大气压下呈液体形式的烃油。Preferably, paraffinic oils may include linear or branched chain hydrocarbons such as mineral oil (e.g., liquid paraffin), paraffin, petrolatum or petrolatum, naphthalene, and the like; hydrogenated polyisobutene, isoeicosane, and decene/butane vinyl copolymers; and mixtures thereof. Preferably, the oil may be selected from hydrocarbon oils which are in liquid form at room temperature and atmospheric pressure.
优选地,该油具有低的分子量,例如700g/mol以下,选自具有短烃链(C1-C12)的酯油(例如肉豆蔻酸异丙酯、棕榈酸异丙酯、异壬酸异壬酯和棕榈酸乙基己酯),烃油(例如异十二烷、异十六烷和角鲨烷),支链和/或不饱和脂肪醇(C12-C30)类型的油,如辛基十二烷醇、油醇,和醚油如二辛基醚。Preferably, the oil has a low molecular weight, e.g. below 700 g/mol, selected from ester oils with short hydrocarbon chains (C 1 -C 12 ) (e.g. isopropyl myristate, isopropyl palmitate, isononanoic acid isononyl and ethylhexyl palmitate), hydrocarbon oils (such as isododecane, isohexadecane and squalane), oils of the branched and/or unsaturated fatty alcohol (C 12 -C 30 ) type , such as octyldodecanol, oleyl alcohol, and ether oils such as dioctyl ether.
该油可选自植物油、动物油、矿物油、合成油、硅油和烃油,优选选自酯油、醚油、烷烃油和甘油三酯油的烃油。The oil may be selected from vegetable oils, animal oils, mineral oils, synthetic oils, silicone oils and hydrocarbon oils, preferably hydrocarbon oils selected from ester oils, ether oils, paraffin oils and triglyceride oils.
本发明的组合物中的油的量不受限制,并且相对于组合物的总重量,可在0.1重量%至50重量%、优选0.5重量%至40重量%、且更优选5重量%至30重量%范围内。The amount of oil in the composition of the invention is not limited and may range from 0.1% to 50% by weight, preferably from 0.5% to 40% by weight, and more preferably from 5% to 30% by weight, relative to the total weight of the composition. in the weight % range.
1-2.非离子表面活性剂1-2. Nonionic surfactant
本发明的组合物包含至少一种非离子表面活性剂。可使用单一类型的非离子表面活性剂,但可组合使用两种或更多种不同类型的非离子表面活性剂。The compositions of the present invention comprise at least one nonionic surfactant. A single type of nonionic surfactant may be used, but two or more different types of nonionic surfactants may be used in combination.
非离子表面活性剂不受限制,但可具有8.0至14.0、优选9.0至13.5且更优选10.0至13.0的HLB(亲水性亲油性平衡)值。如果使用两种或更多种非离子表面活性剂,通过全部非离子表面活性剂的HLB值的重量平均确定HLB值。The nonionic surfactant is not limited, but may have an HLB (Hydrophile-Lipophile Balance) value of 8.0 to 14.0, preferably 9.0 to 13.5, and more preferably 10.0 to 13.0. If two or more nonionic surfactants are used, the HLB value is determined by weight average of the HLB values of all nonionic surfactants.
非离子表面活性剂可选自:Nonionic surfactants may be selected from:
(1)在低于或等于45℃的温度下为流体的表面活性剂,选自至少一种多元醇和至少一种脂肪酸的酯,所述多元醇选自包含1至60个氧化乙烯单元的聚乙二醇、脱水山梨醇、包含2至30个氧化乙烯单元的甘油、包含2至12个甘油单元的聚甘油,所述脂肪酸包含至少一种饱和或不饱和的、直链或支链C8-C22烷基链,(1) Surfactants that are fluid at temperatures lower than or equal to 45°C, selected from esters of at least one polyol and at least one fatty acid selected from polyols containing 1 to 60 ethylene oxide units Ethylene glycol, sorbitan, glycerol containing 2 to 30 ethylene oxide units, polyglycerol containing 2 to 12 glycerol units, the fatty acid containing at least one saturated or unsaturated, linear or branched C8 -C22 Alkyl chain,
(2)脂肪酸或脂肪醇、羧酸和甘油的混合酯,(2) Mixed esters of fatty acids or fatty alcohols, carboxylic acids and glycerol,
(3)糖的脂肪酸酯和糖的脂肪醇醚,(3) Fatty acid esters of sugar and fatty alcohol ethers of sugar,
(4)在低于或等于45℃的温度下为固体的表面活性剂,选自甘油的脂肪酸酯、脱水山梨醇的脂肪酸酯和脱水山梨醇的氧乙烯化脂肪酸酯、乙氧基化脂肪醚和乙氧基化脂肪酸酯,(4) A surfactant that is solid at a temperature lower than or equal to 45°C, selected from fatty acid esters of glycerol, fatty acid esters of sorbitan, and oxyethylenated fatty acid esters of sorbitan, ethoxylated Fatty ethers and ethoxylated fatty acid esters,
(5)氧化乙烯(A)和氧化丙烯(B)的嵌段共聚物,和(5) block copolymers of ethylene oxide (A) and propylene oxide (B), and
(6)硅酮表面活性剂。(6) Silicone surfactants.
(1)在低于或等于45℃的温度下为流体的表面活性剂可特别是:(1) Surfactants that are fluid at temperatures below or equal to 45°C may be, inter alia:
-分子量为400的聚乙二醇的异硬脂酸酯,由Unichema公司以名称PEG 400出售;- isostearate of polyethylene glycol with a molecular weight of 400, sold under the name PEG 400 by the company Unichema;
-二甘油异硬脂酸酯,由Solvay公司出售;- diglyceryl isostearate, sold by the company Solvay;
-包含2个甘油单元的甘油月桂酸酯,由Solvay公司出售;- glyceryl laurate containing 2 glycerol units, sold by the company Solvay;
-脱水山梨醇油酸酯,由ICI公司以名称Span 80出售;- sorbitan oleate, sold under the name Span 80 by the company ICI;
-脱水山梨醇异硬脂酸酯,由Nikko公司以名称Nikkol SI 10R出售;和- sorbitan isostearate, sold under the name Nikkol SI 10R by the company Nikko; and
-α-丁基葡糖苷椰油酸酯或α-丁基葡糖苷癸酸酯,由Ulice公司出售。- Alpha-Butyl Glucoside Cocoate or Alpha-Butyl Glucoside Caprate, sold by the company Ulice.
(2)脂肪酸或脂肪醇、羧酸和甘油的混合酯(其可用作上述非离子表面活性剂)可特别地选自具有含8至22个碳原子的烷基链的脂肪酸或脂肪醇和α-羟基酸和/或琥珀酸与甘油的混合酯。所述α-羟基酸可为,例如柠檬酸、乳酸、乙醇酸或苹果酸及其混合物。(2) Mixed esters of fatty acids or fatty alcohols, carboxylic acids and glycerol (which can be used as the above-mentioned nonionic surfactants) can be selected especially from fatty acids or fatty alcohols having an alkyl chain of 8 to 22 carbon atoms and α - Mixed esters of hydroxy acids and/or succinic acid with glycerol. The alpha-hydroxy acid may be, for example, citric, lactic, glycolic or malic acid and mixtures thereof.
可用于本发明的纳米乳液中的混合酯所衍生自的脂肪酸或醇的烷基链可为直链或支链,并且饱和或不饱和的。它们可特别是硬脂酸酯、异硬脂酸酯、亚油酸酯、油酸酯、山萮酸酯、花生四烯酸酯、棕榈酸酯、肉豆蔻酸酯、月桂酸酯、癸酸酯、异硬脂基、硬脂基、亚油基(linoleyl)、油基、山萮基、肉豆蔻基、月桂基或辛基链,及其混合物。The alkyl chains of the fatty acids or alcohols from which the mixed esters useful in the nanoemulsions of the invention are derived can be straight or branched and saturated or unsaturated. They may be especially stearates, isostearates, linoleates, oleates, behenates, arachidonates, palmitates, myristates, laurates, capric acids Esters, isostearyl, stearyl, linoleyl, oleyl, behenyl, myristyl, lauryl or octyl chains, and mixtures thereof.
作为可在本发明的纳米乳液中使用的混合酯的实例,可提及由Hüls公司以名称Imwitor 375出售的甘油和柠檬酸、乳酸、亚油酸和油酸的混合物的混合酯(CTFA名称:甘油柠檬酸酯/乳酸酯/亚油酸酯/油酸酯);由Hüls公司以名称Imwitor 780K出售的琥珀酸和异硬脂醇与甘油的混合酯(CTFA名称:异硬脂醇二甘油琥珀酸酯);由Hüls公司以名称Imwitor 370出售的柠檬酸和硬脂酸与甘油的混合酯(CTFA名称:甘油硬脂酸酯柠檬酸酯);由Danisco公司以名称Lactodan B30或Rylo LA30出售的乳酸和硬脂酸与甘油的混合酯(CTFA名称:甘油硬脂酸酯乳酸酯)。As an example of a mixed ester that can be used in the nanoemulsion according to the invention, mention may be made of the mixed ester of glycerol and a mixture of citric, lactic, linoleic and oleic acids sold under the name Imwitor 375 by the company Hüls (CTFA name: Glyceryl Citrate/Lactate/Linoleate/Oleate); succinic acid and mixed esters of isostearyl alcohol and glycerol sold under the name Imwitor 780K by the company Hüls (CTFA name: Isostearyl Diglycerol succinate); citric and stearic acid mixed esters with glycerol sold under the name Imwitor 370 by the company Hüls (CTFA name: Glyceryl Stearate Citrate); sold under the name Lactodan B30 or Rylo LA30 by the company Danisco Mixed esters of lactic and stearic acids with glycerin (CTFA name: Glyceryl Stearate Lactate).
(3)糖的脂肪酸酯(其可用作上述的非离子表面活性剂)可优选在低于或等于45℃的温度下为固体并且可特别地选自C8-C22脂肪酸和蔗糖、麦芽糖、葡萄糖或果糖的酯或酯的混合物,以及C14-C22脂肪酸和甲基葡萄糖的酯或酯的混合物。(3) Fatty acid esters of sugars (which can be used as the above-mentioned nonionic surfactants) may preferably be solid at a temperature lower than or equal to 45° C. and may be particularly selected from C 8 -C 22 fatty acids and sucrose, Esters or mixtures of esters of maltose, glucose or fructose, and esters or mixtures of esters of C 14 -C 22 fatty acids and methylglucose.
形成所述酯的脂肪单元的C8-C22或C14-C22脂肪酸包含分别含有8至22或14至22个碳原子的饱和或不饱和的直链烷基链。所述酯的脂肪单元可特别地选自硬脂酸酯、山萮酸酯、花生四烯酸酯、棕榈酸酯、肉豆蔻酸酯、月桂酸酯和癸酸酯及其混合物。硬脂酸酯是优选使用的。 The C8- C22 or C14 - C22 fatty acid forming the fatty unit of the ester comprises a saturated or unsaturated linear alkyl chain containing 8 to 22 or 14 to 22 carbon atoms, respectively. The fatty units of the esters may in particular be chosen from stearates, behenates, arachidonates, palmitates, myristates, laurates and caprates, and mixtures thereof. Stearic acid esters are preferably used.
作为脂肪酸和蔗糖、麦芽糖、葡萄糖或果糖的酯或酯的混合物的实例,可提及蔗糖单硬脂酸酯、蔗糖二硬脂酸酯和蔗糖三硬脂酸酯及其混合物,如由Croda公司以名称Crodesta F50、F70、F110和F160出售的产品;且可提及的脂肪酸和甲基葡萄糖的酯或酯的混合物的实例是由Goldschmidt公司以名称Tego-care 450出售的甲基葡萄糖聚甘油-3二硬脂酸酯。还可提及葡萄糖或麦芽糖单酯,如甲基o-十六酰基-6-D-葡糖苷(methyl o-hexadecanoyl-6-D-glucoside)和o-十六酰基-6-D-麦芽糖苷。As examples of esters or mixtures of esters of fatty acids and sucrose, maltose, glucose or fructose, mention may be made of sucrose monostearate, sucrose distearate and sucrose tristearate and mixtures thereof, as sold by the company Croda Products sold under the names Crodesta F50, F70, F110 and F160; and examples of esters or mixtures of esters of fatty acids and methylglucose that may be mentioned are methylglucose polyglycerol sold under the name Tego-care 450 by the company Goldschmidt- 3 distearate. Mention may also be made of glucose or maltose monoesters such as methyl o-hexadecanoyl-6-D-glucoside and o-hexadecanoyl-6-D-maltoside .
(3)糖的脂肪醇醚(其可用作上述的非离子表面活性剂)可在低于或等于45℃的温度下为固体并且可特别选自C8-C22脂肪醇和葡萄糖、麦芽糖、蔗糖或果糖的醚或醚的混合物,以及C14-C22脂肪醇和甲基葡萄糖的醚或醚的混合物。这些特别是烷基多葡糖苷。(3) Fatty alcohol ethers of sugars (which can be used as the above-mentioned nonionic surfactants) can be solid at a temperature lower than or equal to 45° C. and can be selected especially from C 8 -C 22 fatty alcohols and glucose, maltose, Ethers or mixtures of ethers of sucrose or fructose, and ethers or mixtures of ethers of C 14 -C 22 fatty alcohols and methylglucose. These are especially alkyl polyglucosides.
形成可在本发明的纳米乳液中使用的醚的脂肪单元的C8-C22或C14-C22脂肪醇包含分别含有8至22或14至22个碳原子的饱和或不饱和的直链烷基链。所述醚的脂肪单元可特别选自癸基、鲸蜡基、山萮基、花生基、硬脂基、棕榈基、肉豆蔻基、月桂基、辛基和十六酰基单元,及其混合物,如鲸蜡硬脂基。The C 8 -C 22 or C 14 -C 22 fatty alcohols forming the fatty units of the ethers usable in the nanoemulsions of the invention comprise saturated or unsaturated linear chains containing 8 to 22 or 14 to 22 carbon atoms, respectively. Alkyl chain. The fatty units of the ethers may in particular be selected from decyl, cetyl, behenyl, arachidyl, stearyl, palmityl, myristyl, lauryl, octyl and palmityl units, and mixtures thereof, Such as cetearyl.
作为糖的脂肪醇醚,例如,可提及烷基多葡糖苷,例如由例如Henkel公司分别以名称Plantaren 2000和Plantaren 1200出售的癸基葡糖苷和月桂基葡糖苷,鲸蜡硬脂基葡糖苷(任选地作为与鲸蜡硬脂醇的混合物),例如由SEPPIC公司以名称Montanov 68出售,由Goldschmidt公司以名称Tego-care CG90出售和由Henkel公司以名称Emulgade KE3302出售,以及花生基葡糖苷,例如以花生醇和山萮醇和花生基葡糖苷的混合物的形式,由SEPPIC公司以名称Montanov 202出售。As fatty alcohol ethers of sugars, mention may be made, for example, of alkyl polyglucosides, such as decyl glucoside and lauryl glucoside, cetearyl glucoside, sold for example under the names Plantaren 2000 and Plantaren 1200, respectively, by the company Henkel (optionally as a mixture with cetearyl alcohol), for example sold under the name Montanov 68 by the company SEPPIC, Tego-care CG90 by the company Goldschmidt and Emulgade KE3302 by the company Henkel, and arachidyl glucoside , sold for example under the name Montanov 202 by the company SEPPIC in the form of arachidyl alcohol and a mixture of behenyl alcohol and arachidyl glucoside.
使用的表面活性剂更特别地为蔗糖单硬脂酸酯、蔗糖二硬脂酸酯或蔗糖三硬脂酸酯及其混合物、甲基葡萄糖聚甘油-3二硬脂酸酯和烷基多葡糖苷。The surfactants used are more particularly sucrose monostearate, sucrose distearate or sucrose tristearate and mixtures thereof, methylglucose polyglyceryl-3 distearate and alkylpolyglucose glycosides.
(4)在低于或等于45℃的温度下为固体的甘油的脂肪酸酯(其可用作上述的非离子表面活性剂)可特别地选自由至少一种酸(其包含含有12至22个碳原子的饱和直链烷基链)和1至12个甘油单元形成的酯。这些甘油的脂肪酸酯中的一种或更多种可用于本发明中。(4) Fatty acid esters of glycerin which are solid at a temperature lower than or equal to 45° C. (which can be used as the above-mentioned nonionic surfactant) can be selected from at least one acid (which contains 12 to 22 a saturated linear alkyl chain of 2 carbon atoms) and an ester of 1 to 12 glycerol units. One or more of these fatty acid esters of glycerol can be used in the present invention.
这些酯可特别选自硬脂酸酯、山萮酸酯、花生酸酯和棕榈酸酯及其混合物。硬脂酸酯和棕榈酸酯是更优选使用的。These esters may in particular be chosen from stearates, behenates, arachidates and palmitates and mixtures thereof. Stearates and palmitates are more preferably used.
作为可在本发明中使用的表面活性剂,例如,可提及十甘油单硬脂酸酯、二硬脂酸酯、三硬脂酸酯和五硬脂酸酯(CTFA名称:聚甘油-10硬脂酸酯,聚甘油-10二硬脂酸酯,聚甘油-10三硬脂酸酯,聚甘油-10五硬脂酸酯),如由Nikko公司分别以名称Nikkol Decaglyn 1-S、2-S、3-S和5-S出售的产品,和二甘油单硬脂酸酯(CTFA名称:聚甘油-2硬脂酸酯),如由Nikko公司以名称Nikkol DGMS出售的产品。As surfactants usable in the present invention, for example, decaglyceryl monostearate, distearate, tristearate, and pentastearate (CTFA name: polyglyceryl-10 stearate, polyglyceryl-10 distearate, polyglyceryl-10 tristearate, polyglyceryl-10 pentastearate), such as Nikkol Decaglyn 1-S, 2 - the products sold as S, 3-S and 5-S, and diglyceryl monostearate (CTFA name: polyglyceryl-2 stearate), such as the product sold under the name Nikkol DGMS by the company Nikko.
(4)在低于或等于45℃的温度下为固体的脱水山梨醇的脂肪酸酯(其可用作上述的非离子表面活性剂)可选自脱水山梨醇的C16-C22脂肪酸酯和脱水山梨醇的氧乙烯化C16-C22脂肪酸酯。它们由至少一种脂肪酸和山梨糖醇或乙氧基化山梨糖醇形成,所述至少一种脂肪酸包含分别含有16至22个碳原子的至少一种饱和的直链烷基链。所述氧乙烯化酯通常包含1至100个乙二醇单元以及优选2至40个氧化乙烯(EO)单元。(4) Fatty acid esters of sorbitan that are solid at a temperature lower than or equal to 45° C. (which can be used as the above-mentioned nonionic surfactant) may be selected from C 16 -C 22 fatty acids of sorbitan Esters and oxyethylenated C 16 -C 22 fatty acid esters of sorbitan. They are formed from at least one fatty acid comprising at least one saturated linear alkyl chain each containing 16 to 22 carbon atoms and sorbitol or ethoxylated sorbitol. The oxyethylenated esters generally contain 1 to 100 ethylene glycol units and preferably 2 to 40 ethylene oxide (EO) units.
这些酯可特别地选自硬脂酸酯、山萮酸酯、花生酸酯、棕榈酸酯及其混合物。硬脂酸酯和棕榈酸酯是优选使用的。These esters may in particular be chosen from stearates, behenates, arachidates, palmitates and mixtures thereof. Stearates and palmitates are preferably used.
作为可在本发明中使用的上述的非离子表面活性剂的实例,可提及脱水山梨醇单硬脂酸酯(CTFA名称:脱水山梨醇硬脂酸酯),由ICI公司以名称Span 60出售、脱水山梨醇单棕榈酸酯(CTFA名称:脱水山梨醇棕榈酸酯),由ICI公司以名称Span 40出售、和脱水山梨醇三硬脂酸酯20EO(CTFA名称:聚山梨醇酯65),由ICI公司以名称Tween 65出售。As an example of the aforementioned nonionic surfactants that can be used in the present invention, mention may be made of sorbitan monostearate (CTFA name: sorbitan stearate), sold under the name Span 60 by the company ICI , sorbitan monopalmitate (CTFA name: sorbitan palmitate), sold by ICI Corporation under the name Span 40, and sorbitan tristearate 20EO (CTFA name: polysorbate 65), Sold under the name Tween 65 by ICI Corporation.
(4)在低于或等于45℃的温度下为固体的乙氧基化脂肪醚(其可用作上述的非离子表面活性剂)优选为由1至100个氧化乙烯单元和至少一种含有16至22个碳原子的脂肪醇链形成的醚。所述醚的脂肪链可特别选自山萮基、花生基、硬脂基和鲸蜡基单元及其混合物,如鲸蜡硬脂基。可提及的乙氧基化脂肪醚的实例是包含5、10、20和30个氧化乙烯单元的山萮醇醚(CTFA名称:山萮醇聚醚-5、山萮醇聚醚-10、山萮醇聚醚-20、山萮醇聚醚-30),如由Nikko公司以名称Nikkol BB5、BB10、BB20和BB30出售的产品,和包含2个氧化乙烯单元的硬脂醇醚(CTFA名称:硬脂醇聚醚-2),如由ICI公司以名称Brij 72出售的产品。(4) The ethoxylated fatty ether (which can be used as the above-mentioned nonionic surfactant) which is solid at a temperature lower than or equal to 45° C. is preferably composed of 1 to 100 ethylene oxide units and at least one Ethers formed from fatty alcohol chains of 16 to 22 carbon atoms. The fatty chain of the ether may in particular be selected from behenyl, arachidyl, stearyl and cetyl units and mixtures thereof, such as cetearyl. Examples of ethoxylated fatty ethers that may be mentioned are behenyl ethers comprising 5, 10, 20 and 30 ethylene oxide units (CTFA names: Beheneth-5, Beheneth-10, Beheneth-20, Beheneth-30), such as the products sold by the company Nikko under the names Nikkol BB5, BB10, BB20 and BB30, and stearyl ethers comprising 2 ethylene oxide units (CTFA name : Steareth-2), such as the product sold under the name Brij 72 by the company ICI.
(4)在低于或等于45℃的温度下为固体的乙氧基化脂肪酸酯(其可用作上述的非离子表面活性剂)是由1至100个氧化乙烯单元和至少一种含有16至22个碳原子的脂肪酸链形成的酯。所述酯中的脂肪链可特别选自硬脂酸酯、山萮酸酯、花生酸酯和棕榈酸酯单元及其混合物。可提及的乙氧基化脂肪酸酯的实例是包含40个氧化乙烯单元的硬脂酸的酯,例如由ICI公司以名称Myrj 52(CTFA名称:PEG-40硬脂酸酯)出售的产品,以及包含8个氧化乙烯单元的山萮酸的酯(CTFA名称:PEG-8山萮酸酯),例如由Gattefosse公司以名称Compritol HD5ATO出售的产品。(4) Ethoxylated fatty acid esters solid at temperatures lower than or equal to 45°C (which can be used as the above-mentioned nonionic surfactants) are composed of 1 to 100 ethylene oxide units and at least one type containing Esters formed from fatty acid chains of 16 to 22 carbon atoms. The fatty chain in the ester may in particular be selected from stearate, behenate, arachidate and palmitate units and mixtures thereof. Examples of ethoxylated fatty acid esters that may be mentioned are esters of stearic acid comprising 40 ethylene oxide units, such as the product sold under the name Myrj 52 (CTFA name: PEG-40 Stearate) by the company ICI , and esters of behenic acid comprising 8 ethylene oxide units (CTFA name: PEG-8 behenate), such as the product sold under the name Compritol HD5ATO by the company Gattefosse.
(5)氧化乙烯(A)和氧化丙烯(B)的嵌段共聚物(其可用作根据本发明的纳米乳液中的表面活性剂)可特别选自式(I)的嵌段共聚物及其混合物:(5) Block copolymers of ethylene oxide (A) and propylene oxide (B), which can be used as surfactants in the nanoemulsions according to the invention, can be selected especially from block copolymers of formula (I) and Its mixture:
[式(I)][Formula (I)]
HO(C2H4O)x(C3H6O)y(C2H4O)zH (I)HO(C 2 H 4 O) x (C 3 H 6 O) y (C 2 H 4 O) z H (I)
其中x、y和z是整数,使得x+z在2至100范围内并且y在14至60范围内,并且更特别地选自具有在8.0至14范围内的HLB值的式(IV)的嵌段共聚物。wherein x, y and z are integers such that x+z is in the range of 2 to 100 and y is in the range of 14 to 60, and is more particularly selected from formula (IV) having an HLB value in the range of 8.0 to 14 block copolymers.
作为可根据本发明使用的(6)硅酮表面活性剂,例如,可提及在文献US-A-5364633和US-A-5411744中公开的那些。As the (6) silicone surfactant usable according to the present invention, for example, those disclosed in documents US-A-5364633 and US-A-5411744 can be mentioned.
作为上述的非离子表面活性剂的(6)硅酮表面活性剂可优选为式(II)的化合物:The (6) silicone surfactant as the above-mentioned nonionic surfactant may preferably be a compound of formula (II):
[式(II)][Formula (II)]
其中:in:
R1、R2和R3彼此独立地代表C1-C6烷基或基团R 1 , R 2 and R 3 independently represent C 1 -C 6 alkyl groups or groups
-(CH2)x-(OCH2CH2)y-(OCH2CH2CH2)z-OR4,基团R1、R2或R3中的至少一个不是烷基;R4是氢、烷基或酰基;-(CH 2 ) x -(OCH 2 CH 2 ) y -(OCH 2 CH 2 CH 2 ) z -OR 4 , at least one of the groups R 1 , R 2 or R 3 is not alkyl; R 4 is hydrogen , alkyl or acyl;
A是在0至200范围内的整数;A is an integer in the range of 0 to 200;
B是在0至50范围内的整数;条件是A和B不同时等于零;B is an integer in the range 0 to 50; provided that A and B are not simultaneously equal to zero;
x是在1至6范围内的整数;x is an integer in the range 1 to 6;
y是在1至30范围内的整数;y is an integer in the range 1 to 30;
z是在0至5范围内的整数。z is an integer ranging from 0 to 5.
在优选的实施方案中,在式(II)的化合物中,烷基是甲基,x是在2至6范围内的整数,且y是在4至30范围内的整数。In a preferred embodiment, in the compound of formula (II), alkyl is methyl, x is an integer ranging from 2 to 6, and y is an integer ranging from 4 to 30.
作为式(II)的硅酮表面活性剂,例如,可提及式(III)的化合物:As silicone surfactants of formula (II), for example, compounds of formula (III) may be mentioned:
[式(III)][Formula (III)]
其中A是在20至105范围内的整数,B是在2至10范围内的整数,并且y是在10至20范围内的整数。wherein A is an integer ranging from 20 to 105, B is an integer ranging from 2 to 10, and y is an integer ranging from 10 to 20.
作为式(II)的硅酮表面活性剂的实例,也可提及式(IV)的化合物:As examples of silicone surfactants of formula (II), mention may also be made of compounds of formula (IV):
[式(IV)][Formula (IV)]
H-(OCH2CH2)y-(CH2)3-[(CH3)2SiO]A’-(CH2)3-(OCH2CH2)y-OH (IV)H-(OCH 2 CH 2 ) y -(CH 2 ) 3 -[(CH 3 ) 2 SiO] A' -(CH 2 ) 3 -(OCH 2 CH 2 ) y -OH (IV)
其中A'和y是在10至20范围内的整数。where A' and y are integers in the range of 10 to 20.
可使用的本发明的化合物是由Dow Corning公司以名称DC 5329、DC7439-146、DC 2-5695和Q4-3667出售的那些。所述化合物DC 5329、DC 7439-146和DC 2-5695是式(II)的化合物,其中,分别地,A是22,B是2,并且y是12;A是103,B是10,并且y是12;A是27,B是3,并且y是12。Compounds of the invention which may be used are those sold by the company Dow Corning under the names DC 5329, DC7439-146, DC 2-5695 and Q4-3667. Said compounds DC 5329, DC 7439-146 and DC 2-5695 are compounds of formula (II), wherein, respectively, A is 22, B is 2, and y is 12; A is 103, B is 10, and y is 12; A is 27, B is 3, and y is 12.
化合物Q4-3667是式(III)的化合物,其中A是15并且y是13。Compound Q4-3667 is a compound of formula (III), wherein A is 15 and y is 13.
优选地,非离子表面活性剂可选自:Preferably, nonionic surfactants may be selected from:
-聚乙二醇异硬脂酸酯或油酸酯(8至10mol的氧化乙烯),- macrogol isostearate or oleate (8 to 10 mol of ethylene oxide),
-聚乙二醇异鲸蜡基醚、山萮基醚或异硬脂基醚(8至10mol的氧化乙烯),- polyethylene glycol isocetyl ether, behenyl ether or isostearyl ether (8 to 10 mol of ethylene oxide),
-包含3至6个甘油单元的聚甘油单月桂酸酯或二月桂酸酯,- polyglycerol monolaurate or dilaurate containing 3 to 6 glycerol units,
-包含3至6个甘油单元的聚甘油单(异)硬脂酸酯,- polyglycerol mono(iso)stearate containing 3 to 6 glycerol units,
-包含3至6个甘油单元的聚甘油单油酸酯,和- polyglycerol monooleate comprising 3 to 6 glycerol units, and
-包含3至6个甘油单元的聚甘油二油酸酯。- Polyglycerol dioleate comprising 3 to 6 glycerol units.
优选地,非离子表面活性剂选自聚甘油脂肪酸酯和单或聚氧烯化脂肪酸酯。Preferably, the nonionic surfactant is selected from polyglycerol fatty acid esters and mono- or polyoxyalkylenated fatty acid esters.
优选地,聚甘油脂肪酸酯包括含有70%或更多的聚合度为4或更大的聚甘油的脂肪酸和聚甘油的酯,优选含有等于或大于60%的聚合度在4和11之间的聚甘油的脂肪酸和聚甘油的酯,并且更优选含有等于或大于30%的聚合度为5的聚甘油的脂肪酸和聚甘油的酯。Preferably, polyglycerol fatty acid esters include esters of fatty acids and polyglycerols containing 70% or more of polyglycerol with a degree of polymerization of 4 or more, preferably 60% or more of polyglycerol with a degree of polymerization between 4 and 11 fatty acid of polyglycerol and ester of polyglycerol, and more preferably contains fatty acid of polyglycerol and ester of polyglycerol with a degree of polymerization of 5 equal to or greater than 30%.
聚甘油脂肪酸酯可选自包含2至30个碳原子、优选6至30个碳原子并且更优选8至30个碳原子的饱和的或不饱和的酸,优选饱和的酸,例如月桂酸、油酸、硬脂酸、异硬脂酸、癸酸、辛酸和肉豆蔻酸的单酯、二酯和三酯。Polyglycerol fatty acid esters may be selected from saturated or unsaturated acids, preferably saturated acids, containing 2 to 30 carbon atoms, preferably 6 to 30 carbon atoms and more preferably 8 to 30 carbon atoms, such as lauric acid, Monoesters, Diesters and Triesters of Oleic, Stearic, Isostearic, Capric, Caprylic and Myristic Acids.
聚甘油脂肪酸酯可具有衍生自2至10个甘油、更优选3或4至6个甘油且进一步更优选5或6个甘油的聚甘油部分。The polyglycerol fatty acid ester may have a polyglycerol moiety derived from 2 to 10 glycerols, more preferably 3 or 4 to 6 glycerols and still more preferably 5 or 6 glycerols.
优选地,聚甘油(PG)脂肪酸酯可选自PG-4月桂酸酯、PG-5月桂酸酯、PG-5二月桂酸酯、PG-5油酸酯、PG-5二油酸酯、PG-6三辛酸酯、PG-5肉豆蔻酸酯、PG-5三肉豆蔻酸酯、PG-5硬脂酸酯、PG-5异硬脂酸酯、PG-5三油酸酯、PG-6辛酸酯和PG-6三辛酸酯。Preferably, the polyglycerol (PG) fatty acid ester may be selected from PG-4 laurate, PG-5 laurate, PG-5 dilaurate, PG-5 oleate, PG-5 dioleate , PG-6 Tricaprylate, PG-5 Myristate, PG-5 Trimyristate, PG-5 Stearate, PG-5 Isostearate, PG-5 Trioleate , PG-6 Caprylate and PG-6 Tricaprylate.
优选地,单氧烯化或聚氧烯化的脂肪酸酯具有衍生自1至20个氧化烯,优选3至15个氧化烯,并且更优选8至10个氧化烯的(聚)氧化烯部分。Preferably, the monooxyalkylenated or polyoxyalkylenated fatty acid ester has a (poly)oxyalkylene moiety derived from 1 to 20 alkylene oxides, preferably 3 to 15 alkylene oxides, and more preferably 8 to 10 alkylene oxides .
氧化烯部分可衍生自亚烷基二醇如乙二醇、丙二醇、丁二醇、戊二醇、己二醇等等。氧化烯部分可包含1和100之间并且优选2和50之间的若干摩尔的氧化乙烯和/或氧化丙烯。有利地,非离子表面活性剂不包含任何氧丙烯单元。The oxyalkylene moieties can be derived from alkylene glycols such as ethylene glycol, propylene glycol, butylene glycol, pentanediol, hexylene glycol, and the like. The oxyalkylene moiety may comprise between 1 and 100 and preferably between 2 and 50 moles of ethylene oxide and/or propylene oxide. Advantageously, the nonionic surfactant does not contain any oxypropylene units.
单氧烯化或聚氧烯化的脂肪酸酯可选自包含2至30个碳原子,优选6至30个碳原子并且更优选8至30个碳原子的饱和的或不饱和的酸,优选饱和的酸,如月桂酸、油酸、硬脂酸、异硬脂酸、癸酸、辛酸和肉豆蔻酸的单酯和二酯。The monooxyalkylenated or polyoxyalkylenated fatty acid esters may be selected from saturated or unsaturated acids containing 2 to 30 carbon atoms, preferably 6 to 30 carbon atoms and more preferably 8 to 30 carbon atoms, preferably Monoesters and diesters of saturated acids such as lauric, oleic, stearic, isostearic, capric, caprylic and myristic acids.
可提及的单氧烯化或聚氧烯化的脂肪酸酯的实例包括饱和的或不饱和的、直链或支链C2-C30,优选C6-C30并且更优选C8-C22酸和聚乙二醇的酯。Examples of monooxyalkylenated or polyoxyalkylenated fatty acid esters that may be mentioned include saturated or unsaturated, linear or branched C 2 -C 30 , preferably C 6 -C 30 and more preferably C 8 - Esters of C22 acids and polyethylene glycols.
可提及的单氧烯化或聚氧烯化的脂肪酸酯的实例包括氧化乙烯与月桂酸、肉豆蔻酸、棕榈酸、硬脂酸、异硬脂酸、油酸或山萮酸的酯的加合物,及其混合物,特别是含有8至20个氧乙烯基团的那些,如PEG-8至PEG-20月桂酸酯(作为CTFA名称:PEG-8月桂酸酯至PEG-20月桂酸酯);PEG-8至PEG-20肉豆蔻酸酯(作为CTFA名称:PEG-8肉豆蔻酸酯至PEG-20肉豆蔻酸酯);PEG-8至PEG-20棕榈酸酯(作为CTFA名称:PEG-8棕榈酸酯至PEG-20棕榈酸酯);PEG-8至PEG-20硬脂酸酯(作为CTFA名称:PEG-8硬脂酸酯至PEG-20硬脂酸酯);PEG-8至PEG-20异硬脂酸酯(作为CTFA名称:PEG-8异硬脂酸酯至PEG-20异硬脂酸酯);PEG-8至PEG-20油酸酯(作为CTFA名称:PEG-8油酸酯至PEG-20油酸酯);PEG-8至PEG-20山萮酸酯(作为CTFA名称:PEG-8山萮酸酯至PEG-20山萮酸酯);及其混合物。Examples of monooxyalkylenated or polyoxyalkylenated fatty acid esters that may be mentioned include esters of ethylene oxide with lauric, myristic, palmitic, stearic, isostearic, oleic or behenic acids , and mixtures thereof, especially those containing 8 to 20 oxyethylene groups, such as PEG-8 to PEG-20 Laurate (as CTFA name: PEG-8 Laurate to PEG-20 Laurate esters); PEG-8 to PEG-20 myristate (as CTFA names: PEG-8 myristate to PEG-20 myristate); PEG-8 to PEG-20 palmitate (as CTFA Name: PEG-8 Palmitate to PEG-20 Palmitate); PEG-8 to PEG-20 Stearate (as CTFA name: PEG-8 Stearate to PEG-20 Stearate); PEG-8 to PEG-20 Isostearate (as CTFA Name: PEG-8 Isostearate to PEG-20 Isostearate); PEG-8 to PEG-20 Oleate (as CTFA Name : PEG-8 Oleate to PEG-20 Oleate); PEG-8 to PEG-20 Behenate (as CTFA names: PEG-8 Behenate to PEG-20 Behenate); and its mixture.
优选地,聚乙二醇脂肪酸酯可选自PEG-8异硬脂酸酯、PEG-8硬脂酸酯、PEG-10异硬脂酸酯、PEG-10油酸酯、PEG-10异鲸蜡基醚、PEG-10山萮基醚或PEG-10异硬脂基醚及其混合物。优选的非离子表面活性剂是聚甘油(PG)脂肪酸酯。Preferably, polyethylene glycol fatty acid esters may be selected from PEG-8 isostearate, PEG-8 stearate, PEG-10 isostearate, PEG-10 oleate, PEG-10 isostearate Cetyl ether, PEG-10 behenyl ether or PEG-10 isostearyl ether and mixtures thereof. A preferred nonionic surfactant is polyglycerol (PG) fatty acid ester.
优选地,非离子表面活性剂可选自单氧烯化或聚氧烯化的脂肪酸酯、聚甘油脂肪酸酯表面活性剂、和糖(特别是蔗糖)的脂肪酸酯。Preferably, the nonionic surfactant may be selected from monooxyalkylenated or polyoxyalkylenated fatty acid esters, polyglycerol fatty acid ester surfactants, and fatty acid esters of sugars, especially sucrose.
本发明的组合物中的非离子表面活性剂的量不受限制,并且相对组合物的总重量,可在0.1重量%至30重量%、优选0.5重量%至15重量%并且更优选1重量%至10重量%范围内。The amount of nonionic surfactant in the composition of the invention is not limited and may range from 0.1% to 30% by weight, preferably from 0.5% to 15% by weight and more preferably 1% by weight, relative to the total weight of the composition to within 10% by weight.
1-3.水相1-3. Water phase
本发明的组合物包含至少一个水相。水相包含水作为主要组分。水的量不受限制,并且相对组合物的总重量,可为5重量%至99重量%,优选10重量%至95重量%并且更优选15重量%至90重量%。The compositions of the invention comprise at least one aqueous phase. The aqueous phase contains water as a main component. The amount of water is not limited and may be 5% to 99% by weight, preferably 10% to 95% by weight and more preferably 15% to 90% by weight relative to the total weight of the composition.
水相可进一步包含至少一种有机溶剂,优选与水混溶的有机溶剂。作为有机溶剂,可提及的有,例如C1-C4烷醇如乙醇和异丙醇;芳族醇如苄醇和苯氧基乙醇;其类似产物;及其混合物。与水混溶的有机溶剂的量,相对组合物的总重量,可少于10重量%,优选5重量%或更少,并且更优选1重量%或更少。The aqueous phase may further comprise at least one organic solvent, preferably a water-miscible organic solvent. As the organic solvent, there may be mentioned, for example, C 1 -C 4 alkanols such as ethanol and isopropanol; aromatic alcohols such as benzyl alcohol and phenoxyethanol; analogous products thereof; and mixtures thereof. The amount of the water-miscible organic solvent may be less than 10% by weight, preferably 5% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.
1-4.包含可释放的着色剂的微胶囊1-4. Microcapsules comprising a releasable coloring agent
本文所用的术语“微胶囊”指包含包埋至少一种着色剂并且包围核的至少一个层状涂层的球形微胶囊,所述核与涂层在化学上不同。微胶囊不同于微球,微球由球形的均匀基质组成。The term "microcapsule" as used herein refers to a spherical microcapsule comprising at least one lamellar coating embedding at least one colorant and surrounding a core, which is chemically distinct from the coating. Microcapsules differ from microspheres, which consist of a spherical uniform matrix.
在实施方案中,所述“至少一个层状涂层”是多层涂层,优选有机多层涂层。In an embodiment, said "at least one layered coating" is a multilayer coating, preferably an organic multilayer coating.
术语“多层微胶囊”指由被基于一个或更多个内层的涂层包围的核和一个外层组成的微胶囊。形成该多层微胶囊的多层涂层的一个或更多个内层和该微胶囊的单一外层可由相同或不同的成壁有机化合物形成。The term "multilayer microcapsule" refers to a microcapsule consisting of a core surrounded by a coating based on one or more inner layers and an outer layer. The one or more inner layers forming the multilayer coating of the multilayer microcapsules and the single outer layer of the microcapsules may be formed from the same or different wall-forming organic compounds.
该微胶囊包含被基于一层或更多层的涂层包围的、也被称为“内核”的核。在优选的实施方案中,该微胶囊是“多层”微胶囊,包含至少一个内层和一个外层。形成多层微胶囊的多层涂层的一个或更多个内层和该微胶囊的单一外层可由相同或不同的成壁有机化合物形成。The microcapsules comprise a core, also called "inner core", surrounded by a coating based on one or more layers. In a preferred embodiment, the microcapsules are "multilayered" microcapsules comprising at least one inner layer and one outer layer. The one or more inner layers of the multilayer coating forming the multilayer microcapsules and the single outer layer of the microcapsules may be formed from the same or different wall-forming organic compounds.
在特定实施方案中,内层和外层由相同的成壁有机化合物形成,并且然后核被一层涂层包围。In a particular embodiment, the inner and outer layers are formed from the same wall-forming organic compound, and the core is then surrounded by a coating.
在一个实施方案中,外层不包含任何着色剂。在另一实施方案中,外层包含至少一种着色剂。In one embodiment, the outer layer does not contain any colorants. In another embodiment, the outer layer comprises at least one colorant.
术语“成壁有机化合物”指如本文定义的有机化合物或两种或更多种不同有机化合物的组合,其形成微胶囊的层的组分。在优选的实施方案中,“成壁有机化合物”包含至少一种聚合物。The term "wall-forming organic compound" refers to an organic compound as defined herein or a combination of two or more different organic compounds which form a component of the layers of the microcapsules. In a preferred embodiment, the "wall-forming organic compound" comprises at least one polymer.
在特定实施方案中,相对组合物的总重量,封装的着色剂以封装的颜料的活性物质计可以在0.5重量%至20重量%,特别在1重量%至15重量%且更特别地在2重量%至12重量%范围内的量存在于本发明的组合物中。In a particular embodiment, the encapsulated colorant may range from 0.5 wt. Amounts ranging from wt. % to 12 wt. % are present in the compositions of the invention.
微胶囊通常将在配制的最后阶段并在过滤阶段(如果有的话)以后结合到化妆品配方中,以避免微胶囊破裂。优选地,在50℃以下的温度下添加微胶囊并均匀混合。用桨状物(paddle)而不是均质器轻轻使它们混合。Microcapsules will usually be incorporated into the cosmetic formulation at the last stage of formulation and after the filtration stage (if any) to avoid microcapsule breakage. Preferably, the microcapsules are added at a temperature below 50°C and mixed uniformly. Mix them gently with a paddle instead of a homogenizer.
微胶囊可具有与水相接触、优选与亲水剂(例如水、多元醇、二元醇、醇)接触时更容易破碎的能力。有利地,微胶囊可在与下文所定义的这种亲水剂接触时溶胀。有利地,微胶囊在施用到角蛋白材料上时是可变形的,并从而向使用者提供柔软感。此外,它们的小尺寸有助于在施用时不产生任何不舒适或不适宜的感觉。Microcapsules may have the ability to break up more easily on contact with an aqueous phase, preferably a hydrophilic agent (eg, water, polyols, diols, alcohols). Advantageously, the microcapsules are swellable on contact with such hydrophilic agents as defined below. Advantageously, the microcapsules are deformable when applied to keratin materials and thereby provide a soft feel to the user. Furthermore, their small size contributes to application without any discomfort or unpleasant sensations.
然而,微胶囊足够柔软以在非常轻微地摩擦或按压皮肤时破裂以释放它们的内容物,但是,尽管如此,是足够耐用的以避免制造和储存相应组合物的过程中涂层的破坏。However, the microcapsules are soft enough to rupture to release their contents when very lightly rubbed or pressed against the skin, but are nevertheless durable enough to avoid damage to the coating during manufacture and storage of the corresponding composition.
此外,微胶囊允许使用常规设备来制备本发明的组合物,因为在制造过程中装置基本上不发生着色。Furthermore, microcapsules allow the use of conventional equipment to prepare the compositions of the present invention, since essentially no coloration of the device occurs during the manufacturing process.
从而,微胶囊引起特别兴趣,因为它们可在制造过程和延长的储存期间掩盖封装的着色剂的原始颜色,提高这些着色剂对抗降解的稳定性并且防止封装的着色剂不合意地释放到组合物中。Microcapsules are thus of particular interest because they can mask the original color of the encapsulated colorants during the manufacturing process and during prolonged storage, increase the stability of these colorants against degradation and prevent undesired release of the encapsulated colorants into the composition middle.
相对组合物的总重量,组合物可至少包含0.1重量%至20重量%,优选0.5重量%至15重量%并且更优选2重量%至10重量%的微胶囊。The composition may comprise at least 0.1% to 20% by weight, preferably 0.5% to 15% by weight and more preferably 2% to 10% by weight of microcapsules, relative to the total weight of the composition.
下面将详细描述微胶囊的优选构成。A preferred constitution of the microcapsules will be described in detail below.
1-4-1.包含可释放的着色剂的微胶囊的第一实施方案1-4-1. First Embodiment of Microcapsules Containing Releasable Coloring Agent
在第一实施方案中,通常微胶囊具有直径小于800μm、更优选小于约400μm、有利地1μm至300μm、特别地5μm至200μm且更特别地10μm至100μm的平均粒径。In a first embodiment, typically the microcapsules have an average particle size of less than 800 μm, more preferably less than about 400 μm, advantageously 1 to 300 μm, especially 5 to 200 μm and more particularly 10 to 100 μm in diameter.
包含可释放的着色剂的微胶囊是多层微胶囊。该微胶囊包含:Microcapsules containing a releasable colorant are multilayered microcapsules. The microcapsules contain:
-核,优选未着色的核,包含一种有机材料,优选由一种有机材料组成,和- core, preferably unpigmented core, comprises an organic material, preferably consists of an organic material, and
-包围所述核的至少一个层状涂层,该层状涂层包含至少一种聚合物,和至少一种着色剂。有利地,它包含至少一种粘合剂。- At least one layered coating surrounding said core, said layered coating comprising at least one polymer, and at least one colorant. Advantageously, it contains at least one binder.
优选地,微胶囊包含至少两层,优选至少一个有机着色内层和一个有机外层,所述有机外层的颜色与所述有机着色内层的颜色不同。Preferably, the microcapsules comprise at least two layers, preferably at least one organically colored inner layer and one organic outer layer, said organic outer layer being of a different color than said organically colored inner layer.
优选地,所述核包含至少一种单糖或其衍生物作为有机材料,特别是单糖-多元醇,有利地选自甘露糖醇、赤藓糖醇、木糖醇、山梨糖醇及其混合物,优选甘露糖醇。Preferably, the core comprises at least one monosaccharide or derivative thereof as organic material, in particular a monosaccharide-polyol, advantageously selected from the group consisting of mannitol, erythritol, xylitol, sorbitol and Mixtures, preferably mannitol.
有利地,包围核的该层状涂层包含至少一种亲水性聚合物,其选自多糖及其衍生物,优选包含一种类型的糖(ose)或若干种类型的糖,优选包括至少D-葡萄糖单元的若干种类型的糖的多糖及其衍生物,尤其淀粉和衍生物,纤维素或其衍生物,并且更优选淀粉和衍生物。Advantageously, this layered coating surrounding the core comprises at least one hydrophilic polymer selected from polysaccharides and their derivatives, preferably comprising one type of ose or several types of ose, preferably comprising at least Polysaccharides of several types of sugars of D-glucose units and their derivatives, especially starch and derivatives, cellulose or its derivatives, and more preferably starch and derivatives.
优选地,微胶囊包括至少一种基于脂质的材料,优选具有两亲性质,例如卵磷脂,且尤其是氢化卵磷脂。Preferably, the microcapsules comprise at least one lipid-based material, preferably of amphipathic nature, such as lecithin, and especially hydrogenated lecithin.
有利地,相对于微胶囊的总重量,核代表10重量%至90重量%,优选20重量%至80重量%,更优选30重量%至70重量%,且再更优选40重量%至60重量%。Advantageously, the core represents 10% to 90% by weight, preferably 20% to 80% by weight, more preferably 30% to 70% by weight, and still more preferably 40% to 60% by weight, relative to the total weight of the microcapsules %.
有利地,相对于微胶囊,着色剂代表20重量%至90重量%,优选30重量%至80重量%且尤其是50重量%至75重量%。Advantageously, the colorant represents 20% to 90% by weight, preferably 30% to 80% by weight and especially 50% to 75% by weight, relative to the microcapsules.
尤其,所述微胶囊至少包括:In particular, the microcapsules at least include:
-由单糖-多元醇(优选甘露糖醇)制成的内核,- an inner core made of monosaccharide-polyols, preferably mannitol,
-彼此颜色不同的至少两个层,- at least two layers of different colors from each other,
-至少一种亲水性聚合物,优选地选自多糖或其衍生物、且更优选地选自淀粉或衍生物,以及有利地,至少一种基于脂质的材料,优选两亲化合物,且更优选磷脂、甚至更优选磷酸酰基甘油(phosphoacylglycerol),例如氢化卵磷脂。- at least one hydrophilic polymer, preferably selected from polysaccharides or derivatives thereof, and more preferably from starch or derivatives, and advantageously at least one lipid-based material, preferably an amphiphile, and More preferred are phospholipids, even more preferred phosphoacylglycerols, such as hydrogenated lecithin.
在一个实施方案中,来自微胶囊的各层包含至少一种特定着色剂或着色剂的特定共混物。在一个实施方案中,来自微胶囊的外层包含至少一种特定的着色剂或着色剂的特定共混物。尤其,所述着色剂为颜料,优选地选自金属氧化物。在一个实施方案中,来自微胶囊的一层包含铁氧化物和二氧化钛(TiO2)作为着色剂。在一个实施方案中,来自微胶囊的一层仅包含TiO2作为着色剂。In one embodiment, each layer from the microcapsules comprises at least one specific colorant or a specific blend of colorants. In one embodiment, the outer layer from the microcapsules comprises at least one specified colorant or a specified blend of colorants. In particular, said colorants are pigments, preferably selected from metal oxides. In one embodiment, one layer from the microcapsules comprises iron oxide and titanium dioxide (TiO 2 ) as colorants. In one embodiment, one layer from the microcapsules contains only TiO2 as colorant.
相对于组合物的重量,本发明的组合物还可包括0.1重量%至70重量%的另外的化妆品成分,其选自挥发性的和非挥发性的硅油或烃油、表面活性剂、填料、另外的凝胶化剂、增稠剂、成膜剂、聚合物、防腐剂、硅酮弹性体、仿晒黑剂(self-tanning agent)、另外的非包埋的着色剂、化妆品活性剂、pH调节剂、香料、UV过滤剂、及其混合物。The composition according to the invention may also comprise from 0.1% to 70% by weight, relative to the weight of the composition, of additional cosmetic ingredients selected from volatile and non-volatile silicone or hydrocarbon oils, surfactants, fillers, Additional gelling agents, thickeners, film formers, polymers, preservatives, silicone elastomers, self-tanning agents, additional non-entrapping colourants, cosmetic active agents, pH adjusters, fragrances, UV filters, and mixtures thereof.
1-4-1-1.核1-4-1-1. Nuclear
在本发明的第一实施方案中,核由至少有机材料制成。核的尺寸优选直径在500nm至150μm范围内。优选地,所述核在室温、大气压下为固体形式和/或晶体形式。在特定的实施方案中,有机材料可具有高的水溶解性。In a first embodiment of the invention, the core is made of at least an organic material. The size of the core is preferably in the range of 500 nm to 150 μm in diameter. Preferably, the core is in solid and/or crystalline form at room temperature and atmospheric pressure. In certain embodiments, the organic material may have high water solubility.
优选地,核为水溶性的或水分散性的。Preferably, the core is water soluble or water dispersible.
在特定的实施方案中,核是未着色的,即,它不包含着色剂材料。In a particular embodiment, the core is unpigmented, ie it does not contain colorant material.
在特定的实施方案中,核仅由一种化合物组成。该化合物为有机的且更优选地为天然化合物。In a particular embodiment, the core consists of only one compound. The compound is organic and more preferably a natural compound.
在优选的实施方案中,核是糖-醇、优选地为单糖-多元醇,有利地选自甘露糖醇、赤藓糖醇、木糖醇、山梨糖醇。在特定的实施方案中,核由甘露糖醇制成,且更优选地仅由甘露糖醇制成。在供选的实施方案中,核包含至少甘露糖醇和至少一种另外的成分,该另外的成分优选地为选自亲水性聚合物的聚合物。特别地,这种核可包括甘露糖醇和在纤维素聚合物、淀粉聚合物和它们的混合物、优选它们的混合物中选择的亲水性聚合物。在优选的实施方案中,纤维素聚合物为羧甲基纤维素,且淀粉聚合物为未改性的天然淀粉,例如玉米淀粉。In a preferred embodiment, the core is a sugar-alcohol, preferably a monosaccharide-polyol, advantageously selected from mannitol, erythritol, xylitol, sorbitol. In a particular embodiment, the core is made of mannitol, and more preferably only of mannitol. In an alternative embodiment, the core comprises at least mannitol and at least one additional ingredient, preferably a polymer selected from hydrophilic polymers. In particular, such a core may comprise mannitol and a hydrophilic polymer selected among cellulosic polymers, starch polymers and mixtures thereof, preferably mixtures thereof. In a preferred embodiment, the cellulosic polymer is carboxymethyl cellulose and the starch polymer is unmodified native starch, such as corn starch.
核可由上述材料中的一种材料的晶种(或晶体)构成。The core may consist of a seed (or crystal) of one of the above materials.
相对于微胶囊的总重量,优选地以1重量%至50重量%,优选4重量%至40重量%,尤其5重量%至30重量%,且更特别地10重量%至20重量%的量包括核。Preferably in an amount of 1% to 50% by weight, preferably 4% to 40% by weight, especially 5% to 30% by weight, and more particularly 10% to 20% by weight, relative to the total weight of the microcapsules including nuclei.
相对于核的总重量,优选地以2重量%至100重量%,优选5重量%至100重量%,且尤其100重量%的量包括甘露糖醇。Mannitol is preferably included in an amount of 2% to 100% by weight, preferably 5% to 100% by weight, and especially 100% by weight relative to the total weight of the core.
相对于微胶囊的总重量,优选地以1重量%至50重量%,优选4重量%至40重量%,尤其5重量%至30重量%,且尤其10重量%至20重量%的量包括甘露糖醇。Manna is preferably included in an amount of 1% to 50% by weight, preferably 4% to 40% by weight, especially 5% to 30% by weight, and especially 10% to 20% by weight, relative to the total weight of the microcapsules sugar alcohol.
1-4-1-2.外部层(external layer)1-4-1-2. External layer (external layer)
如之前所公开的,核有利地被外部层包围,该外部层优选地包含至少一个内层和一个外层)。在第一实施方案中,这些层优选地相对于核同心地延伸。所述层优选地是有机的,即包含至少一种有机化合物作为成壁材料。优选地,内层和/或外层包括至少一种聚合物,且尤其是亲水性聚合物。As previously disclosed, the core is advantageously surrounded by an outer layer, which preferably comprises at least one inner layer and one outer layer). In a first embodiment, the layers preferably extend concentrically with respect to the core. The layer is preferably organic, ie contains at least one organic compound as wall-forming material. Preferably, the inner and/or outer layer comprises at least one polymer, and especially a hydrophilic polymer.
(a)聚合物(a) polymer
在第一实施方案中,微胶囊,且尤其是外部层包含选自多糖和衍生物、丙烯酸或甲基丙烯酸均聚物或共聚物或其盐和酯,以及它们的混合物的亲水性聚合物。In a first embodiment, the microcapsules, and especially the outer layer, comprise a hydrophilic polymer selected from polysaccharides and derivatives, acrylic or methacrylic acid homopolymers or copolymers or salts and esters thereof, and mixtures thereof .
在优选的实施方案中,微胶囊,且尤其是外部层包含选自多糖和衍生物,且特别是淀粉聚合物的亲水性聚合物。In a preferred embodiment, the microcapsules, and especially the outer layer, comprise a hydrophilic polymer selected from polysaccharides and derivatives, and especially starch polymers.
该聚合物有利地选自(聚)(烷基)(甲基)丙烯酸和它们的衍生物,尤其是(聚)(烷基)(甲基)丙烯酸酯和它们的衍生物,优选选自烷基丙烯酸/烷基甲基丙烯酸共聚物和它们的衍生物,且最优选来自Evonik Degussa以商品名EUDRAGIT RSPO提供的丙烯酸乙酯、甲基丙烯酸甲酯和低含量具有季铵基团的甲基丙烯酸酯的共聚物。The polymer is advantageously selected from (poly)(alkyl)(meth)acrylic acids and their derivatives, especially (poly)(alkyl)(meth)acrylates and their derivatives, preferably from Alkyl acrylic acid/alkyl methacrylic acid copolymers and their derivatives, and most preferably ethyl acrylate, methyl methacrylate and low content of methacrylates with quaternary ammonium groups from Evonik Degussa under the trade name EUDRAGIT RSPO copolymer.
多糖和衍生物优选选自壳聚糖聚合物、甲壳素聚合物、纤维素聚合物、淀粉聚合物、半乳甘露聚糖、藻酸盐、角叉菜胶、粘多糖、和它们的衍生物,及其混合物。Polysaccharides and derivatives are preferably selected from chitosan polymers, chitin polymers, cellulose polymers, starch polymers, galactomannans, alginates, carrageenans, mucopolysaccharides, and their derivatives , and mixtures thereof.
在优选的实施方案中,外部层不具有微晶纤维素。In a preferred embodiment, the outer layer is free of microcrystalline cellulose.
在特别优选的实施方案中,多糖和它们的衍生物优选选自包含一种类型的糖或若干种类型的糖、优选地若干种类型的糖、尤其是至少作为糖的D-葡萄糖单元的那些,优选淀粉聚合物、纤维素聚合物和衍生物、及其混合物。In a particularly preferred embodiment, the polysaccharides and their derivatives are preferably selected from those comprising one type of sugar or several types of sugars, preferably several types of sugars, especially at least as D-glucose units of sugars , preferably starch polymers, cellulose polymers and derivatives, and mixtures thereof.
在优选的实施方案中,微胶囊包含至少一种亲水性聚合物,该亲水性聚合物选自淀粉及其衍生物,尤其玉米淀粉;纤维素及其衍生物;甲基丙烯酸和/或甲基丙烯酸酯的均聚物和/或共聚物或(烷基)丙烯酸和/或(烷基)甲基丙烯酸的共聚物和它们的衍生物,优选它们的盐和它们的酯;且尤其是,胶囊包含聚甲基丙烯酸甲酯。In a preferred embodiment, the microcapsules comprise at least one hydrophilic polymer selected from starch and its derivatives, especially corn starch; cellulose and its derivatives; methacrylic acid and/or Homopolymers and/or copolymers of methacrylates or copolymers of (alk)acrylic acid and/or (alk)methacrylic acid and their derivatives, preferably their salts and their esters; and especially , capsules containing polymethylmethacrylate.
在优选的实施方案中,微胶囊包含选自淀粉及其衍生物,尤其玉米淀粉的至少一种亲水性聚合物。In a preferred embodiment, the microcapsules comprise at least one hydrophilic polymer selected from starch and its derivatives, especially corn starch.
根据本发明可用的淀粉通常由植物原材料(诸如大米、大豆、土豆或玉米)产生。淀粉可为未改性的或(与纤维素类比)改性的淀粉。在优选的实施方案中,淀粉是未改性的。The starches usable according to the invention are generally produced from plant raw materials such as rice, soybeans, potatoes or corn. The starch can be unmodified or (in analogy with cellulose) modified starch. In preferred embodiments, the starch is unmodified.
甲基丙烯酸和/或甲基丙烯酸酯的优选的均聚物和/或共聚物为其中甲基丙烯酸甲酯和丙烯酸乙酯的共聚物具有750kDa至850kDa的分子量的那些。Preferred homopolymers and/or copolymers of methacrylic acid and/or methacrylate esters are those in which the copolymer of methyl methacrylate and ethyl acrylate has a molecular weight of 750 kDa to 850 kDa.
例如,纤维素衍生物包括碱纤维素羧甲基纤维素(CMC)、纤维素酯和纤维素醚、以及氨基纤维素。在特定的实施方案中,纤维素为羧甲基纤维素(CMC)。For example, cellulose derivatives include the alkali cellulose carboxymethylcellulose (CMC), cellulose esters and ethers, and aminocellulose. In a particular embodiment, the cellulose is carboxymethylcellulose (CMC).
在优选的实施方案中,胶囊至少包含淀粉衍生物(尤其玉米淀粉)、聚甲基丙烯酸甲酯、(烷基)丙烯酸和/或(烷基)甲基丙烯酸的共聚物和它们的衍生物(优选它们的盐和它们的酯)、和/或纤维素衍生物。In a preferred embodiment, the capsule comprises at least starch derivatives (especially corn starch), polymethylmethacrylate, copolymers of (alk)acrylic acid and/or (alk)methacrylic acid and their derivatives ( Preference is given to their salts and their esters), and/or cellulose derivatives.
优选地,微胶囊包含不交联的聚合物。聚合物可在一个层或若干个层中。在另一实施方案中,聚合物可在核中。微胶囊可在核和/或层中包含聚合物。在特定的实施方案中,聚合物在核以及层中。在实施方案中,核至少包含作为聚合物的淀粉和/或纤维素衍生物。当淀粉包含在核内时,它代表这种核的主要成分,即,淀粉的重量大于核的其它化合物的各自的量。聚合物可代表微胶囊的0.5重量%至20重量%,尤其代表微胶囊的1重量%至10重量%并且优选2重量%至8重量%。Preferably, the microcapsules comprise non-crosslinked polymers. The polymers can be in one layer or in several layers. In another embodiment, the polymer can be in the core. Microcapsules may contain polymers in the core and/or layers. In particular embodiments, the polymer is in the core as well as the layers. In an embodiment, the core comprises at least starch and/or cellulose derivatives as polymers. When starch is contained within a core, it represents the main constituent of such a core, ie the weight of starch is greater than the respective amounts of the other compounds of the core. The polymer may represent 0.5% to 20% by weight of the microcapsules, especially 1% to 10% by weight and preferably 2% to 8% by weight of the microcapsules.
形成涂层的不同层可基于相同的或不同的聚合物。有利地,它们将由同一聚合物形成。相反,各层将有利地是不同着色的。该不同的颜色可通过使用不同的着色剂来获得,而且当用于两个层的着色剂将相同时,可通过使用至少一种着色剂的不同浓度来获得。The different layers forming the coating can be based on the same or different polymers. Advantageously, they will be formed from the same polymer. Rather, the layers will advantageously be differently colored. The different colors can be obtained by using different colorants and, when the colorants used for the two layers will be the same, by using different concentrations of at least one colorant.
在特定的实施方案中,外层包含至少一种着色剂。在另一实施方案中,外层不包含任何着色剂。In a particular embodiment, the outer layer comprises at least one colorant. In another embodiment, the outer layer does not contain any colorants.
(b)着色剂(b) Colorant
在第一实施方案中,微胶囊且特别是外部层包含着色剂。In a first embodiment, the microcapsules and in particular the outer layer comprise a colorant.
术语“着色剂”包括由用于化妆品配方的CTFA和FDA批准用于化妆品中的任何有机或无机颜料或着色剂。因此,术语“着色剂”指:有机颜料,如选自众所周知的FD&C或D&C染料的任一种的合成或天然染料;无机颜料,如金属氧化物,或色淀如基于胭脂虫红、钡、锶、钙或铝的色淀,和它们的任何组合(共混物)。在下文中详细描述这类着色剂。在特定实施方案中,着色剂可为水溶性或水分散性的。在另一实施方案中,根据本发明可用的着色剂可为油溶性的或油分散性的或在水中具有有限的溶解度。在优选实施方案中,着色剂是无机颜料,更优选金属氧化物。有利地,多层微胶囊的着色剂是选自铁氧化物、二氧化钛、氧化铝、氧化锆、氧化钴、氧化铈、氧化镍、氧化锡或氧化锌的原生金属氧化物(primary metaloxide),或复合氧化物,更优选选自红色铁氧化物、黄色铁氧化物或黑色铁氧化物的铁氧化物,或其混合物。The term "colorant" includes any organic or inorganic pigment or colorant approved for use in cosmetics by the CTFA and FDA for cosmetic formulations. Thus, the term "colorant" refers to: organic pigments, such as synthetic or natural dyes selected from any of the well-known FD&C or D&C dyes; inorganic pigments, such as metal oxides, or color lakes such as those based on carmine, barium, Lakes of strontium, calcium or aluminum, and any combination (blend) thereof. Such colorants are described in detail hereinafter. In particular embodiments, colorants can be water soluble or water dispersible. In another embodiment, colorants useful according to the invention may be oil-soluble or oil-dispersible or have limited solubility in water. In a preferred embodiment, the colorant is an inorganic pigment, more preferably a metal oxide. Advantageously, the colorant of the multilayer microcapsules is a primary metal oxide selected from iron oxide, titanium dioxide, aluminum oxide, zirconium oxide, cobalt oxide, cerium oxide, nickel oxide, tin oxide or zinc oxide, or The composite oxide is more preferably an iron oxide selected from red iron oxide, yellow iron oxide, or black iron oxide, or a mixture thereof.
所述层还可包含对应于固定至基底的有机着色剂的色淀。这种色淀有利地选自以下材料,和它们的混合物:The layer may also comprise a lake corresponding to the organic colorant fixed to the substrate. Such lakes are advantageously selected from the following materials, and mixtures thereof:
-胭脂虫红;- carmine;
-偶氮、蒽醌、靛蓝、呫吨、芘、喹啉、三苯基甲烷、荧烷着色剂的有机颜料;在有机颜料中,可提及以以下商标编号已知的那些:D&C Blue No.4、D&C BrownNo.1、D&C Green No.5、D&C Green No.6、D&C Orange No.4、D&C Orange No.5、D&C Orange No.10、D&C Orange No.11、D&C Red No.6、D&C Red No.7、D&C Red No.17、D&C Red No.21、D&C Red No.22、D&C Red No.27、D&C RedNo.28、D&C Red No.30、D&C Red No.31、D&C Red No.33、D&C Red No.34、D&C Red No.36、D&C Violet No.2、D&C Yellow No.7、D&C Yellow No.8、D&CYellow No.10、D&C Yellow No.11、FD&C Blue No.1、FD&C Green No.3、FD&CRed No.40、FD&C Yellow No.5和FD&C Yellow No.6;-Organic pigments of azo, anthraquinone, indigo, xanthene, pyrene, quinoline, triphenylmethane, fluorane colorants; among the organic pigments, mention may be made of those known under the following trademark numbers: D&C Blue No. .4, D&C Brown No.1, D&C Green No.5, D&C Green No.6, D&C Orange No.4, D&C Orange No.5, D&C Orange No.10, D&C Orange No.11, D&C Red No.6, D&C Red No.7, D&C Red No.17, D&C Red No.21, D&C Red No.22, D&C Red No.27, D&C Red No.28, D&C Red No.30, D&C Red No.31, D&C Red No. .33, D&C Red No.34, D&C Red No.36, D&C Violet No.2, D&C Yellow No.7, D&C Yellow No.8, D&C Yellow No.10, D&C Yellow No.11, FD&C Blue No.1, FD&C Green No.3, FD&CRed No.40, FD&C Yellow No.5 and FD&C Yellow No.6;
-酸性着色剂,如偶氮、蒽醌、靛蓝、呫吨、芘、喹啉、三苯基甲烷、和荧烷着色剂的水不溶性钠、钾、钙、钡、铝、锆、锶、钛盐,这些着色剂可包含至少一个羧酸基或磺酸基。- Acidic colorants such as azo, anthraquinone, indigo, xanthene, pyrene, quinoline, triphenylmethane, and water-insoluble sodium, potassium, calcium, barium, aluminum, zirconium, strontium, titanium, and fluoran colorants Salts, these colorants may contain at least one carboxylic or sulfonic acid group.
有机色淀也可被有机载体(诸如松香或苯甲酸铝)保护。Organic lakes can also be protected by organic vehicles such as rosin or aluminum benzoate.
在有机色淀当中,我们可特别提到以以下名称而被得知的那些:D&C Red No.2铝色淀、D&C Red No.3铝色淀、D&C Red No.4铝色淀、D&C Red No.6铝色淀、D&C Red No.6钡色淀、D&C Red No.6钡/锶色淀、D&C Red No.6锶色淀、D&C Red No.6钾色淀、D&C Red No.6钠色淀、D&C Red No.7铝色淀、D&C RedNo.7钡色淀、D&C Red No.7钙色淀、D&C Red No.7钙/锶色淀、D&C Red No.7锆色淀、D&C Red No.8钠色淀、D&C Red No.9铝色淀、D&C Red No.9钡色淀、D&C Red No.9钡/锶色淀、D&C Red No.9锆色淀、D&C Red No.10钠色淀、D&CRed No.19铝色淀、20D&C Red No.19钡色淀、D&C Red No.19锆色淀、D&C RedNo.21铝色淀、D&C Red No.21锆色淀、D&C Red No.22铝色淀、D&C Red No.27铝色淀、D&C Red No.27铝/钛/锆色淀、D&C Red No.27钡色淀、D&C Red No.27钙色淀、D&C Red No.27锆色淀、D&C Red No.28铝色淀、D&C Red No.28钠色淀、D&C Red No.30色淀、25D&C Red No.31钙色淀、D&C Red No.33铝色淀、D&C Red No.34钙色淀、D&C Red No.36色淀、D&C Red No.40铝色淀、D&C BlueNo.1铝色淀、D&C Green No.3铝色淀、D&C Orange No.4铝色淀、D&C OrangeNo.5铝色淀、D&C Orange No.5锆色淀、D&C Orange No.10铝色淀、D&C OrangeNo.17钡色淀、D&C Yellow No.5铝色淀、D&C Yellow No.5锆色淀、D&C YellowNo.6铝色淀、D&C Yellow No.7锆色淀、D&C Yellow No.10铝色淀、FD&C BlueNo.1铝色淀、FD&C Red No.4铝色淀、FD&C Red No.40铝色淀、FD&C Yellow No.5铝色淀和FD&C Yellow No.6铝色淀。Among the organic lakes we may mention in particular those known under the names: D&C Red No.2 Aluminum Lake, D&C Red No.3 Aluminum Lake, D&C Red No.4 Aluminum Lake, D&C Red No.6 Aluminum Lake, D&C Red No.6 Barium Lake, D&C Red No.6 Barium/Strontium Lake, D&C Red No.6 Strontium Lake, D&C Red No.6 Potassium Lake, D&C Red No.6 Sodium Lake, D&C Red No.7 Aluminum Lake, D&C Red No.7 Barium Lake, D&C Red No.7 Calcium Lake, D&C Red No.7 Calcium/Strontium Lake, D&C Red No.7 Zirconium Lake, D&C Red No.8 Sodium Lake, D&C Red No.9 Aluminum Lake, D&C Red No.9 Barium Lake, D&C Red No.9 Barium/Strontium Lake, D&C Red No.9 Zirconium Lake, D&C Red No. .10 sodium lake, D&CRed No.19 aluminum lake, 20D&C Red No.19 barium lake, D&C Red No.19 zirconium lake, D&C RedNo.21 aluminum lake, D&C Red No.21 zirconium lake, D&C Red No.22 Aluminum Lake, D&C Red No.27 Aluminum Lake, D&C Red No.27 Aluminum/Titanium/Zirconium Lake, D&C Red No.27 Barium Lake, D&C Red No.27 Calcium Lake, D&C Red No.27 Zirconium Lake, D&C Red No.28 Aluminum Lake, D&C Red No.28 Sodium Lake, D&C Red No.30 Lake, 25D&C Red No.31 Calcium Lake, D&C Red No.33 Aluminum Lake , D&C Red No.34 Calcium Lake, D&C Red No.36 Lake, D&C Red No.40 Aluminum Lake, D&C BlueNo.1 Aluminum Lake, D&C Green No.3 Aluminum Lake, D&C Orange No.4 Aluminum Lake Lake, D&C Orange No.5 Aluminum Lake, D&C Orange No.5 Zirconium Lake, D&C Orange No.10 Aluminum Lake, D&C Orange No.17 Barium Lake, D&C Yellow No.5 Aluminum Lake, D&C Yellow No. 5 Zirconium Lake, D&C YellowNo.6 Aluminum Lake, D&C Yellow No.7 Zirconium Lake, D&C Yellow No.10 Aluminum Lake, FD&C BlueNo.1 Aluminum Lake, FD&C Red No.4 Aluminum Lake, FD&C Red No.40 Aluminum Lake, FD&C Yellow No.5 Aluminum Lake and FD&C Yellow No.6 Aluminum Lake.
对应于先前所提到的这些有机着色剂中的每一种的化学材料在由<化妆品、盥洗用品和香精协会>(<The Cosmetic,Toiletry,and Fragrance Association>)出版的称作<国际化妆品原料词典和手册>(<International Cosmetic Ingredient Dictionary andHandbook>)(1997版)的书,第371至386页和第524至528页中提到,该书的内容特此通过引用方式并入本说明书中。Chemical materials corresponding to each of these previously mentioned organic colorants are described in <The Cosmetic, Toiletry, and Fragrance Association> published by <The Cosmetic, Toiletry, and Fragrance Association> called <International Cosmetic Raw Materials <International Cosmetic Ingredient Dictionary and Handbook> (<International Cosmetic Ingredient Dictionary and Handbook>) (1997 Edition), pages 371 to 386 and pages 524 to 528, the contents of which are hereby incorporated by reference into this specification.
在优选的实施方案中,色淀选自:胭脂虫红;和酸性着色剂例如偶氮、蒽醌、靛蓝、呫吨、芘、喹啉、三苯基甲烷、和荧烷着色剂的水不溶性的钠、钾、钙、钡、铝、锆、锶、钛盐(考虑到这些着色剂可包括至少一个羧酸基或者磺酸基);和它们的混合物。In a preferred embodiment, the color lake is selected from the group consisting of: cochineal; and water-insoluble colorants of acidic colorants such as azo, anthraquinone, indigo, xanthene, pyrene, quinoline, triphenylmethane, and fluorane colorants. sodium, potassium, calcium, barium, aluminum, zirconium, strontium, titanium salts (taking into account that these colorants may include at least one carboxylic or sulfonic acid group); and mixtures thereof.
在优选的实施方案中,色淀选自:胭脂虫红和水不溶性的钠、钙、铝盐,和它们的混合物。In a preferred embodiment, the lake is selected from the group consisting of cochineal and water insoluble sodium, calcium, aluminum salts, and mixtures thereof.
作为结合有胭脂红的色淀,我们可提到商品编号:As a lake combined with carmine we may mention the article numbers:
CARMIN COVALAC W 3508、CLOISONNE RED 424C以及CHROMA-LITEMAGENTA CL4505。CARMIN COVALAC W 3508, CLOISONNE RED 424C, and CHROMA-LITEMAGENTA CL4505.
水不溶性铝盐优选选自FDC Yellow No.5铝色淀、FDC Blue No.1铝色淀、FDC Red No.40铝色淀、FDC Red No.30铝色淀、FDC Green No.5铝色淀、和它们的混合物。作为结合有这种无机色淀的化合物,可尤其提及商品编号:INTENZAFIREFLY C91-1211、INTENZA AZURE ALLURE C91-1251、INTENZA THINKPINK C91-1236。The water-insoluble aluminum salt is preferably selected from FDC Yellow No.5 aluminum lake, FDC Blue No.1 aluminum lake, FDC Red No.40 aluminum lake, FDC Red No.30 aluminum lake, FDC Green No.5 aluminum lake starches, and their mixtures. As compounds incorporating such inorganic lakes, mention may especially be made of the article numbers: INTENZAFIREFLY C91-1211, INTENZA AZURE ALLURE C91-1251, INTENZA THINKPINK C91-1236.
水不溶性钙盐优选选自Red No.7钙色淀。作为结合有这种无机色淀的化合物,可尤其提及商品编号:INTENZA MAGENTITUDE C91-1234、INTENZAHAUTE PINK C91-1232、INTENZA RAZZLED ROSE C91-1231、INTENZAAMETHYST FORCE C91-7231、INTENZA PLUSH PLUM C91-7441、INTENZAELECTRIC CORAL 30C91-1233、FLORASOMES-JOJOBA-SMS-10%CELLINIRED-NATURAL和它们的混合物。The water insoluble calcium salt is preferably selected from Red No. 7 calcium lakes. As compounds incorporating such inorganic lakes, mention may especially be made of the product numbers: INTENZA MAGENTITUDE C91-1234, INTENZAHAUTE PINK C91-1232, INTENZA RAZZLED ROSE C91-1231, INTENZAAMETHYST FORCE C91-7231, INTENZA PLUSH PLUM C91-7441, INTENZAELECTRIC CORAL 30C91-1233, FLORASOMES-JOJOBA-SMS-10% CELLINIRED-NATURAL and mixtures thereof.
水不溶性钠盐优选选自Red No.6钠色淀和Red No.28钠色淀和它们的混合物。作为结合有这种无机色淀的化合物,可尤其提及商品编号:INTENZA MANGOTANGO C91-1221和INTENZA NITRO PINK C91-1235。The water insoluble sodium salt is preferably selected from Red No. 6 sodium lakes and Red No. 28 sodium lakes and mixtures thereof. As compounds incorporating such inorganic lakes, mention may especially be made of the product numbers: INTENZA MANGOTANGO C91-1221 and INTENZA NITRO PINK C91-1235.
在实施方案中,微胶囊中存在的着色剂选自无机颜料、有机颜料和它们的混合物,优选是至少一种无机颜料、更优选至少无机颜料的混合物,甚至更优选选自金属氧化物,且特别地选自铁氧化物、二氧化钛颗粒和它们的混合物,优选它们的混合物。In an embodiment, the colorant present in the microcapsules is selected from inorganic pigments, organic pigments and mixtures thereof, preferably at least one inorganic pigment, more preferably at least a mixture of inorganic pigments, even more preferably selected from metal oxides, and Especially selected from iron oxides, titanium dioxide particles and mixtures thereof, preferably mixtures thereof.
本发明的组合物可包括两种或更多种着色剂的混合物,着色剂被单独地封装在微胶囊中和/或着色剂的一种或更多种共混物被封装在多层微胶囊内。在此特定的实施方案中,微胶囊的各层可包含至少一种特定的着色剂或者着色剂的特定共混物。在此特定实施方案中,本发明的组合物包含两种或更多种具有不同颜色的微胶囊。The compositions of the present invention may comprise a mixture of two or more colorants encapsulated individually in microcapsules and/or a blend of one or more colorants encapsulated in multilayer microcapsules Inside. In this particular embodiment, each layer of the microcapsules may comprise at least one specified colorant or a specified blend of colorants. In this particular embodiment, the composition of the invention comprises two or more microcapsules of different colours.
本领域技术人员知道如何选择着色剂以及着色剂的组合,以产生所需的颜色效应或颜色变化。如先前所述,微胶囊在它们的涂层中优选地包含至少二氧化钛和/或铁氧化物,优选地至少二氧化钛。在优选的实施方案中,微胶囊在它们的涂层中包含至少二氧化钛和铁氧化物。在特定的实施方案中,微胶囊的外层包含二氧化钛,更优选地作为唯一的着色剂。Those skilled in the art know how to select colorants and combinations of colorants to produce the desired color effect or color change. As stated previously, the microcapsules preferably comprise in their coating at least titanium dioxide and/or iron oxide, preferably at least titanium dioxide. In a preferred embodiment, the microcapsules comprise at least titanium dioxide and iron oxide in their coating. In a particular embodiment, the outer layer of the microcapsules comprises titanium dioxide, more preferably as the sole colorant.
在特定实施方案中,微胶囊的外层包含有机颜料或铁氧化物。In certain embodiments, the outer layer of the microcapsules comprises organic pigments or iron oxides.
相对微胶囊的总重量,着色剂以在20重量%至90重量%、优选30重量%至80重量%并且更优选50重量%至75重量%范围内的量存在。The colorant is present in an amount ranging from 20% to 90% by weight, preferably from 30% to 80% by weight and more preferably from 50% to 75% by weight relative to the total weight of the microcapsules.
在特定实施方案中,微胶囊包含选自铁氧化物和钛氧化物的金属氧化物,相对微胶囊的总重量,其以在20重量%至90重量%、优选30重量%至85重量%并且更优选50重量%至85重量%范围内的量存在。In a particular embodiment, the microcapsules comprise a metal oxide selected from iron oxides and titanium oxides in an amount ranging from 20% to 90% by weight, preferably from 30% to 85% by weight, relative to the total weight of the microcapsules and More preferably present in an amount ranging from 50% to 85% by weight.
特别地,相对于微胶囊的总重量,钛氧化物可以28重量%至80重量%、优选30重量%至75重量%并且更优选30重量%至50重量%存在。在特定实施方案中,相对于微胶囊的总重量,钛氧化物可以50重量%至80重量%、特别地55重量%至70重量%并且更特别地55重量%至65重量%存在。In particular, titanium oxide may be present in an amount of 28% to 80% by weight, preferably 30% to 75% by weight and more preferably 30% to 50% by weight, relative to the total weight of the microcapsules. In a particular embodiment, the titanium oxide may be present in 50% to 80% by weight, specifically 55% to 70% by weight and more particularly 55% to 65% by weight relative to the total weight of the microcapsules.
特别地,相对于微胶囊的总重量,铁氧化物可以5重量%至75重量%、优选8重量%至65重量%存在。在特定实施方案中,相对于微胶囊的总重量,铁氧化物可以高于15重量%、优选高于30重量%并且特别地40重量%至65重量%的量存在。In particular, iron oxides may be present from 5% to 75% by weight, preferably from 8% to 65% by weight, relative to the total weight of the microcapsules. In a particular embodiment, iron oxides may be present in an amount higher than 15% by weight, preferably higher than 30% by weight and in particular between 40% and 65% by weight relative to the total weight of the microcapsules.
在优选实施方案中,在至少一层中,且优选在每层中,着色剂为主要的成分,即代表层的至少40重量%,优选层的至少75重量%,更优选层的总重量的至少95重量%。In a preferred embodiment, in at least one layer, and preferably in each layer, the colorant is a major constituent, i.e. representing at least 40% by weight of the layer, preferably at least 75% by weight of the layer, more preferably 1% of the total weight of the layer At least 95% by weight.
在优选的实施方案中,二氧化钛层的平均厚度在5μm至150μm范围内。In a preferred embodiment, the titanium dioxide layer has an average thickness in the range of 5 μm to 150 μm.
(c)粘合剂或基于脂质的材料(c) Adhesives or lipid-based materials
内层和/或外层还可有利地包括至少一种粘合剂,优选基于脂质的材料。在本发明的特定实施方案中,这种基于脂质的材料可具有两亲性质,即具有非极性部分和极性部分。The inner and/or outer layer may also advantageously comprise at least one binder, preferably a lipid-based material. In particular embodiments of the invention, such lipid-based materials may be amphiphilic in nature, ie have a non-polar part and a polar part.
这种基于脂质的材料可包括至少一个或若干个C12-C22脂肪酸链,例如,选自硬脂酸、棕榈酸、油酸、亚油酸、亚麻酸等的那些,及其混合物。优选地,这些脂肪酸链被氢化。最终,这些脂肪酸链可为基于脂质的材料的非极性部分。Such lipid-based materials may comprise at least one or several C12-C22 fatty acid chains, eg, those selected from stearic acid, palmitic acid, oleic acid, linoleic acid, linolenic acid, etc., and mixtures thereof. Preferably, these fatty acid chains are hydrogenated. Ultimately, these fatty acid chains can be the non-polar part of the lipid-based material.
这种基于脂质的材料优选选自磷脂。这些磷脂优选选自磷酸酰基甘油,更优选选自卵磷脂,且尤其是氢化卵磷脂。Such lipid-based materials are preferably selected from phospholipids. These phospholipids are preferably selected from phosphoacylglycerols, more preferably from lecithins, and especially hydrogenated lecithins.
基于脂质的材料可代表微胶囊的0.05重量%至5重量%,特别地代表微胶囊的0.1重量%至1重量%。The lipid-based material may represent 0.05% to 5% by weight of the microcapsules, in particular 0.1% to 1% by weight of the microcapsules.
通过在微胶囊中组合具有不同硬度和/或水溶解度的三种或更多种化合物(例如糖醇、聚合物、基于脂质的材料),可能调节封装着色剂的微胶囊在皮肤上破裂所需的时间,以便通过改变施用到皮肤上的方法或强度,可能调节优选的着色或渐变图案(gradation pattern)。By combining three or more compounds (e.g. sugar alcohols, polymers, lipid-based materials) with different hardness and/or water solubility in the microcapsules, it is possible to modulate the rate at which microcapsules encapsulating colorants rupture on the skin. Over time, it is possible to adjust the preferred coloration or gradation pattern by varying the method or intensity of application to the skin.
因此,在优选的实施方案中,多层涂层至少包含作为聚合物的淀粉以及至少一种基于脂质的材料(优选卵磷脂)。Thus, in a preferred embodiment, the multilayer coating comprises at least starch as polymer and at least one lipid-based material (preferably lecithin).
在有利的实施方案中,微胶囊包括至少一种单糖或其衍生物以及至少一种多糖或其衍生物。In an advantageous embodiment, the microcapsules comprise at least one monosaccharide or derivative thereof and at least one polysaccharide or derivative thereof.
在优选的实施方案中,微胶囊包括包含单糖衍生物的核和包含多糖(或其衍生物)的涂层,该多糖(或其衍生物)包括一种类型的糖或若干种类型的糖、优选若干种类型的糖。In a preferred embodiment, the microcapsules comprise a core comprising a monosaccharide derivative and a coating comprising a polysaccharide (or derivative thereof) comprising one type of sugar or several types of sugar , preferably several types of sugars.
在更优选的实施方案中,微胶囊包括包含单糖多元醇(优选选自甘露糖醇、赤藓糖醇、木糖醇、山梨糖醇)的核,和包含多糖(或其衍生物)的涂层,该多糖(或其衍生物)包含作为糖的至少一种或更多种D-葡萄糖单元。In a more preferred embodiment, the microcapsules comprise a core comprising a monosaccharide polyalcohol (preferably selected from mannitol, erythritol, xylitol, sorbitol), and a core comprising a polysaccharide (or a derivative thereof) Coating, the polysaccharide (or derivative thereof) comprises at least one or more D-glucose units as sugar.
在优选的实施方案中,微胶囊包括在不同层中的三种或更多种着色剂。In preferred embodiments, the microcapsules include three or more colorants in different layers.
在优选的实施方案中,微胶囊另外包含粘合剂,例如选自磷脂,有利地选自磷酸酰基甘油且特别选自卵磷脂的基于脂质的材料。In a preferred embodiment, the microcapsules additionally comprise a binder, for example a lipid-based material selected from phospholipids, advantageously from phosphoacylglycerols and especially from lecithins.
在特定实施方案中,微胶囊包括甘露糖醇、淀粉聚合物和基于脂质的材料。In particular embodiments, microcapsules include mannitol, starch polymers, and lipid-based materials.
参考图1,在优选实施方案中,本发明有利地提供变色微胶囊,其包含:With reference to Fig. 1, in a preferred embodiment, the present invention advantageously provides color-changing microcapsules, comprising:
i)核(A),优选具有直径小于800μm、更优选小于约400μm、有利地为1μm至300μm、特别地为5μm至200μm、且更特别地为10μm至100μm的尺寸,其优选不含任何着色剂,并包含优选选自至少一种糖醇的至少一个有机核,所述糖醇优选单糖-多元醇,有利地选自甘露糖醇、赤藓糖醇、木糖醇和山梨糖醇;i) core (A), preferably having a diameter of less than 800 μm, more preferably less than about 400 μm, advantageously 1 to 300 μm, in particular 5 to 200 μm, and more particularly 10 to 100 μm in size, which preferably does not contain any coloring and comprising at least one organic core preferably selected from at least one sugar alcohol, preferably a monosaccharide-polyol, advantageously selected from mannitol, erythritol, xylitol and sorbitol;
ii)包围所述核的一个第一层(B),包含:ii) a first layer (B) surrounding said core, comprising:
-至少一种着色剂,优选铁氧化物,和- at least one colorant, preferably iron oxide, and
-粘合剂,选自聚合物和基于脂质的材料,优选它们的混合物;- a binder selected from polymers and lipid-based materials, preferably mixtures thereof;
iii)包围第一层(B)的一个第二层(C),优选具有5μm至500μm的厚度,包含:iii) a second layer (C) surrounding the first layer (B), preferably having a thickness of 5 μm to 500 μm, comprising:
-二氧化钛颗粒,和- titanium dioxide particles, and
-粘合剂,选自聚合物和基于脂质的材料,优选它们的混合物;- a binder selected from polymers and lipid-based materials, preferably mixtures thereof;
iv)任选地,包围第二层(C)的一个第三层(D),包含:iv) Optionally, a third layer (D) surrounding the second layer (C), comprising:
-至少一种着色剂,和- at least one colorant, and
-粘合剂,选自聚合物和基于脂质的材料,优选它们的混合物;- a binder selected from polymers and lipid-based materials, preferably mixtures thereof;
v)任选地,包围第三层(D)(如果有第三层的话)或者包围第二层(C)的一个第四层(E),包含:v) Optionally, a fourth layer (E) surrounding the third layer (D) (if present) or surrounding the second layer (C), comprising:
-至少一种成壁聚合物,优选选自:多糖,如纤维素衍生物,尤其纤维素醚和纤维素酯;(聚)(烷基)(甲基)丙烯酸及其衍生物,尤其是(聚)(烷基)(甲基)丙烯酸酯及其衍生物;以及优选选自烷基丙烯酸/烷基甲基丙烯酸共聚物和它们的衍生物。- at least one wall-forming polymer, preferably selected from: polysaccharides, such as cellulose derivatives, especially cellulose ethers and cellulose esters; (poly)(alkyl)(meth)acrylic acid and derivatives thereof, especially ( poly)(alkyl)(meth)acrylates and derivatives thereof; and preferably selected from alkacrylic acid/alkylmethacrylic acid copolymers and their derivatives.
在优选的实施方案中,聚合物为选自淀粉及其衍生物,特别是玉米淀粉的亲水性聚合物。In a preferred embodiment, the polymer is a hydrophilic polymer selected from starch and its derivatives, especially corn starch.
作为商业上可获得的用于本发明的组合物的微胶囊的实例,我们可提到由Korea Particle Technology KPT以以下商业名生产的以下微胶囊:As examples of commercially available microcapsules for use in the composition of the invention, we may mention the following microcapsules produced by Korea Particle Technology KPT under the following trade names:
-来自KPT的Magic50-BW0105:包含甘露糖醇、铁氧化物红、铁氧化物黄、铁氧化物黑、氢化卵磷脂、二氧化钛、玉蜀黍(玉米)淀粉的淡灰色球形微胶囊,具有60-200目粒径。- Magic50-BW0105 from KPT: light gray spherical microcapsules containing mannitol, iron oxide red, iron oxide yellow, iron oxide black, hydrogenated lecithin, titanium dioxide, maize (corn) starch, with 60-200 Mesh particle size.
1-4-2.包含可释放的着色剂的微胶囊的第二实施方案1-4-2. Second Embodiment of Microcapsules Containing Releasable Coloring Agent
在第二实施方案中,微胶囊包含:In a second embodiment, the microcapsules comprise:
-核,其包括至少一个着色核和最终至少一个内部颜色层,和- a kernel comprising at least one coloring kernel and finally at least one inner color layer, and
-壳,其具有至少一个包围所述核的可压破(pressure-breakable)壁层、任选的外部颜色层和任选的最外层壳。- A shell having at least one pressure-breakable wall layer surrounding said core, an optional outer color layer and an optional outermost shell.
在优选实施方案中,微胶囊包括选自无机颜料,优选选自金属氧化物,如铁氧化物和钛氧化物的着色剂。In a preferred embodiment, the microcapsules comprise a colorant selected from inorganic pigments, preferably from metal oxides, such as iron oxides and titanium oxides.
优选地,着色核包括有利地选自至少一种金属氧化物,更有利地选自至少一种铁氧化物的至少一种无机颜料。Preferably, the coloring nucleus comprises at least one inorganic pigment, advantageously chosen from at least one metal oxide, more advantageously at least one iron oxide.
优选地,可压破壁层包括有利地选自至少一种金属氧化物,更有利地选自至少一种钛氧化物的至少一种无机颜料。Preferably, the crushable wall layer comprises at least one inorganic pigment, advantageously selected from at least one metal oxide, more advantageously selected from at least one titanium oxide.
优选地,此类铁氧化物至少位于着色核中,且钛氧化物至少位于包围所述核的可压破壁层中。Preferably, such iron oxides are located at least in the colored core and titanium oxides are located at least in the crushable wall layer surrounding said core.
相比于微胶囊的总重量,微胶囊包含至少70重量%的着色剂,优选无机颜料,优选无机颜料的混合物,优选金属氧化物如铁氧化物和钛氧化物。The microcapsules comprise at least 70% by weight of colorants, preferably inorganic pigments, preferably mixtures of inorganic pigments, preferably metal oxides such as iron oxides and titanium oxides, relative to the total weight of the microcapsules.
通常,根据本发明使用至多约800微米的着色剂微胶囊平均粒径(直径)。对于皮肤护理应用而言,该着色剂微胶囊的平均粒径(直径)优选小于约400微米。有利地,平均粒径(直径)在约10至350微米范围内。优选平均粒径将为50μm至800μm,且特别是60μm至400μm。Typically, an average colorant microcapsule size (diameter) of up to about 800 microns is used in accordance with the present invention. For skin care applications, the average particle size (diameter) of the colorant microcapsules is preferably less than about 400 microns. Advantageously, the average particle size (diameter) is in the range of about 10 to 350 microns. Preferably the average particle size will be from 50 μm to 800 μm, and especially from 60 μm to 400 μm.
有利地,微胶囊具有约18至270目(大约1000μm至53μm),特别是约25至170目(大约710μm至90μm)的平均粒径。Advantageously, the microcapsules have an average particle size of about 18 to 270 mesh (about 1000 μm to 53 μm), in particular about 25 to 170 mesh (about 710 μm to 90 μm).
特别对于本发明的皮肤护理组合物而言,相对于组合物的总重量,微胶囊的量将在0.1重量%至5重量%、优选0.2重量%至3重量%范围内。In particular for the skin care compositions of the invention, the amount of microcapsules will range from 0.1% to 5% by weight, preferably from 0.2% to 3% by weight, relative to the total weight of the composition.
特别对于本发明的化妆组合物而言,相对于组合物的总重量,微胶囊的量将在0.5重量%至20重量%、优选1重量%至15重量%、更优选2重量%至10重量%范围内。In particular for the cosmetic compositions according to the invention, the amount of microcapsules will be between 0.5% and 20% by weight, preferably between 1% and 15% by weight, more preferably between 2% and 10% by weight, relative to the total weight of the composition % range.
在特定实施方案中,相对于组合物的总重量,封装的着色剂以封装的颜料的活性物质计可以在0.5重量%至20重量%、特别是1重量%至15重量%、且更特别是2重量%至12重量%范围内的量存在于本发明的组合物中。In particular embodiments, the encapsulated colorant may range from 0.5% to 20% by weight, in particular from 1% to 15% by weight, and more particularly Amounts ranging from 2% to 12% by weight are present in the compositions of the invention.
它们通常将在配制的最后阶段和在过滤阶段(如果有的话)之后结合到化妆品配方中,以避免破裂。优选地,本发明的微胶囊在50℃以下的温度添加并均匀混合。用桨状物而不是均质器轻轻使它们混合。They will usually be incorporated into the cosmetic formulation at the final stage of formulation and after the filtration stage (if any) to avoid breakage. Preferably, the microcapsules of the present invention are added and uniformly mixed at a temperature below 50°C. Mix them lightly with a paddle, not a homogenizer.
在本发明的特定方面中,多于60%,优选多于70%,特别多于80%,且更特别多于90%的微胶囊将在用手或工具按压、摩擦、擦拭和/或擦洗后的1分钟、优选1至40秒、特别是1至30秒、且更特别是1至20秒之内破裂以释放内部着色剂。但是,所述比率和时限在本发明中不是关键的。In a particular aspect of the invention, more than 60%, preferably more than 70%, especially more than 80%, and more especially more than 90% of the microcapsules will be pressed, rubbed, wiped and/or scrubbed with hands or tools. within 1 minute, preferably 1 to 40 seconds, especially 1 to 30 seconds, and more particularly 1 to 20 seconds, to release the internal colorant. However, the ratio and time limit are not critical in the present invention.
1-4-2-1.核(着色剂和粘合剂或基于脂质的材料)1-4-2-1. Core (colorant and binder or lipid-based material)
在第二实施方案中,该微胶囊的核包含着色核,其包含至少一种着色剂和有利地至少一种粘合剂,例如基于脂质的材料。In a second embodiment, the core of the microcapsule comprises a colored core comprising at least one colorant and advantageously at least one binder, for example a lipid-based material.
着色剂不受特别限定,且以上描述的种类是优选使用的。The colorant is not particularly limited, and the above-described kinds are preferably used.
粘合剂优选选自至少一种亲水性聚合物、至少一种基于脂质的材料和它们的混合物,优选它们的混合物。通常,难以通过仅使用着色剂组分或颗粒而不使用任何粘合剂来形成涂布层(coating layer)。此外,即使困难地形成没有粘合剂的涂布层,这种涂布层可容易损坏或破裂或任何组分或颗粒可容易从涂布层中去除。因此,可使用粘合剂来促进涂布过程并改善涂布层的耐用性。这种粘合剂选自粘性聚合物材料,其可起到成壁材料(成壁聚合物材料)的作用。The binder is preferably selected from at least one hydrophilic polymer, at least one lipid-based material and mixtures thereof, preferably mixtures thereof. Generally, it is difficult to form a coating layer by using only colorant components or particles without using any binder. Furthermore, even if it is difficult to form a coating layer without a binder, such a coating layer may be easily damaged or cracked or any components or particles may be easily removed from the coating layer. Therefore, adhesives can be used to facilitate the coating process and improve the durability of the coating layer. This binder is selected from sticky polymeric materials which can function as wall-forming material (wall-forming polymeric material).
在本发明中,粘合剂优选选自至少一种成壁材料、基于脂质的材料和它们的混合物。更优选地,粘合剂是包含作为成壁材料的聚合物和作为涂层基底(coatingbase)的基于脂质的材料二者的混合物。In the present invention, the binder is preferably selected from at least one wall-forming material, lipid-based material and mixtures thereof. More preferably, the binder is a mixture comprising both a polymer as wall forming material and a lipid based material as coating base.
涂层基底指亲水性涂层基底、疏水性涂层基底或基于脂质的涂层基底。由于亲水性涂层基底可与着色剂一起被提取并且疏水性涂层基底由于其太强的膜性质可产生存在外来物质的感觉,优选使用基于脂质的涂层基底。Coating substrates refer to hydrophilic coating substrates, hydrophobic coating substrates or lipid-based coating substrates. Since a hydrophilic coating base can be extracted together with the colorant and a hydrophobic coating base can give a perception of the presence of foreign substances due to its too strong film properties, it is preferable to use a lipid-based coating base.
在特定实施方案中,这种基于脂质的材料可具有两亲性质,即具有非极性部分和极性部分。In certain embodiments, such lipid-based materials may be amphiphilic in nature, ie, have a non-polar portion and a polar portion.
这种基于脂质的材料可包括至少一个或若干个C12-C22脂肪酸链,例如,选自硬脂酸、棕榈酸、油酸、亚油酸、亚麻酸等及其混合物。优选地,这些脂肪酸链被氢化。最终,这些脂肪酸链可为基于脂质的材料的非极性部分。Such lipid-based materials may comprise at least one or several chains of C 12 -C 22 fatty acids, eg selected from stearic acid, palmitic acid, oleic acid, linoleic acid, linolenic acid, etc. and mixtures thereof. Preferably, these fatty acid chains are hydrogenated. Ultimately, these fatty acid chains can be the non-polar part of the lipid-based material.
基于脂质的材料是在一个分子中具有极性部分和非极性部分二者的两亲材料,并且包括,例如,选自硬脂酸、棕榈酸、油酸、亚油酸、亚麻酸及其混合物的C12-C22脂肪酸链。该脂肪酸链可被氢化,并且任选地形成基于脂质的材料的非极性部分。Lipid-based materials are amphiphilic materials having both a polar portion and a non-polar portion in one molecule, and include, for example, selected from the group consisting of stearic acid, palmitic acid, oleic acid, linoleic acid, linolenic acid and Its mixture of C 12 -C 22 fatty acid chains. The fatty acid chains can be hydrogenated and optionally form the non-polar portion of the lipid-based material.
基于脂质的材料可选自磷脂如磷脂酰胆碱、磷脂酰乙醇胺、磷脂酸或磷脂酰丝氨酸,鞘脂类如1-磷酸鞘氨醇或鞘磷脂和神经酰胺,优选神经酰胺或卵磷脂,其为磷脂混合物,尤其氢化卵磷脂。The lipid-based material may be selected from phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidic acid or phosphatidylserine, sphingolipids such as sphingosine-1-phosphate or sphingomyelin and ceramides, preferably ceramides or lecithins, It is a mixture of phospholipids, especially hydrogenated lecithin.
基于脂质的材料的量可通过考虑成壁聚合物以及其它组分如着色剂和/或二氧化钛颗粒的类型和量来确定。然而,总地来说,就各层的总重量而言,基于脂质的材料的量可选自0.1重量%至30重量%,特别地0.2重量%至25重量%,优选0.3重量%至20重量%且更优选0.4重量%至20重量%。当基于脂质的材料的量小于0.1重量%时,可破碎性或溶解能力可能降低,且当其超过25重量%时,耐用性可能降低或加工和储存期间的稳定性可能降低。The amount of lipid-based material can be determined by taking into account the type and amount of wall-forming polymers as well as other components such as colorants and/or titanium dioxide particles. In general, however, the amount of lipid-based material may be selected from 0.1% to 30% by weight, in particular 0.2% to 25% by weight, preferably 0.3% to 20% by weight, with respect to the total weight of the layers. % by weight and more preferably 0.4% by weight to 20% by weight. When the amount of lipid-based material is less than 0.1% by weight, breakability or dissolving ability may decrease, and when it exceeds 25% by weight, durability may decrease or stability during processing and storage may decrease.
在本发明中,成壁聚合物选自亲水性聚合物。术语“亲水性聚合物”指可与水或醇化合物(尤其是选自低级醇、二元醇和多元醇)形成氢键的聚合物,尤其是在分子中具有O-H、N-H和S-H键的那些。In the present invention, the wall-forming polymer is selected from hydrophilic polymers. The term "hydrophilic polymer" refers to polymers capable of forming hydrogen bonds with water or alcoholic compounds, especially those selected from lower alcohols, diols and polyols, especially those having O-H, N-H and S-H bonds in the molecule .
亲水性聚合物可选自以下聚合物或其混合物:The hydrophilic polymer may be selected from the following polymers or mixtures thereof:
-丙烯酸或甲基丙烯酸均聚物或共聚物或其盐和酯,且尤其是:由Allied Colloid公司以名称Versicol F或Versicol K出售的产品;由Ciba-Geigy公司以名称Ultrahold 8出售的产品;以及Synthalen K类型的聚丙烯酸;和聚丙烯酸的盐,尤其是钠盐(对应于INCI名称丙烯酸钠共聚物)、且更特别是由BASF公司以名称Luvigel EM出售的交联的聚丙烯酸钠(对应于INCI名称丙烯酸钠共聚物(和)辛酸/癸酸甘油三酯);- acrylic or methacrylic acid homopolymers or copolymers or salts and esters thereof, and in particular: products sold under the name Versicol F or Versicol K by the company Allied Colloid; products sold under the name Ultrahold 8 by the company Ciba-Geigy; and polyacrylic acid of the Synthalen K type; and salts of polyacrylic acid, especially the sodium salt (corresponding to the INCI name Sodium Acrylate Copolymer), and more particularly the crosslinked sodium polyacrylate sold under the name Luvigel EM by the company BASF (corresponding to In the INCI name Sodium Acrylate Copolymer (and) Caprylic/Capric Triglyceride);
-以其钠盐形式由Hercules公司以名称Reten出售的丙烯酸和丙烯酰胺的共聚物、由Vanderbilt公司以名称Darvan No.7出售的聚甲基丙烯酸钠、和由Henkel公司以名称Hydagen F出售的多羟基羧酸的钠盐;- Copolymers of acrylic acid and acrylamide sold under the name Reten by the company Hercules in the form of their sodium salts, sodium polymethacrylate sold under the name Darvan No. Sodium salts of hydroxycarboxylic acids;
-聚丙烯酸/烷基丙烯酸酯共聚物,优选改性的或未改性的羧乙烯基聚合物;最特别优选的共聚物为丙烯酸酯/C10-C30烷基丙烯酸酯共聚物(INCI名称:丙烯酸酯/C10-30烷基丙烯酸酯交联聚合物),例如由Lubrizol公司以商品名Pemulen TR1、Pemulen TR2、Carbopol 1382和Carbopol ETD2020、Carbopol Ultrez 21出售的产品,且甚至更优选Pemulen TR-2;- polyacrylic acid/alkyl acrylate copolymers, preferably modified or unmodified carboxyvinyl polymers; most particularly preferred copolymers are acrylates/C 10 -C 30 alkyl acrylate copolymers (INCI name : Acrylates/C 10-30 Alkyl Acrylate Crosspolymer), such as the products sold by the company Lubrizol under the trade names Pemulen TR1, Pemulen TR2, Carbopol 1382 and Carbopol ETD2020, Carbopol Ultrez 21, and even more preferably Pemulen TR -2;
-烷基丙烯酸/烷基甲基丙烯酸共聚物和它们的衍生物,特别是它们的盐和它们的酯,例如来自Evonik Degussa的以商品名EUDRAGIT RSPO提供的丙烯酸乙酯、甲基丙烯酸甲酯和低含量的具有季铵基团的甲基丙烯酸酯的共聚物;- Alkacrylic acid/alkylmethacrylic acid copolymers and their derivatives, especially their salts and their esters, such as ethyl acrylate, methyl methacrylate and low content of methacrylate copolymers with quaternary ammonium groups;
-由Clariant公司出售的AMPS(用氨水部分中和且高度交联的聚丙烯酰胺基甲基丙磺酸);- AMPS (polyacrylamidomethylpropanesulfonic acid partially neutralized and highly cross-linked with ammonia) sold by the company Clariant;
-AMPS/丙烯酰胺共聚物,例如由SEPPIC公司出售的产品Sepigel或Simulgel,尤其是INCI名称聚丙烯酰胺(和)C13-C14异链烷烃(和)月桂醇聚醚-7的共聚物;- AMPS/acrylamide copolymers, such as the products Sepigel or Simulgel sold by the company SEPPIC, especially copolymers of INCI name polyacrylamide (and) C 13 -C 14 isoparaffin (and) laureth-7;
-如由Clariant公司出售的Aristoflex HMS类型的聚氧乙烯化AMPS/烷基甲基丙烯酸酯共聚物(交联的或非交联的);- polyoxyethylated AMPS/alkylmethacrylate copolymers (crosslinked or non-crosslinked) of the type Aristoflex HMS as sold by the company Clariant;
-阴离子的、阳离子的、两性的或非离子的甲壳素或壳聚糖聚合物;- anionic, cationic, amphoteric or nonionic chitin or chitosan polymers;
-纤维素聚合物和它们的衍生物,优选地除烷基纤维素之外,选自羟乙基纤维素、羟丙基纤维素、羟甲基纤维素、乙基羟乙基纤维素和羧甲基纤维素、以及还有季铵化的纤维素衍生物;在优选的实施方案中,纤维素聚合物为羧甲基纤维素;- cellulosic polymers and their derivatives, preferably selected from hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxymethyl cellulose, ethyl hydroxyethyl cellulose and carboxyl cellulose in addition to alkyl cellulose methylcellulose, and also quaternized cellulose derivatives; in a preferred embodiment, the cellulose polymer is carboxymethylcellulose;
-最终改性的淀粉聚合物和它们的衍生物;在优选的实施方案中,淀粉聚合物为天然淀粉;- final modified starch polymers and their derivatives; in a preferred embodiment the starch polymers are native starches;
-乙烯基聚合物,例如聚乙烯基吡咯烷酮、甲基乙烯基醚和马来酸酐的共聚物、乙酸乙烯酯和巴豆酸的共聚物、乙烯基吡咯烷酮和乙酸乙烯酯的共聚物、乙烯基吡咯烷酮和己内酰胺的共聚物、聚乙烯醇;- vinyl polymers such as polyvinylpyrrolidone, copolymers of methyl vinyl ether and maleic anhydride, copolymers of vinyl acetate and crotonic acid, copolymers of vinylpyrrolidone and vinyl acetate, vinylpyrrolidone and Copolymers of caprolactam, polyvinyl alcohol;
-天然来源的任选改性的聚合物,例如半乳甘露聚糖及其衍生物,如魔芋胶(konjac gum)、结冷胶、刺槐豆胶、香豆胶、卡拉亚胶(karaya gum)、黄蓍胶、阿拉伯胶、金合欢胶(acacia gum)、瓜尔胶、羟丙基瓜尔胶、用甲基羧酸钠基团改性的羟丙基瓜尔胶(Jaguar XC97-1,Rhodia)、瓜尔胶羟丙基三甲基氯化铵、以及黄原胶衍生物;- optionally modified polymers of natural origin, such as galactomannan and its derivatives, such as konjac gum, gellan gum, locust bean gum, couma gum, karaya gum , gum tragacanth, gum arabic, acacia gum, guar gum, hydroxypropyl guar gum, hydroxypropyl guar gum modified with sodium methyl carboxylate groups (Jaguar XC97-1, Rhodia), guar hydroxypropyltrimonium chloride, and xanthan gum derivatives;
-藻酸盐和角叉菜胶;- alginate and carrageenan;
-糖胺聚糖(glycoaminoglycan)、透明质酸及其衍生物;和- glycosaminoglycans (glycoaminoglycan), hyaluronic acid and their derivatives; and
-粘多糖,例如透明质酸和硫酸软骨素、及其混合物。- Mucopolysaccharides, such as hyaluronic acid and chondroitin sulfate, and mixtures thereof.
优选地,本发明的亲水性聚合物可选自多糖和它们的衍生物、丙烯酸或甲基丙烯酸的均聚物和/或共聚物或其盐和酯、和它们的混合物。Preferably, the hydrophilic polymer of the present invention may be selected from polysaccharides and their derivatives, homopolymers and/or copolymers of acrylic acid or methacrylic acid or salts and esters thereof, and mixtures thereof.
多糖和它们的衍生物可选自壳聚糖聚合物、甲壳素聚合物、纤维素聚合物、淀粉聚合物、半乳甘露聚糖、藻酸盐、角叉菜胶、粘多糖、和它们的衍生物、及其混合物。Polysaccharides and their derivatives may be selected from chitosan polymers, chitin polymers, cellulose polymers, starch polymers, galactomannans, alginates, carrageenans, mucopolysaccharides, and their derivatives, and mixtures thereof.
多糖和它们的衍生物优选选自淀粉聚合物。Polysaccharides and their derivatives are preferably selected from starch polymers.
优选地,亲水性聚合物可选自玉米淀粉、聚甲基丙烯酸甲酯、纤维素或其衍生物如羧甲基纤维素(CMC)、纤维素酯和醚和氨基纤维素、及其混合物。Preferably, the hydrophilic polymer may be selected from corn starch, polymethyl methacrylate, cellulose or its derivatives such as carboxymethyl cellulose (CMC), cellulose esters and ethers and amino cellulose, and mixtures thereof .
优选地,亲水性聚合物可选自玉米淀粉、聚甲基丙烯酸甲酯、它们的衍生物、及其混合物。Preferably, the hydrophilic polymer may be selected from cornstarch, polymethylmethacrylate, their derivatives, and mixtures thereof.
甲基丙烯酸和/或甲基丙烯酸酯的优选的均聚物和/或共聚物为其中甲基丙烯酸甲酯和丙烯酸乙酯的共聚物具有750kDa至850kDa的分子量的那些。Preferred homopolymers and/or copolymers of methacrylic acid and/or methacrylate esters are those in which the copolymer of methyl methacrylate and ethyl acrylate has a molecular weight of 750 kDa to 850 kDa.
在本发明中用作成壁材料的亲水性聚合物不是交联的。The hydrophilic polymers used as wall-forming materials in the present invention are not cross-linked.
聚合物或成壁聚合物的量可通过考虑着色剂、二氧化钛颗粒和/或基于脂质的材料的类型和量来确定。然而,总地来说,就各层的总重量而言,各层中聚合物或成壁聚合物的量可选自0.1重量%至30重量%,特别地0.2重量%至25重量%,优选0.3重量%至20重量%且更优选0.4重量%至20重量%。当基于脂质的材料的含量小于0.1重量%时,可破碎性或溶解能力可能降低,且当其超过25重量%时,耐用性可能降低或加工和储存期间的稳定性可能降低。在此部分中描述的这种亲水性聚合物可用作成壳聚合物和粘合剂二者。The amount of polymer or wall-forming polymer can be determined by considering the type and amount of colorant, titanium dioxide particles, and/or lipid-based material. In general, however, the amount of polymer or wall-forming polymer in each layer may be selected from 0.1% to 30% by weight, in particular 0.2% to 25% by weight, with respect to the total weight of the layers, preferably 0.3% to 20% by weight and more preferably 0.4% to 20% by weight. When the content of the lipid-based material is less than 0.1% by weight, breakability or dissolving ability may decrease, and when it exceeds 25% by weight, durability may decrease or stability during processing and storage may decrease. Such hydrophilic polymers described in this section can be used as both shell-forming polymers and binders.
该核可例如通过在溶剂中包含至少一种着色剂、至少一种作为成壁材料的聚合物和至少一种基于脂质的材料的溶液的喷雾干燥或流化床工艺以颗粒、粉末、粒子(granule)、微球和微胶囊的形式制备。The core can be obtained as granules, powders, granules, for example by spray-drying or fluidized-bed processes of a solution comprising at least one colorant, at least one polymer as wall-forming material and at least one lipid-based material in a solvent. (granule), microspheres and microcapsules.
着色核,且更一般而言核的尺寸不受特别限制,并可根据最终需要的微胶囊来适当地选择。例如,着色核,且更一般而言核的尺寸可大于20μm或更大,特别是30μm或更大,优选40μm或更大,更优选50μm或更大,且小于800μm或更小,特别是700μm或更小,优选600μm或更小,更优选500μm或更小。The coloring core, and more generally the size of the core is not particularly limited and can be appropriately selected according to the final desired microcapsules. For example, the coloring nuclei, and more generally the nuclei, may have a size greater than 20 μm or greater, especially 30 μm or greater, preferably 40 μm or greater, more preferably 50 μm or greater, and less than 800 μm or less, especially 700 μm or less, preferably 600 μm or less, more preferably 500 μm or less.
相对于微胶囊的总半径,核的半径大于50%,尤其是大于60%,优选大于70%,且更优选大于80%。例如,核半径与壳厚度之间的比率可为1:0.05至1:0.5。The radius of the core is greater than 50%, especially greater than 60%, preferably greater than 70%, and more preferably greater than 80%, relative to the total radius of the microcapsule. For example, the ratio between core radius and shell thickness may be 1:0.05 to 1:0.5.
供选地,相对于微胶囊的总重量,核的量可大于30重量%,尤其是大于40重量%,优选大于50重量%,且更优选大于60重量%。因此,微胶囊在颗粒中具有大负载量的着色剂。Alternatively, the amount of core may be greater than 30 wt%, especially greater than 40 wt%, preferably greater than 50 wt%, and more preferably greater than 60 wt%, relative to the total weight of the microcapsules. Therefore, microcapsules have a large loading of colorants in the particles.
该核可具有包围着色核的一个或更多个内部颜色层。内部颜色层可为位于着色核和可压破壁层之间的每一层。The core may have one or more inner color layers surrounding the shading core. The inner color layer can be every layer located between the color core and the crushable wall layer.
内部颜色层包括,例如,第一内部颜色层、第二内部颜色层和第三内部颜色层等,其中各内部颜色层中所含的着色剂和粘合剂彼此相同或不同。在优选实施方案中,该着色核可包含一个或两个内部颜色层,优选一个内部颜色层。The inner color layers include, for example, a first inner color layer, a second inner color layer, a third inner color layer, etc., wherein the colorants and binders contained in the respective inner color layers are the same as or different from each other. In preferred embodiments, the colored core may comprise one or two inner color layers, preferably one inner color layer.
当该核具有着色核和内部颜色层时,可通过包含至少一种着色剂和优选至少一种粘合剂的着色核的溶液的造粒形成着色核,可通过用包含至少一种着色剂和优选至少一种粘合剂的内部颜色层的溶液涂布着色核形成内部颜色层。涂布过程可通过流化床涂布方法进行。When the core has a colored core and an inner color layer, the colored core can be formed by granulation of a solution of a colored core comprising at least one colorant and preferably at least one binder, Preferably a solution of the inner colored layer of at least one binder coats the colored core to form the inner colored layer. The coating process can be performed by a fluidized bed coating method.
内部颜色层的厚度不受特别限制并可根据最终需要的微胶囊适当地选择。例如,着色核,且更一般而言核的厚度可大于20μm或更大,特别是40μm或更大,优选60μm或更大,更优选80μm或更大,且小于200μm或更小,特别是160μm或更小,优选120μm或更小,更优选100μm或更小。The thickness of the inner color layer is not particularly limited and can be properly selected according to the final required microcapsules. For example, the coloring nucleus, and more generally the thickness of the nucleus may be greater than 20 μm or greater, especially 40 μm or greater, preferably 60 μm or greater, more preferably 80 μm or greater, and less than 200 μm or less, especially 160 μm or less, preferably 120 μm or less, more preferably 100 μm or less.
供选地,相对核的总重量,内部颜色层的量可为20重量%至80重量%,特别地30重量%至70重量%,且优选40重量%至60重量%。Alternatively, the amount of the inner color layer may be 20% to 80% by weight, especially 30% to 70% by weight, and preferably 40% to 60% by weight, relative to the total weight of the core.
在特定实施方案中,该着色核不含粘合剂并被包含着色剂和粘合剂的内部颜色层包围,由此该核中所含的颜料将在微胶囊破裂时更容易分散。In a particular embodiment, the colored core is free of binder and surrounded by an inner color layer comprising colorant and binder, whereby the pigment contained in the core will disperse more easily upon rupture of the microcapsules.
在着色核中,可以在涂布过程中和/或在除去溶剂后着色剂不会散开或与层分离的量使用粘合剂,并相对于着色核的总重量,通常可以选自1重量%至30重量%,优选2重量%至25重量%,特别地5重量%至20重量%,且更特别地5重量%至15重量%的量使用。In the coloring core, the binder can be used in an amount in which the coloring agent does not scatter or separate from the layer during the coating process and/or after removal of the solvent, and with respect to the total weight of the coloring core, it can usually be selected from 1 wt. % to 30% by weight, preferably 2% to 25% by weight, especially 5% to 20% by weight, and more particularly 5% to 15% by weight.
在优选实施方案中,相对于核的总重量,着色剂,且优选颜料,再更优选铁氧化物,以至少70重量%,尤其至少75重量%,优选至少80重量%,更优选至少85重量%,如80重量%至99重量%的量存在于核中。In a preferred embodiment, the colorants, and preferably pigments, even more preferably iron oxides, are present in an amount of at least 70% by weight, especially at least 75% by weight, preferably at least 80% by weight, more preferably at least 85% by weight, relative to the total weight of the core %, such as 80% to 99% by weight, is present in the core.
在优选实施方案中,相对于微胶囊的总重量,着色剂,且优选颜料,更优选铁氧化物,以至少30重量%,尤其至少35重量%,优选至少40重量%,如40重量%至60重量%的量存在。In a preferred embodiment, the colorants, and preferably pigments, more preferably iron oxides, are present in an amount of at least 30% by weight, especially at least 35% by weight, preferably at least 40% by weight, such as 40% by weight, relative to the total weight of the microcapsules. An amount of 60% by weight is present.
相对于微胶囊的总重量,该微胶囊中的铁氧化物颗粒的量可为20重量%至60重量%,优选25重量%至55重量%,更优选30重量%至50重量%。更优选地,相对于微胶囊的总重量,该微胶囊中的铁氧化物颗粒的量可为30重量%至58重量%,优选35重量%至55重量%,且更优选40重量%至50重量%。The amount of iron oxide particles in the microcapsules may be 20% to 60% by weight, preferably 25% to 55% by weight, more preferably 30% to 50% by weight, relative to the total weight of the microcapsules. More preferably, the amount of iron oxide particles in the microcapsules may be 30% to 58% by weight, preferably 35% to 55% by weight, and more preferably 40% to 50% by weight, relative to the total weight of the microcapsules. weight%.
1-4-2-2.可压破壁层或二氧化钛颗粒层1-4-2-2. Crushable wall layer or titanium dioxide particle layer
微胶囊具有包含至少一种着色剂的可压破壁层。着色剂优选选自无机颜料,更优选选自金属氧化物,且再更优选选自二氧化钛颗粒。The microcapsules have a crushable wall layer comprising at least one colorant. The colorant is preferably selected from inorganic pigments, more preferably from metal oxides, and still more preferably from titanium dioxide particles.
优选地,包含在可压破壁层中的着色剂不同于包含在着色核中的着色剂,例如都是彼此不同的金属氧化物。Preferably, the colorants contained in the crushable wall layer are different from the colorants contained in the color core, for example both are different metal oxides from each other.
在优选实施方案中,二氧化钛颗粒不连续地分散在该层中并通过粘合剂互相连接。In a preferred embodiment, titanium dioxide particles are dispersed discontinuously in the layer and are interconnected by a binder.
术语“可压破的”或“可压碎的”指在用手或工具如布、海绵或纸按压、摩擦、擦拭和/或擦洗时可容易地制造破裂。The term "crushable" or "crushable" means that a rupture can be easily made when pressed, rubbed, wiped and/or scrubbed by hand or with an implement such as a cloth, sponge or paper.
可压破的二氧化钛颗粒层可包含二氧化钛颗粒和粘合剂,且所述粘合剂可包含成壁材料。The crushable layer of titanium dioxide particles may comprise titanium dioxide particles and a binder, and the binder may comprise wall forming material.
在本发明的可压破壁层中,据信嵌在成壁材料中的二氧化钛颗粒将以不可逆方式破坏可压破壁层,并促进或提高所述壁层的崩解或溶解。此外,还预期,二氧化钛颗粒就该壁层的强度、耐久性、可压破性和获得的感觉而言起到重要作用。In the crushable wall layer of the present invention, it is believed that the titanium dioxide particles embedded in the wall forming material will irreversibly damage the crushable wall layer and facilitate or enhance the disintegration or dissolution of said wall layer. In addition, titanium dioxide particles are also expected to play an important role with regard to the strength, durability, crushability and feel of the wall layer.
例如,该可压破壁层可通过下列步骤形成:For example, the crushable wall layer can be formed by the following steps:
(a)将二氧化钛颗粒和粘合剂溶解或分散在适当的溶剂中,以产生包含二氧化钛颗粒和粘合剂的溶液,(a) dissolving or dispersing titanium dioxide particles and binder in a suitable solvent to produce a solution comprising titanium dioxide particles and binder,
(b)用以上(a)中获得的溶液涂布具有内部颜色层的颗粒,和(b) coating particles having an internal color layer with the solution obtained in (a) above, and
(c)任选将以上(b)中获得的所得颗粒干燥。(c) Optionally drying the resulting granules obtained in (b) above.
所述涂布可通过使用流化床方法进行,但如果必要,也可利用其它涂布方法。关于上述步骤中可利用的适当的溶剂,可提到水或低沸点溶剂,如二氯甲烷、甲醇和乙醇。The coating can be performed by using a fluidized bed method, but other coating methods can also be utilized if necessary. As suitable solvents usable in the above steps, water or low boiling point solvents such as dichloromethane, methanol and ethanol may be mentioned.
该二氧化钛颗粒层(其厚度可根据所用二氧化钛的量和/或粘合剂的类型而变)可具有10μm或更大,优选20μm或更大,更优选30μm或更大,特别是40μm或更大,通常300μm或更小,优选250μm或更小,更优选200μm或更小,且特别是150μm或更小的厚度。The layer of titanium dioxide particles (the thickness of which can vary depending on the amount of titanium dioxide used and/or the type of binder) can have a thickness of 10 μm or greater, preferably 20 μm or greater, more preferably 30 μm or greater, especially 40 μm or greater , usually 300 μm or less, preferably 250 μm or less, more preferably 200 μm or less, and especially 150 μm or less in thickness.
就可压破壁层的总重量而言,该可压破壁层中的二氧化钛颗粒的量优选选自50重量%至99重量%,更优选60重量%至98重量%,甚至更优选70重量%至97重量%,且特别地80重量%至95重量%。优选地,所述着色剂,且特别是二氧化钛颗粒的量代表可压破壁层的不到100%。The amount of titanium dioxide particles in the crushable wall layer is preferably selected from 50% to 99% by weight, more preferably 60% to 98% by weight, even more preferably 70% by weight, with respect to the total weight of the crushable wall layer % to 97% by weight, and especially 80% to 95% by weight. Preferably, the amount of said colorant, and especially titanium dioxide particles, represents less than 100% of the crushable wall layer.
相对于微胶囊的总重量,该微胶囊中的二氧化钛颗粒的量优选选自20重量%至60重量%,优选25重量%至55重量%,且更优选30重量%至50重量%。The amount of titanium dioxide particles in the microcapsules is preferably selected from 20% to 60% by weight, preferably 25% to 55% by weight, and more preferably 30% to 50% by weight, relative to the total weight of the microcapsules.
着色核中的着色剂(优选铁氧化物)和可压破壁层中的着色剂(优选二氧化钛颗粒)均以各自的总量存在于微胶囊中如(such as)着色核中的着色剂(且优选铁氧化物)相对于可压破壁层中的着色剂(优选二氧化钛颗粒)的重量比大于或等于1。The coloring agent (preferably iron oxide) in the coloring core and the coloring agent (preferably titanium dioxide particles) in the crushable wall layer are present in the microcapsules in respective total amounts such as (such as) the coloring agent in the coloring core ( and preferably iron oxide) relative to the colorant (preferably titanium dioxide particles) in the crushable wall layer is greater than or equal to 1 by weight.
铁氧化物和二氧化钛颗粒均以各自的总量存在于微胶囊中如铁氧化物相对于二氧化钛颗粒的重量比大于或等于1。Both iron oxide and titanium dioxide particles are present in the microcapsules in their respective total amounts such that the weight ratio of iron oxide to titanium dioxide particles is greater than or equal to 1.
二氧化钛颗粒的平均直径或尺寸不受特别限制,但具有通常10nm至20μm,优选50nm至10μm,更优选100nm至5μm,且特别是150nm至5μm的平均直径。二氧化钛颗粒的小于10nm的平均直径或尺寸可导致可压破能力降低,且大于20μm的平均直径可使得难以形成二氧化钛颗粒层。具有小于上述范围的第一粒径但具有落在上述粒径范围内的第二粒径的二氧化钛颗粒可适用于本发明。The average diameter or size of titanium dioxide particles is not particularly limited, but has an average diameter of generally 10 nm to 20 μm, preferably 50 nm to 10 μm, more preferably 100 nm to 5 μm, and especially 150 nm to 5 μm. An average diameter or size of titanium dioxide particles of less than 10 nm may result in reduced crushability, and an average diameter of more than 20 μm may make it difficult to form a layer of titanium dioxide particles. Titanium dioxide particles having a first particle size smaller than the aforementioned range but having a second particle size falling within the aforementioned particle size range are suitable for use in the present invention.
1-4-2-3.任选的外部颜色层1-4-2-3. Optional external color layer
微胶囊另外包含在可压破二氧化钛颗粒层上的任选的外部颜色层。可通过用具有着色剂和粘合剂的溶液,例如通过流化床方法涂布二氧化钛颗粒层来形成该外部颜色层。用于外部颜色层中的着色剂和粘合剂可与用于内部颜色层的那些相同或不同。The microcapsules additionally comprise an optional outer layer of color on the layer of crushable titanium dioxide particles. The outer color layer may be formed by coating a layer of titanium dioxide particles with a solution having a colorant and a binder, for example by a fluidized bed method. Colorants and binders used in the outer color layer may be the same as or different from those used in the inner color layer.
一般而言,提供外部颜色层以赋予与由二氧化钛颗粒层产生的白色和/或内部颜色层的颜色不同的视觉颜色。因此,外部颜色层中的着色剂可以不干扰在擦洗微胶囊时由内部颜色层显现出的颜色的量来使用。Generally, the outer color layer is provided to impart a visual color different from the white color produced by the titanium dioxide particle layer and/or the color of the inner color layer. Therefore, the colorant in the outer color layer can be used in an amount that does not interfere with the color developed by the inner color layer when the microcapsules are scrubbed.
相对于核的总重量,外部颜色层的量可为1重量%至60重量%,优选2重量%至50重量%,更优选3重量%至40重量%,且特别是4重量%至30重量%。然而,相对于内部颜色层中的着色剂的总重量,外部颜色层中的着色剂的量可为0.01重量%至5重量%,优选0.05重量%至4.5重量%,更优选0.1重量%至4重量%,且特别是0.5重量%至3.5重量%。The amount of the outer color layer may be 1% to 60% by weight, preferably 2% to 50% by weight, more preferably 3% to 40% by weight, and especially 4% to 30% by weight, relative to the total weight of the core %. However, the amount of the colorant in the outer color layer may be 0.01% by weight to 5% by weight, preferably 0.05% by weight to 4.5% by weight, more preferably 0.1% by weight to 4% by weight, relative to the total weight of the colorant in the inner color layer. % by weight, and especially 0.5% by weight to 3.5% by weight.
如果外部颜色层的颜色将不干扰内部颜色层的颜色,可额外提高外部颜色层中的着色剂的量。本领域中技术人员可通过考虑内部颜色层中所含的着色剂的颜色和量以及最终要显现出的所需颜色而以适当方式选择外部颜色层中的着色剂的颜色和量。The amount of colorant in the outer color layer can be increased additionally if the color of the outer color layer will not interfere with the color of the inner color layer. Those skilled in the art can select the color and amount of the colorant in the outer color layer in an appropriate manner by considering the color and amount of the colorant contained in the inner color layer and the desired color to be finally developed.
外部颜色层的厚度不受特别限制并可根据最终需要的微胶囊适当地选择。例如,外部颜色层可具有大于20μm,特别是40μm,优选60μm,且更优选80μm,和小于200μm,特别是150μm,优选120μm,且更优选100μm的厚度。The thickness of the outer color layer is not particularly limited and can be properly selected according to the final required microcapsules. For example, the outer color layer may have a thickness greater than 20 μm, especially 40 μm, preferably 60 μm, and more preferably 80 μm, and less than 200 μm, especially 150 μm, preferably 120 μm, and more preferably 100 μm.
1-4-2-4.最外层壳1-4-2-4. Outermost shell
微胶囊可包含在可压破二氧化钛颗粒层或另外的外部颜色层上的保护性最外层壳,以保护微胶囊在储存过程中免受空气中水分的影响或确保微胶囊在载体尤其是在溶液中的长期稳定性。The microcapsules may comprise a protective outermost shell on a layer of crushable titanium dioxide particles or an additional outer color layer to protect the microcapsules from moisture in the air during storage or to secure the microcapsules in a carrier, especially in Long-term stability in solution.
最外层壳可由至少一种聚合物制成,且优选可由选自以下的至少一种聚合物制成:多糖和它们的衍生物、丙烯酸或甲基丙烯酸均聚物或共聚物或其盐和酯、聚苯乙烯-马来酸酐共聚物、和它们的混合物,例如聚(甲基)丙烯酸酯、纤维素醚、纤维素酯和它们的衍生物,以及它们的混合物。The outermost shell may be made of at least one polymer, and preferably may be made of at least one polymer selected from polysaccharides and their derivatives, acrylic or methacrylic acid homopolymers or copolymers or salts thereof and Esters, polystyrene-maleic anhydride copolymers, and mixtures thereof, such as poly(meth)acrylates, cellulose ethers, cellulose esters, and derivatives thereof, and mixtures thereof.
就微胶囊的总重量而言,最外层壳的量选自0.1重量%至20.0重量%并且优选选自0.5重量%至15重量%。当最外层壳的量小于0.1重量%时,壳涂层可能是无意义的,且当它超过20.0重量%时,可能引起存在外来物质的感觉。The amount of the outermost shell is selected from 0.1% to 20.0% by weight and preferably from 0.5% to 15% by weight, relative to the total weight of the microcapsules. When the amount of the outermost shell is less than 0.1% by weight, the shell coating may be meaningless, and when it exceeds 20.0% by weight, it may cause a feeling that foreign substances are present.
最外层壳的厚度不受特别限定并且可根据最终需要的微胶囊适当地选择。例如,最外层壳可具有大于20μm、尤其30μm、优选40μm并且更优选50μm且小于200μm、尤其150μm、优选120μm并且更优选90μm的厚度。The thickness of the outermost shell is not particularly limited and may be appropriately selected according to the final desired microcapsules. For example, the outermost shell may have a thickness greater than 20 μm, especially 30 μm, preferably 40 μm and more preferably 50 μm and less than 200 μm, especially 150 μm, preferably 120 μm and more preferably 90 μm.
可作为最外层壳实施的聚合物的其它实例将在稍后描述可用于本发明的微胶囊中的粘合剂期间给出。Further examples of polymers that can be implemented as the outermost shell will be given later during the description of binders that can be used in the microcapsules of the present invention.
1-4-3.方法1-4-3. Method
微胶囊可通过在涂布或封装领域(domain)内的领域中已知的常规方法生产,所述方包括成球(pelletization)、造粒、涂布等。例如,微胶囊可通过如在WO01/35933和WO2011/027960中所公开的包含化合物的混合物(活性剂、颜料、聚合物、溶剂)并干燥以形成胶囊的步骤获得,或者通过如在FR2841155中所公开的造粒和通过喷雾干燥涂布的步骤获得、或者通过已经用在食品和制药行业中的流化床技术获得。可引用WO08/139053中的实例,制备包括糖芯和药物活性剂的同心层的球状体多层。通过浸渍或粉碎或喷射进行药物活性剂在核上的固定,并随后在施加第二层之前干燥第一层。Microcapsules can be produced by conventional methods known in the art within the coating or encapsulation domain, including pelletization, granulation, coating, and the like. For example, microcapsules can be obtained by comprising a mixture of compounds (active agent, pigment, polymer, solvent) as disclosed in WO01/35933 and WO2011/027960 and drying to form capsules, or by The disclosed granulation and is obtained by spray-drying coating steps, or by fluidized bed techniques already used in the food and pharmaceutical industries. The example in WO 08/139053 may be cited for the preparation of multilayered spheroids comprising a sugar core and concentric layers of pharmaceutically active agent. Immobilization of the pharmaceutically active agent on the core is carried out by dipping or pulverizing or spraying, with subsequent drying of the first layer before applying the second layer.
优选地,引入本发明的组合物中的微胶囊通过后面描述的流化床技术是可获得的,且优选通过后面描述的流化床技术获得,至少部分获得。流化床方法的特征在于与喷雾干燥相比,其得到真正的胶囊,所述喷雾干燥得到通过颗粒凝聚形成的粒状颗粒或得到核材料无规分散到聚合物中的基质。特别地,使用流化床方法允许具有基本上为球形的核的基本上为球形的微胶囊,所述微胶囊由圆周包围所述的核的至少一个层和优选地圆周包围内层的至少一个外层包围。Preferably, the microcapsules incorporated into the composition of the invention are obtainable, and preferably obtained, at least in part, by the fluidized bed technique described hereinafter. The fluidized bed process is characterized in that it results in true capsules in contrast to spray drying which gives granular particles formed by particle agglomeration or a matrix in which the core material is randomly dispersed into the polymer. In particular, the use of a fluidized bed process allows substantially spherical microcapsules with a substantially spherical core, said microcapsules being composed of at least one layer circumferentially surrounding said core and preferably at least one of an inner layer Outer surround.
例如,在’Fluid-Bed Coating,Teunou,E.;Poncelet,2005,D.Food Science andTechnology(BocaRaton,FL,United States),第146卷,刊(Issue)Encapsulated andPowdered Foods,第197-212页中公开了流化床方法。本领域技术人员知道如何调节允许再生产根据本发明的微胶囊的空气量、液体量和温度。For example, in 'Fluid-Bed Coating, Teunou, E.; Poncelet, 2005, D. Food Science and Technology (Boca Raton, FL, United States), Vol. 146, Issue (Issue) Encapsulated and Powdered Foods, pp. 197-212 A fluidized bed process is disclosed. A person skilled in the art knows how to adjust the amount of air, liquid and temperature that allow the reproduction of the microcapsules according to the invention.
优选流化床方法包括Würster方法和/或切向喷涂(tangential spray)方法。与成球方法不同,此类方法允许具有被一个或更多个圆周层包围的核的球形胶囊。Preferred fluidized bed methods include the Würster method and/or the tangential spray method. Unlike spheronization methods, such methods allow spherical capsules with a core surrounded by one or more circumferential layers.
通过在微胶囊中组合具有不同硬度和/或水溶解度的两种或更多种化合物(例如聚合物、基于脂质的材料)与二氧化钛颗粒,可能调节封装着色剂的微胶囊在皮肤上破裂所需的时间,以便通过改变施用到皮肤上的方法或强度,可能调节优选的着色或渐变图案。By combining two or more compounds (e.g., polymers, lipid-based materials) with different hardness and/or water solubility with titanium dioxide particles in the microcapsules, it is possible to modulate the rate at which microcapsules encapsulating colorants rupture on the skin. Over time, it is possible to adjust the preferred coloring or gradation pattern by varying the method or intensity of application to the skin.
优选地,该多层涂层包含至少淀粉作为聚合物,以及至少一种基于脂质的材料且优选卵磷脂。Preferably, the multilayer coating comprises at least starch as polymer, and at least one lipid-based material and preferably lecithin.
优选地,该微胶囊另外包括选自磷脂,有利地选自磷酸酰基甘油且特别是卵磷脂的基于脂质的材料。Preferably, the microcapsules additionally comprise a lipid-based material selected from phospholipids, advantageously from phosphoacylglycerols and especially lecithin.
优选地,该微胶囊包括三种或更多种不同的着色剂(就颜色而言)。更优选,所述着色剂是无机颜料,且甚至更优选金属氧化物。Preferably, the microcapsules comprise three or more different colorants (in terms of color). More preferably, the colorant is an inorganic pigment, and even more preferably a metal oxide.
在本发明中,在流化床涂布方法中所用的涂布溶液的制备中可使用有机溶剂。该有机溶剂不受特别限制,但优选包括二氯甲烷、甲醇、乙醇及其混合物。可能使用任何有机溶剂,只要其可溶解或分散所述聚合物和/或基于脂质的材料,具有小于水的沸点的沸点,并具有低残留毒性。In the present invention, an organic solvent may be used in the preparation of the coating solution used in the fluidized bed coating method. The organic solvent is not particularly limited, but preferably includes methylene chloride, methanol, ethanol and mixtures thereof. Any organic solvent may be used as long as it can dissolve or disperse the polymer and/or lipid-based material, has a boiling point less than that of water, and has low residual toxicity.
用于本发明的微胶囊通过下列步骤是可获得的,并且优选通过下列步骤获得:Microcapsules for use in the present invention are obtainable, and preferably obtained, by the following steps:
(a-1)制备包含至少一种着色剂和至少一种粘合剂的着色核(A-1)的颗粒,和(a-1) preparing particles of colored cores (A-1) comprising at least one colorant and at least one binder, and
(a-2)任选用一种溶液涂布上述步骤(a-1)中制备的着色核,在所述溶液中溶解或分散与上述步骤(a-1)中所用的那些相同或不同的着色剂和粘合剂,以形成内部颜色层(A-2),(a-2) Optionally coat the coloring core prepared in the above step (a-1) with a solution in which the same or different coloring agents as those used in the above step (a-1) are dissolved or dispersed. Colorants and binders to form the inner color layer (A-2),
(b)用一种溶液涂布上述步骤(a-1)或(a-2)中制备的颗粒,在所述溶液中二氧化钛颗粒和粘合剂形成可压破壁层(B),(b) coating the particles prepared in step (a-1) or (a-2) above with a solution in which titanium dioxide particles and a binder form a crushable wall layer (B),
(c-1)任选用一种溶液涂布上述步骤(b)中获得的颗粒,在所述溶液中溶解或分散与上述步骤(a-1)或(a-2)中所用的那些相同或不同的着色剂和粘合剂,以形成外部颜色层(C-1),(c-1) optionally coating the particles obtained in the above step (b) with a solution in which the same as those used in the above step (a-1) or (a-2) are dissolved or dispersed or different colorants and binders to form the outer color layer (C-1),
(c-2)任选用一种溶液涂布上述步骤(b)或(c-1)中获得的颗粒,在所述溶液中溶解或分散成壳聚合物,以形成最外层壳。(c-2) Optionally coating the particles obtained in the above step (b) or (c-1) with a solution in which the shell polymer is dissolved or dispersed to form the outermost shell.
将通过以下实施例进一步解释本发明,但不限于它们。The present invention will be further explained by the following examples, without being limited to them.
1-4-4微胶囊的性质Properties of 1-4-4 microcapsules
微胶囊在本发明的组合物中是稳定的,优选在高温下、例如大于或等于40℃的温度下,例如在45℃的烘箱中稳定1个月、更好地两个月、且再更好地三个月;或者在60℃的烘箱中稳定15天。The microcapsules are stable in the compositions of the invention, preferably at elevated temperatures, such as at temperatures greater than or equal to 40°C, such as in an oven at 45°C for 1 month, better for two months, and still more Good for three months; or stable for 15 days in an oven at 60°C.
优选地,微胶囊呈现出适当的软化动力学。更优选地,在与配方中的其它化合物接触至少三小时后,微胶囊的硬度(hardness)有利地为5至50克、更优选地6至20克、且再更优选地7至10克。这种硬度与用于制备包括这种微胶囊的组合物的工业方法相适应。软化动力学和硬度的这样的值允许不仅提供美观的微胶囊,而且提供总体美观的组合物。Preferably, the microcapsules exhibit suitable softening kinetics. More preferably, the hardness of the microcapsules is advantageously from 5 to 50 grams, more preferably from 6 to 20 grams, and even more preferably from 7 to 10 grams, after at least three hours of contact with the other compounds in the formulation. This hardness is compatible with the industrial processes used to prepare compositions comprising such microcapsules. Such values of softening kinetics and hardness allow to provide not only aesthetically pleasing microcapsules, but also overall aesthetically pleasing compositions.
尤其,组合物可根据摩擦的强度导致不同的色调(shades)或颜色渐变。如在CIE实验体系1976中所测定的,组合物可有利地呈现高的色度C*。In particular, the composition may result in different shades or color gradations depending on the intensity of the rubbing. The composition may advantageously exhibit a high color C* as determined in the CIE Test System 1976.
1-5.另外的表面活性剂1-5. Additional surfactants
除了以上(b)外,本发明的组合物可进一步包含至少一种另外的表面活性剂。可使用单一类型的另外的表面活性剂,但可组合使用两种或更多种不同类型的另外的表面活性剂。In addition to (b) above, the composition of the present invention may further comprise at least one additional surfactant. A single type of additional surfactant may be used, but two or more different types of additional surfactant may be used in combination.
作为另外的表面活性剂,可使用至少一种离子表面活性剂。所述离子表面活性剂可选自阳离子表面活性剂、阴离子表面活性剂和两性表面活性剂,优选选自阴离子表面活性剂和两性表面活性剂且更优选阴离子表面活性剂。As additional surfactant, at least one ionic surfactant can be used. The ionic surfactant may be selected from cationic surfactants, anionic surfactants and amphoteric surfactants, preferably selected from anionic surfactants and amphoteric surfactants and more preferably anionic surfactants.
1-5-1.阳离子表面活性剂1-5-1. Cationic surfactant
阳离子表面活性剂不受限制。阳离子表面活性剂可任选地选自聚氧烯化的伯、仲或叔脂肪胺盐、季铵盐及其混合物。Cationic surfactants are not limited. The cationic surfactant may optionally be selected from polyoxyalkylenated primary, secondary or tertiary fatty amine salts, quaternary ammonium salts and mixtures thereof.
可提及的季铵盐的实例包括,但不限于下面通式(V)的那些:Examples of quaternary ammonium salts that may be mentioned include, but are not limited to, those of the following general formula (V):
[式(V)][Formula (V)]
其中R1、R2、R3和R4可相同或不同,选自含有1至30个碳原子并且任选含有杂原子如氧、氮、硫和卤素的直链和支链脂族基团。所述脂族基团可选自,例如烷基、烷氧基、C2-C6聚氧化烯基、烷基酰胺基、(C12-C22)烷基酰胺(C2-C6)烷基、(C12-C22)烷基乙酸酯基和羟烷基;和芳族基团如芳基和烷基芳基;并且X-选自卤化物、磷酸盐、乙酸盐、乳酸盐、(C2-C6)烷基硫酸盐和烷基-或烷基芳基-磺酸盐;咪唑啉的季铵盐;双季铵盐;和包含至少一个酯官能团的季铵盐。wherein R 1 , R 2 , R 3 and R 4 may be the same or different and are selected from straight and branched chain aliphatic groups containing 1 to 30 carbon atoms and optionally containing heteroatoms such as oxygen, nitrogen, sulfur and halogen . The aliphatic group may be selected from, for example, alkyl, alkoxy, C 2 -C 6 polyoxyalkylene, alkylamide, (C 12 -C 22 )alkylamide (C 2 -C 6 ) Alkyl, (C 12 -C 22 ) alkyl acetate and hydroxyalkyl; and aromatic groups such as aryl and alkylaryl; and X - selected from the group consisting of halides, phosphates, acetates, Lactates, (C 2 -C 6 )alkylsulfates and alkyl- or alkylaryl-sulfonates; quaternary ammonium salts of imidazolines; diquaternary ammonium salts; and quaternary ammonium salts containing at least one ester function Salt.
上面提到的可用在根据本发明的组合物中的季铵盐包括但不限于,四烷基氯化铵,例如二烷基二甲基氯化铵和烷基三甲基氯化铵,其中所述烷基包含约12至22个碳原子,如山萮基三甲基氯化铵、二硬脂基二甲基氯化铵、鲸蜡基三甲基氯化铵和苄基二甲基硬脂基氯化铵;棕榈酰胺丙基三甲基氯化铵;和硬脂酰胺丙基二甲基(乙酸肉豆蔻酯)氯化铵(stearamidopropyldimethyl(myristyl acetate)ammoniumchloride),由Van Dyk公司以名称出售。The above-mentioned quaternary ammonium salts that can be used in the composition according to the present invention include, but are not limited to, tetraalkylammonium chlorides, such as dialkyldimethylammonium chloride and alkyltrimethylammonium chloride, wherein The alkyl group contains about 12 to 22 carbon atoms, such as behenyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, cetyl trimethyl ammonium chloride and benzyl dimethyl stearyl ammonium chloride. Tatyl ammonium chloride; palmitamidopropyl trimethyl ammonium chloride; and stearamidopropyl dimethyl (myristyl acetate) ammonium chloride sold by the Van Dyk Company under the name sell.
在一个实施方案中,可在本发明的组合物中使用的阳离子表面活性剂选自季铵盐,例如,选自山萮基三甲基氯化铵、鲸蜡基三甲基氯化铵、Quaternium-83、Quaternium-87、Quaternium-22、山萮酰胺丙基-2,3-二羟丙基二甲基氯化铵、棕榈酰胺丙基三甲基氯化铵和硬脂酰胺丙基二甲基胺。In one embodiment, the cationic surfactants which may be used in the compositions of the invention are selected from quaternary ammonium salts, for example, selected from behenyltrimethylammonium chloride, cetyltrimethylammonium chloride, Quaternium-83, Quaternium-87, Quaternium-22, Behenamidopropyl-2,3-Dihydroxypropyl Dimethyl Ammonium Chloride, Palmitomidopropyl Trimethyl Ammonium Chloride and Stearamidopropyl Dimethyl Ammonium Chloride Methylamine.
1-5-2.阴离子表面活性剂1-5-2. Anionic surfactant
阴离子表面活性剂不受限制。阴离子表面活性剂可特别选自植物来源的蛋白质或丝蛋白的阴离子衍生物、磷酸酯(phosphate)和烷基磷酸酯、羧酸盐、磺基琥珀酸酯(sulphosuccinate)、氨基酸衍生物、烷基硫酸酯(alkyl sulphate)、烷基醚硫酸酯、磺酸盐、羟乙基磺酸盐、牛磺酸盐、烷基磺基乙酸盐(alkyl sulphoacetate)、多肽、烷基多葡糖苷的阴离子衍生物,和它们的混合物。Anionic surfactants are not limited. Anionic surfactants may in particular be selected from anionic derivatives of proteins of vegetable origin or silk proteins, phosphates and alkyl phosphates, carboxylates, sulphosuccinates, amino acid derivatives, alkyl Anion of alkyl sulphate, alkyl ether sulphate, sulphonate, isethionate, taurate, alkyl sulphoacetate, polypeptide, alkyl polyglucoside derivatives, and mixtures thereof.
1)植物来源的蛋白质的阴离子衍生物是包含疏水性基团的蛋白质水解产物,对于所述疏水性基团而言其可能天然存在于蛋白质中或由蛋白质和/或蛋白质水解产物与疏水化合物的反应而加入。所述蛋白质是植物来源的或衍生自丝,并且所述疏水性基团可特别为脂肪链,例如含有10至22个碳原子的烷基链。作为植物来源的蛋白质的阴离子衍生物,可更特别提及包含具有10至22个碳原子的烷基链的苹果、小麦、大豆或燕麦蛋白质水解产物,和它们的盐。所述烷基链可特别是月桂基链,并且所述盐可为钠、钾和/或铵盐。1) Anionic derivatives of proteins of vegetable origin are protein hydrolysates comprising hydrophobic groups for which they may naturally occur in proteins or which result from the combination of proteins and/or protein hydrolysates with hydrophobic compounds React and join. The protein is of vegetable origin or derived from silk, and the hydrophobic group may in particular be an aliphatic chain, for example an alkyl chain containing 10 to 22 carbon atoms. As anionic derivatives of proteins of vegetable origin, mention may be made more particularly of apple, wheat, soybean or oat protein hydrolysates comprising alkyl chains having 10 to 22 carbon atoms, and their salts. The alkyl chain may in particular be a lauryl chain, and the salt may be a sodium, potassium and/or ammonium salt.
因此,作为包含疏水性基团的蛋白质水解产物,可提及例如蛋白质水解产物的盐,其中所述蛋白质是由月桂酸改性的丝蛋白,如由Kawaken以名称Kawa Silk出售的产品;蛋白质水解产物的盐,其中所述蛋白质是由月桂酸改性的小麦蛋白,如由Croda以名称Aminofoam W OR出售的钾盐(CTFA名称:月桂酰小麦氨基酸钾),以及由Seppic以名称Proteol LW 30出售的钠盐(CTFA名称:月桂酰小麦氨基酸钠);蛋白质水解产物的盐,其中所述蛋白质是包含具有10至22个碳原子的烷基链的燕麦蛋白,并且更尤其是蛋白质水解产物的盐,其中所述蛋白质是由月桂酸改性的燕麦蛋白,如由Seppic以名称Proteol OAT(30%水溶液)出售的钠盐(CTFA名称:月桂酰燕麦氨基酸钠);或包含具有10至22个碳原子的烷基链的苹果蛋白水解产物的盐,如由Seppic以名称Proteol APL(30%的水/乙二醇溶液)出售的钠盐(CTFA名称:椰油酰苹果氨基酸钠)。还可提到由Seppic以名称Proteol SAV50S出售的用N-甲基甘氨酸钠中和的月桂酰氨基酸(天冬氨酸、谷氨酸、甘氨酸、丙氨酸)的混合物(CTFA名称:椰油酰氨基酸钠)。Thus, as protein hydrolysates comprising hydrophobic groups, mention may be made, for example, of salts of protein hydrolysates, wherein said protein is silk protein modified with lauric acid, such as the product sold under the name Kawa Silk by Kawaken; protein hydrolysates Salts of products wherein the protein is a wheat protein modified with lauric acid, such as the potassium salt sold under the name Aminofoam W OR by Croda (CTFA name: Potassium Lauroyl Wheat Amino Acid) and Proteol LW 30 by Seppic (CTFA name: sodium lauroyl wheat amino acid); salts of protein hydrolysates, wherein the protein is oat protein comprising alkyl chains having 10 to 22 carbon atoms, and more especially salts of protein hydrolysates , wherein the protein is oat protein modified with lauric acid, such as the sodium salt sold by Seppic under the name Proteol OAT (30% in water) (CTFA name: sodium lauroyl oat amino acid); or contains A salt of an apple protein hydrolyzate of an alkyl chain of atoms, such as the sodium salt sold by Seppic under the name Proteol APL (30% solution in water/glycol) (CTFA name: sodium cocoyl apple amino acid). Mention may also be made of the mixture of lauroyl amino acids (aspartic acid, glutamic acid, glycine, alanine) neutralized with sodium N-methylglycinate sold under the name Proteol SAV50S by Seppic (CTFA name: Cocoyl amino acid sodium).
2)作为磷酸酯和烷基磷酸酯,可提及例如单烷基磷酸酯和二烷基磷酸酯,如由Kao Chemicals以名称出售的月桂基单磷酸酯,十二烷基磷酸酯的钾盐,由Cognis以名称出售的单酯和二酯的混合物(主要是二酯),由Cognis以名称出售的辛基磷酸单酯和二酯的混合物,由Condea以名称出售的乙氧基化(7mol的EO)2-丁基辛基磷酸单酯和二酯的混合物,由Uniqema以编号和 出售的单(C12-C13)烷基磷酸酯的钾盐或三乙醇胺盐,由Rhodia Chimie以名称出售的月桂基磷酸酯钾,和由Uniqema以名称Arlatone MAP 160K出售的鲸蜡基磷酸酯钾。2) As phosphates and alkyl phosphates, mention may be made, for example, of mono- and di-alkyl phosphates, as produced by Kao Chemicals under the name Lauryl monophosphate, potassium salt of lauryl phosphate, sold by Cognis under the name Mixtures of monoesters and diesters (mainly diesters) sold by Cognis under the name A mixture of octyl phosphate mono- and diesters sold by Condea under the name Mixtures of ethoxylated (7 mol of EO) 2-butyloctyl phosphate mono- and diesters sold by Uniqema under the code and The potassium or triethanolamine salts of mono(C 12 -C 13 ) alkyl phosphates sold by Rhodia Chimie under the name Potassium lauryl phosphate, and potassium cetyl phosphate sold under the name Arlatone MAP 160K by Uniqema.
3)作为羧酸盐可提及:3) As carboxylates there may be mentioned:
-酰胺基醚羧酸盐(AEC),如月桂基酰胺基醚羧酸钠(3EO),由Kao Chemicals以名称出售;- Amido ether carboxylates (AEC), such as sodium lauryl amido ether carboxylate (3EO), sold by Kao Chemicals under the name sell;
-聚氧乙烯化羧酸盐,如氧乙烯化(6EO)月桂基醚羧酸钠(65/25/10C12-C14-C16),由Kao Chemicals以名称出售,源自橄榄油的聚氧乙烯化和羧甲基化的脂肪酸,由Biologia E Tecnologia以名称出售,或氧乙烯化(6EO)十三烷基醚羧酸钠,由Nikkol以名称出售;和- Polyoxyethylenated carboxylates, such as oxyethylenated (6EO) sodium lauryl ether carboxylate (65/25/10C 12 -C 14 -C 16 ), sold by Kao Chemicals under the name Sold, polyoxyethylated and carboxymethylated fatty acids derived from olive oil, by Biologia E Tecnologia under the name Sold, or sodium oxyethylenated (6EO) tridecyl ether carboxylate, by Nikkol under the name sell; and
-用有机或无机碱(如氢氧化钾、氢氧化钠、三乙醇胺、N-甲基葡糖胺、赖氨酸和精氨酸)中和的具有C6至C22烷基链的脂肪酸的盐(皂)。- Fatty acids with C6 to C22 alkyl chains neutralized with organic or inorganic bases such as potassium hydroxide, sodium hydroxide, triethanolamine, N-methylglucamine, lysine and arginine salt (soap).
4)作为氨基酸衍生物,可特别提及氨基酸的碱金属盐,例如:4) As amino acid derivatives, mention may especially be made of alkali metal salts of amino acids, such as:
-肌氨酸盐,如月桂酰肌氨酸钠,由Ciba以名称出售或由Seppic以名称出售,肉豆蔻酰肌氨酸钠,由Nikkol以名称 出售,或棕榈酰肌氨酸钠,由Nikkol以名称出售;- Sarcosinates, such as sodium lauroyl sarcosinate, marketed by Ciba under the name sold by or by Seppic under the name Sold, Sodium Myristoyl Sarcosinate, by Nikkol under the name Sold, or sodium palmitoyl sarcosinate, by Nikkol under the name sell;
-丙氨酸盐,如N-月桂酰-N-甲基酰胺基丙酸钠,由Nikkol以名称 出售或由Kawaken以名称出售,或N-月桂酰-N-甲基丙氨酸三乙醇胺,由Kawaken以名称出售;- Alanine salts, such as sodium N-lauroyl-N-methylamidopropionate, sold by Nikkol under the name sold by or by Kawaken under the name Sold, or N-lauroyl-N-methylalanine triethanolamine, by Kawaken under the name sell;
-谷氨酸盐,如单椰油酰谷氨酸三乙醇胺,由Ajinomoto以名称 出售,月桂酰谷氨酸三乙醇胺,由Ajinomoto以名称出售;-Glutamates, such as triethanolamine monococoyl glutamate, by Ajinomoto under the name Sold, Triethanolamine Lauroyl Glutamate, by Ajinomoto under the name sell;
-天冬氨酸盐,如N-月桂酰天冬氨酸三乙醇胺和N-肉豆蔻酰天冬氨酸三乙醇胺的混合物,由Mitsubishi以名称出售;- Aspartate, such as a mixture of N-lauroyl aspartic acid triethanolamine and N-myristoyl aspartic acid triethanolamine, manufactured by Mitsubishi under the name sell;
-甘氨酸衍生物(甘氨酸盐),如N-椰油酰甘氨酸钠,由Ajinomoto以名称和Amilite GCK 12出售;- Glycine derivatives (glycine salts), such as sodium N-cocoyl glycinate, by Ajinomoto under the name and Amilite GCK 12 for sale;
-柠檬酸酯(citrates),如氧乙烯化(9mol)椰油醇的柠檬酸单酯,由Goldschmidt以名称Witconol EC 1129出售;和- citrates, such as oxyethylenated (9 mol) citrate monoester of cocoyl alcohol, sold under the name Witconol EC 1129 by Goldschmidt; and
-半乳糖醛酸盐,如十二烷基D-半乳糖苷糖醛酸钠(sodium dodecylD-galactoside uronate),由Soliance出售。- Galacturonates, such as sodium dodecyl D-galactoside uronate, sold by Soliance.
5)作为磺基琥珀酸酯,可提及例如氧乙烯化(3EO)月桂(70/30C12/C14)醇单磺基琥珀酸酯,由Witco以名称和出售,C12-C14醇的半磺基琥珀酸酯的二钠盐,由Zschimmer Schwarz以名称 出售,氧乙烯化(2EO)油酰胺基磺基琥珀酸酯二钠,由Cognis以名称出售,氧乙烯化(5EO)月桂酰胺单磺基琥珀酸酯,由Sanyo以名称出售,氧乙烯化(10EO)月桂基柠檬酸酯单磺基琥珀酸酯的二钠盐,由Witco以名称出售,或蓖麻油酸单乙醇酰胺单磺基琥珀酸酯,由Witco以名称出售。也可使用聚二甲基硅氧烷磺基琥珀酸酯,如PEG-12二甲基聚硅氧烷磺基琥珀酸酯二钠,由MacIntyre以名称Mackanate-DC 30出售。5) As sulfosuccinates, mention may be made, for example, of oxyethylenated (3EO) lauryl (70/30C 12 /C 14 ) alcohol monosulfosuccinate, sold by Witco under the name and Sold, disodium salt of hemisulfosuccinates of C 12 -C 14 alcohols, by Zschimmer Schwarz under the name Sold, disodium oxyethylenated (2EO) oleamide sulfosuccinate, by Cognis under the name Sold, oxyethylenated (5EO) lauramide monosulfosuccinate, by Sanyo under the name Sold, disodium salt of oxyethylenated (10EO) lauryl citrate monosulfosuccinate, by Witco under the name Sold, or ricinoleic acid monoethanolamide monosulfosuccinate, by Witco under the name sell. Dimethicone sulfosuccinates such as PEG-12 disodium dimethicone sulfosuccinate sold under the name Mackanate-DC 30 by MacIntyre may also be used.
6)作为烷基硫酸酯,可提及例如月桂基硫酸酯三乙醇胺(CTFA名称:TEA月桂基硫酸酯盐),如由Huntsman以名称Empicol TL40FL出售的产品或由Cognis以名称Texapon T42出售的产品,该产品是以40%在水溶液中。还可提到月桂基硫酸酯铵(ammonium lauryl sulphate,CTFA名称:月桂基硫酸酯铵),如由Huntsman以名称Empicol AL 30FL出售的产品,其以30%在水溶液中。6) As alkyl sulfates, mention may be made, for example, of triethanolamine lauryl sulfate (CTFA name: TEA lauryl sulfate), such as the product sold under the name Empicol TL40FL by Huntsman or Texapon T42 by Cognis , the product is 40% in aqueous solution. Mention may also be made of ammonium lauryl sulphate (CTFA name: ammonium lauryl sulphate), such as the product sold under the name Empicol AL 30FL by Huntsman, which is 30% in aqueous solution.
7)作为烷基醚硫酸酯,可提及例如月桂基醚硫酸酯钠(CTFA名称:月桂醇聚醚硫酸酯钠),如由Cognis以名称Texapon N40和Texapon AOS 225UP出售的,或月桂基醚硫酸酯铵(CTFA名称:月桂醇聚醚硫酸酯铵),如由Cognis以名称Standapol EA-2出售的。7) As alkyl ether sulfates, mention may be made, for example, of sodium lauryl ether sulfate (CTFA name: sodium laureth sulfate), as sold by Cognis under the names Texapon N40 and Texapon AOS 225UP, or lauryl ether sulfate Ammonium sulfate (CTFA name: Ammonium Laureth Sulfate), as sold under the name Standapol EA-2 by Cognis.
8)作为磺酸盐,可提及例如α-烯烃磺酸盐,如α-烯烃磺酸钠(C14-C16),由Stepan以名称出售,由Witco以名称和出售或由Stepan以名称出售,仲烯烃磺酸钠(secondary sodium olefinsulphonate),由Clariant以名称出售;或直链烷基芳基磺酸盐,如二甲苯磺酸钠,由Manro以名称 和出售。8) As sulfonates, mention may be made, for example, of α-olefin sulfonates, such as sodium α-olefin sulfonate (C 14 -C 16 ), described by Stepan under the name Sold by Witco under the name and sold by or by Stepan under the name Sold, secondary sodium olefin sulfonate (secondary sodium olefinsulphonate), by Clariant under the name or linear alkylaryl sulfonates such as sodium xylene sulfonate sold by Manro under the name and sell.
9)作为羟乙基磺酸盐,可提及酰基羟乙基磺酸盐,如椰油酰羟乙基磺酸钠,如由Jordan以名称出售的产品。9) As isethionates, mention may be made of acyl isethionates, such as sodium cocoyl isethionate, as described by Jordan under the name products for sale.
10)作为牛磺酸盐,可提及棕榈仁油甲基牛磺酸的钠盐,由Clariant以名称出售;N-酰基-N-甲基牛磺酸盐,如N-椰油酰-N-甲基牛磺酸钠,由Clariant以名称出售或由Nikkol以名称出售,由Nikkol以名称出售的甲基硬脂酰基牛磺酸钠或以名称 出售的棕榈酰甲基牛磺酸钠。10) As taurine, mention may be made of the sodium salt of palm kernel oil methyl taurine, sold by Clariant under the name Sold; N-acyl-N-methyl taurates such as sodium N-cocoyl-N-methyl taurate sold by Clariant under the name sold by or by Nikkol under the name Sold by Nikkol under the name Sodium methyl stearoyl taurate sold under the name Sodium Palmitoyl Methyl Taurate For Sale.
11)烷基多葡糖苷的阴离子衍生物可特别是获自烷基多葡糖苷的柠檬酸酯、酒石酸酯、磺基琥珀酸酯、碳酸酯和甘油醚。可提及例如椰油酰多葡糖苷(1,4)酒石酸酯的钠盐,由Cesalpinia以名称出售,椰油酰多葡糖苷(1,4)磺基琥珀酸酯的二钠盐,由Seppic以名称出售,或椰油酰多葡糖苷(1,4)柠檬酸酯的钠盐,由Cesalpinia以名称出售。11) Anionic derivatives of alkyl polyglucosides can be obtained in particular from citrates, tartrates, sulfosuccinates, carbonates and glyceryl ethers of alkyl polyglucosides. Mention may be made, for example, of the sodium salt of cocoyl polyglucoside (1,4) tartrate, sold by Cesalpinia under the name Sold, disodium salt of cocoyl polyglucoside (1,4) sulfosuccinate, by Seppic under the name sold, or sodium salt of cocoyl polyglucoside (1,4) citrate, by Cesalpinia under the name sell.
优选所述氨基酸衍生物可为酰基甘氨酸衍生物或甘氨酸衍生物,特别是酰基甘氨酸盐。Preferably, the amino acid derivative may be an acylglycine derivative or a glycine derivative, especially an acylglycine salt.
酰基甘氨酸衍生物或甘氨酸衍生物可选自酰基甘氨酸盐(acyl glycine salt或acyl glycinate)或甘氨酸盐(glycine salt或glycinate),并且特别选自以下。The acylglycine derivative or glycine derivative may be selected from acyl glycine salt or acyl glycinate or glycine salt or glycinate, and is particularly selected from the following.
i)式R-HNCH2COOX的酰基甘氨酸盐i) Acylglycine salts of formula R-HNCH 2 COOX
其中in
-R代表酰基R'C=O,其中R',其代表饱和或不饱和、直链或支链的烃链,优选包含10至30个碳原子、更优选12至22个碳原子、甚至更优选14至22个碳原子并且更好地16至20个碳原子,和-R represents an acyl group R'C=O, wherein R' represents a saturated or unsaturated, straight or branched hydrocarbon chain, preferably comprising 10 to 30 carbon atoms, more preferably 12 to 22 carbon atoms, even more preferably 14 to 22 carbon atoms and better 16 to 20 carbon atoms, and
-X代表选自例如碱金属(如Na、Li或K,优选Na或K)的离子、碱土金属(例如Mg)的离子、铵基和它们的混合物的阳离子。-X represents a cation selected from, for example, ions of alkali metals (such as Na, Li or K, preferably Na or K), ions of alkaline earth metals (such as Mg), ammonium groups, and mixtures thereof.
所述酰基可特别选自月桂酰基、肉豆蔻酰基、山萮酰基、棕榈酰基、硬脂酰基、异硬脂酰基、橄榄油酰基(olivoyl)、椰油酰基或油酰基和它们的混合物。The acyl group may in particular be selected from lauroyl, myristoyl, behenoyl, palmitoyl, stearoyl, isostearoyl, olivoyl, cocoyl or oleoyl groups and mixtures thereof.
优选地,R是椰油酰基。Preferably, R is cocoyl.
ii)下式(VI)的甘氨酸盐:ii) Glycinate salts of the following formula (VI):
[式(VI)][Formula (VI)]
其中:in:
-R1代表饱和或不饱和的、直链或支链的烃链,其包含10至30个碳原子、优选12至22个碳原子并且更好地16至20个碳原子;R1有利地选自月桂基、肉豆蔻基、棕榈基、硬脂基、鲸蜡基、鲸蜡硬脂基或油基和它们的混合物,并且优选选自硬脂基和油基,-R represents a saturated or unsaturated, linear or branched hydrocarbon chain comprising 10 to 30 carbon atoms, preferably 12 to 22 carbon atoms and better 16 to 20 carbon atoms; R advantageously selected from lauryl, myristyl, palmityl, stearyl, cetyl, cetearyl or oleyl and mixtures thereof, and preferably from stearyl and oleyl,
-R2基团,其为相同或不同,代表R”OH基团,R”是含有2至10个碳原子、优选2至5个碳原子的烷基。-R groups, which are the same or different, represent a R"OH group, R" being an alkyl group containing 2 to 10 carbon atoms, preferably 2 to 5 carbon atoms.
作为式(VI)的化合物,可提及例如具有INCI名称椰油酰甘氨酸钠的化合物,诸如,例如,由Ajinomoto出售的Amilite GCS-12,或椰油酰甘氨酸钾,诸如,例如,来自Ajinomoto的Amilite GCK-12。As compounds of formula (VI), mention may be made, for example, of compounds having the INCI name Sodium Cocoyl Glycinate, such as, for example, Amilite GCS-12 sold by Ajinomoto, or Potassium Cocoyl Glycinate, such as, for example, Cocoyl Glycinate from Ajinomoto Amilite GCK-12.
作为式(VI)的化合物,可使用二羟乙基油基甘氨酸盐或二羟乙基硬脂基甘氨酸盐。As the compound of formula (VI), dihydroxyethyl oleyl glycinate or dihydroxyethyl stearyl glycinate can be used.
1-5-3.两性表面活性剂1-5-3. Amphoteric surfactants
两性表面活性剂不受限制。两性或两性离子表面活性剂可以是,例如(非限制性清单),胺衍生物如脂族仲胺或叔胺,以及任选季铵化的胺衍生物,其中脂族基团是包含8至22个碳原子并包含至少一种水溶解性阴离子基团(例如,羧酸盐,磺酸盐,硫酸盐,磷酸盐或膦酸盐)的直链或支链。Amphoteric surfactants are not limited. Amphoteric or zwitterionic surfactants may be, for example (non-limiting list), amine derivatives such as aliphatic secondary or tertiary amines, and optionally quaternized amine derivatives, wherein the aliphatic group is comprised of 8 to A straight or branched chain of 22 carbon atoms and containing at least one water-soluble anionic group (eg, carboxylate, sulfonate, sulfate, phosphate or phosphonate).
在酰胺基胺羧化衍生物中,可提及以名称Miranol出售的产品,如在美国专利第2,528,378号和第2,781,354号中描述并归类于CTFA词典,第三版,1982(其公开的内容通过引用并入本文)中两性基羧基甘氨酸盐和两性基羧基丙酸盐名称下,各自的结构为:Among the amidoamine carboxylated derivatives, mention may be made of the product sold under the name Miranol, as described in US Patent Nos. 2,528,378 and 2,781,354 and classified in the CTFA Dictionary, Third Edition, 1982 (the disclosure of Incorporated herein by reference), under the names amphocarboxyglycinate and amphocarboxypropionate, the respective structures are:
R1-CONHCH2CH2-N+(R2)(R3)(CH2COO-)R 1 -CONHCH 2 CH 2 -N + (R 2 )(R 3 )(CH 2 COO - )
其中:R1表示水解椰油中存在的酸R1-COOH的烷基,庚基,壬基或十一烷基,where: R1 represents the alkyl, heptyl, nonyl or undecyl group of the acid R1 - COOH present in hydrolyzed coconut oil,
R2表示β-羟乙基,和R2 represents β - hydroxyethyl, and
R3表示羧甲基;和 R represents carboxymethyl; and
R1'-CONHCH2CH2-N(B)(C)R 1 '-CONHCH 2 CH 2 -N(B)(C)
其中:B代表-CH2CH2OX',Among them: B stands for -CH 2 CH 2 OX',
C代表-(CH2)z-Y',其中z=1或2,C represents -(CH 2 ) z -Y', where z=1 or 2,
X'表示-CH2CH2-COOH基团、-CH2-COOZ’、-CH2CH2-COOH、-CH2CH2-COOZ’或氢原子,X' represents a -CH 2 CH 2 -COOH group, -CH 2 -COOZ', -CH 2 CH 2 -COOH, -CH 2 CH 2 -COOZ' or a hydrogen atom,
Y'表示-COOH、-COOZ'、-CH2-CHOH-SO3Z’或-CH2-CHOH-SO3H基团,Y' represents -COOH, -COOZ', -CH 2 -CHOH-SO 3 Z' or -CH 2 -CHOH-SO 3 H groups,
Z'代表碱金属或碱土金属例如钠的离子,铵离子或产生自有机胺的离子,和Z' represents an ion of an alkali or alkaline earth metal such as sodium, ammonium or an ion derived from an organic amine, and
R1'表示椰油或水解亚麻籽油中存在的酸R1'-COOH的烷基,烷基,例如C7、C9、C11或C13烷基,C17烷基及其异构形式,或不饱和的C17基团。R1' represents the alkyl, alkyl, e.g. C7, C9 , C11 or C13 alkyl, C17 alkyl and its isomeric forms of the acid R1' -COOH present in coconut oil or hydrolyzed linseed oil , or an unsaturated C 17 group.
优选所述两性表面活性剂选自(C8-C24)-烷基两性基单乙酸盐、(C8-C24)烷基两性基二乙酸盐、(C8-C24)烷基两性基单丙酸盐和(C8-C24)烷基两性基二丙酸盐。Preferably the amphoteric surfactant is selected from (C 8 -C 24 )-alkyl amphomonoacetates, (C 8 -C 24 ) alkyl amphodiacetates, (C 8 -C 24 )alkane (C 8 -C 24 )alkylamphodipropionates.
这些化合物被归类于CTFA词典,第5版,1993,椰油酰两性基二乙酸二钠(Disodium Cocoamphodipropionate)、月桂酰两性基二乙酸二钠(DisodiumLauroamphodiacetate)、辛基两性基二乙酸二钠(Disodium Caprylamphodiacetate)、辛酰两性基二乙酸二钠(Disodium Capryloamphodiacetate)、椰油酰两性基二丙酸二钠、月桂酰两性基丙酸二钠、辛基两性基二丙酸二钠、辛基两性基二丙酸二钠、月桂酰两性基二丙酸和椰油酰两性基二丙酸名下。These compounds are classified in the CTFA Dictionary, 5th Edition, 1993, Disodium Cocoamphodipropionate, Disodium Lauroamphodiacetate, Disodium Octylamphodiacetate ( Disodium Caprylamphodiacetate), Disodium Capryloamphodiacetate, Disodium Cocoamphodipropionate, Disodium Lauroylamphodiacetate, Disodium Caprylamphodiacetate, Caprylamphodiacetate disodium dipropionate, lauroamphodipropionate and cocoamphodipropionate.
通过举例方式,可提及由Rhodia Chimie公司以商品名浓缩物出售的椰油酰两性基二乙酸盐。By way of example, mention may be made of the Rhodia Chimie company under the trade name Cocoamphodiacetate sold in concentrate.
优选地,所述两性表面活性剂可为甜菜碱。Preferably, the amphoteric surfactant may be betaine.
甜菜碱型两性表面活性剂优选选自烷基甜菜碱、烷基酰胺基烷基甜菜碱、烷基磺基甜菜碱、烷基磷酸酯甜菜碱(alkylphosphobetaine)和烷基酰胺基烷基磺基甜菜碱,特别是(C8-C24)烷基甜菜碱、(C8-C24)烷基酰胺基(C1-C8)烷基甜菜碱、(C8-C24)烷基磺基甜菜碱,和(C8-C24)烷基酰胺基(C1-C8)烷基磺基甜菜碱。在一个实施方案中,甜菜碱型的两性表面活性剂选自(C8-C24)烷基甜菜碱、(C8-C24)烷基酰胺基(C1-C8)烷基磺基甜菜碱、(C8-C24)烷基磺基甜菜碱和烷基(C8-C24)磷酸酯甜菜碱。Betaine-type amphoteric surfactants are preferably selected from the group consisting of alkylbetaines, alkylamidoalkylbetaines, alkylsultaines, alkylphosphobetaines and alkylamidoalkylsultaines Bases, especially (C 8 -C 24 ) alkyl betaines, (C 8 -C 24 ) alkyl amido (C 1 -C 8 ) alkyl betaines, (C 8 -C 24 ) alkyl sulfo Betaines, and (C 8 -C 24 )alkylamido(C 1 -C 8 )alkylsultaines. In one embodiment, the betaine-type amphoteric surfactant is selected from (C 8 -C 24 )alkyl betaines, (C 8 -C 24 )alkylamido (C 1 -C 8 )alkylsulfo Betaines, (C 8 -C 24 ) alkyl sultaines and alkyl (C 8 -C 24 ) phosphate betaines.
可提及的非限制性实例包括归类于CTFA词典,第9版,2002中椰油基甜菜碱、月桂基甜菜碱、鲸蜡基甜菜碱、椰油基/油酰胺基丙基甜菜碱、椰油酰胺基丙基甜菜碱、棕榈酰胺基丙基甜菜碱、硬脂酰胺基丙基甜菜碱、椰油酰胺基乙基甜菜碱、椰油酰胺基丙基羟基磺基甜菜碱、油酰胺基丙基羟基磺基甜菜碱、椰油基羟基磺基甜菜碱、月桂基羟基磺基甜菜碱和椰油基磺基甜菜碱名下的化合物,单独地或作为混合物。Non-limiting examples that may be mentioned include coco betaine, lauryl betaine, cetyl betaine, coco/oleamidopropyl betaine, Cocamidopropyl Betaine, Palmamidopropyl Betaine, Stearamidopropyl Betaine, Cocamidoethyl Betaine, Cocamidopropyl Hydroxysultaine, Oleamido Compounds under the names Propyl Hydroxysultaine, Cocoyl Hydroxysultaine, Lauryl Hydroxysultaine and Cocosultaine, alone or as a mixture.
甜菜碱型两性表面活性剂优选为烷基甜菜碱和烷基酰胺基烷基甜菜碱,特别是椰油基甜菜碱和椰油酰胺基丙基甜菜碱。Betaine-type amphoteric surfactants are preferably alkylbetaines and alkylamidoalkylbetaines, especially cocobetaines and cocamidopropyl betaines.
相对组合物的总重量,另外的表面活性剂(如果使用)的量可为0.01重量%至20重量%,优选0.10重量%至10重量%,且更优选1重量%至5重量%。Additional surfactants, if used, may be present in amounts of 0.01% to 20%, preferably 0.10% to 10%, and more preferably 1% to 5% by weight relative to the total weight of the composition.
1-5-4.多元醇1-5-4. Polyols
本发明的组合物还可包含至少一种多元醇。可使用单一类型的多元醇,但可组合使用两种或更多种不同类型的多元醇。The compositions of the invention may also comprise at least one polyol. A single type of polyol may be used, but two or more different types of polyols may be used in combination.
术语“多元醇”在这里是指具有两个或更多个羟基的醇,并且不涵盖糖或其衍生物。糖的衍生物包括通过还原糖的一个或更多个羰基获得的糖醇,以及其中其一个或更多个羟基中的一个或更多个氢原子已被至少一个取代基(例如烷基、羟烷基、烷氧基、酰基或羰基)取代的糖或糖醇。The term "polyol" here refers to alcohols having two or more hydroxyl groups and does not cover sugars or derivatives thereof. Derivatives of sugars include sugar alcohols obtained by reducing one or more carbonyl groups of sugars, and wherein one or more hydrogen atoms in one or more of its hydroxyl groups have been replaced by at least one substituent (e.g., alkyl, hydroxy Alkyl, alkoxy, acyl or carbonyl) substituted sugars or sugar alcohols.
所述多元醇可为C2-C12多元醇,优选C2-9多元醇,其包含至少2个羟基,且优选2至5个羟基。The polyol may be a C 2 -C 12 polyol, preferably a C 2-9 polyol, comprising at least 2 hydroxyl groups, and preferably 2 to 5 hydroxyl groups.
所述多元醇可为天然的或合成的多元醇。所述多元醇可具有直链、支链或环状分子结构。The polyols may be natural or synthetic polyols. The polyol may have a linear, branched or cyclic molecular structure.
所述多元醇可选自甘油和二元醇,更优选丙二醇、丁二醇、戊二醇、己二醇、一缩二丙二醇、一缩二乙二醇、乙基己基甘油、辛乙二醇、二醇醚,优选单丙二醇、一缩二丙二醇或二缩三丙二醇的烷基(C1-C4)醚或单乙二醇、一缩二乙二醇或二缩三乙二醇的烷基(C1-C4)醚,及其混合物,再更优选多元醇为甘油和/或丁二醇。The polyhydric alcohol may be selected from glycerol and glycols, more preferably propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol, diethylene glycol, ethylhexylglycerin, caprylyl glycol , glycol ether, preferably monopropylene glycol, dipropylene glycol or tripropylene glycol alkyl (C 1 -C 4 ) ether or monoethylene glycol, diethylene glycol or triethylene glycol alkane (C 1 -C 4 ) ethers, and mixtures thereof, even more preferably the polyol is glycerol and/or butanediol.
相对于组合物的总重量,所述多元醇可以在0.01重量%至30重量%,并优选0.1重量%至20重量%,如1重量%至10重量%范围内的量存在。The polyol may be present in an amount ranging from 0.01% to 30% by weight, and preferably from 0.1% to 20% by weight, such as 1% to 10% by weight, relative to the total weight of the composition.
1-5-5.增稠剂1-5-5. Thickener
本发明的组合物还可包含至少一种增稠剂。可使用单一类型的增稠剂,但可组合使用两种或更多种不同类型的增稠剂。The compositions of the invention may also comprise at least one thickener. A single type of thickener may be used, but two or more different types of thickeners may be used in combination.
所述增稠剂可选自如下:The thickener can be selected from the following:
(i)缔合性增稠剂,其为包含亲水性单元和疏水性单元二者,例如包含至少一种C8-C30脂肪链和至少一种亲水性单元的两亲增稠剂;(i) associative thickeners, which are amphiphilic thickeners comprising both hydrophilic and hydrophobic units, for example comprising at least one C8- C30 fatty chain and at least one hydrophilic unit ;
(ii)交联的丙烯酸均聚物;(ii) a crosslinked acrylic acid homopolymer;
(iii)(甲基)丙烯酸和(C1-C6)烷基丙烯酸酯的交联的共聚物;(iii) crosslinked copolymers of (meth)acrylic acid and (C 1 -C 6 ) alkyl acrylates;
(iv)包含烯键式不饱和酯单体和烯键式不饱和酰胺单体中的至少一种的非离子均聚物和共聚物;(iv) nonionic homopolymers and copolymers comprising at least one of ethylenically unsaturated ester monomers and ethylenically unsaturated amide monomers;
(v)丙烯酸铵均聚物及丙烯酸铵和丙烯酰胺的共聚物;(v) ammonium acrylate homopolymers and copolymers of ammonium acrylate and acrylamide;
(vi)C12-C30脂肪醇;(vi) C 12 -C 30 fatty alcohols;
(vii)(未)改性羧乙烯基聚合物,如由Goodrich公司以名称Carbopol(CTFA名称:卡波姆,Carbomer)出售的产品;聚丙烯酸酯;(vii) (un)modified carboxyvinyl polymers such as the products sold under the name Carbopol (CTFA name: Carbomer) by the company Goodrich; polyacrylates;
(viii)聚甲基丙烯酸酯,如由Guardian公司以名称Lubrajel和Norgel和由Hispano Chimica公司以名称Hispagel出售的产品;(viii) Polymethacrylates such as those sold under the names Lubrajel and Norgel by the company Guardian and Hispagel by the company Hispano Chimica;
(ix)聚丙烯酰胺,任选交联的;(ix) polyacrylamide, optionally crosslinked;
(x)中和的2-丙烯酰胺基-2-甲基丙磺酸聚合物和共聚物,例如由Clariant公司以名称Hostacerin AMPS(CTFA名称:聚丙烯酰基二甲基牛磺酸铵)出售的聚(2-丙烯酰胺基-2-甲基丙磺酸);(x) Neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, such as those sold under the name Hostacerin AMPS (CTFA name: Ammonium Polyacryloyldimethyltaurate) by the company Clariant Poly(2-acrylamido-2-methylpropanesulfonic acid);
(xi)丙烯酰胺和AMPS的交联的阴离子共聚物,其为W/O乳液的形式,如由SEPPIC公司以名称Sepigel 305(CTFA名称:聚丙烯酰胺/C13-C14异链烷烃/月桂醇聚醚-7)和以名称Simulgel 600(CTFA名称:丙烯酰胺/丙烯酰基二甲基牛磺酸钠共聚物/异十六烷/聚山梨醇酯80)出售的那些;(xi) Cross-linked anionic copolymers of acrylamide and AMPS in the form of W/O emulsions, such as those sold by the company SEPPIC under the name Sepigel 305 (CTFA name: Polyacrylamide/C 13 -C 14 Isoparaffin/Lauryl Alcohol-7) and those sold under the name Simulgel 600 (CTFA name: Acrylamide/Sodium Acryloyldimethyltaurate Copolymer/Isohexadecane/Polysorbate 80);
(xii)多糖生物聚合物,例如黄原胶、瓜尔胶、角豆树胶、阿拉伯胶、硬葡聚糖、甲壳素和壳聚糖衍生物、角叉菜胶、结冷胶、藻酸盐;(xii) Polysaccharide biopolymers such as xanthan gum, guar gum, carob gum, acacia gum, scleroglucan, chitin and chitosan derivatives, carrageenan, gellan gum, alginates ;
(xiii)纤维素如微晶纤维素、羧甲基纤维素、羟甲基纤维素和羟丙基纤维素,及其混合物,优选选自丙烯酸酯/C10-C30烷基丙烯酸酯交联聚合物,如Carbopolultrez 20、Carbopol ultrez 21、Permulen TR-1、Permulen TR-2、Carbopol 1382、Carbopol ETD 2020,卡波姆如Synthalen K、carbopol 980、丙烯酰基二甲基牛磺酸铵/硬脂醇聚醚-8甲基丙烯酸酯共聚物如Aristoflex SNC、丙烯酸酯共聚物如Carbopol Aqua SF-1、丙烯酰基二甲基牛磺酸铵/硬脂醇聚醚-25甲基丙烯酸酯交联聚合物如Aristoflex HMS、丙烯酰基二甲基牛磺酸铵如Arisfoflex AVC、和黄原胶如Keltrol CG;以及还有不仅有助于维持合适的粘度、进一步有助于非常好地制备胶囊悬浮液以及进一步有助于使得其就保存期而言是稳定的,而且有助于提供透明度的任何聚合物。(xiii) Cellulose such as microcrystalline cellulose, carboxymethyl cellulose, hydroxymethyl cellulose and hydroxypropyl cellulose, and mixtures thereof, preferably selected from acrylates/C 10 -C 30 alkyl acrylate crosslinks Polymers such as Carbopolltrez 20, Carbopol ultrez 21, Permulen TR-1, Permulen TR-2, Carbopol 1382, Carbopol ETD 2020, carbomers such as Synthalen K, carbopol 980, ammonium acryloyldimethyltaurate/stearate Aleth-8 methacrylate copolymers such as Aristoflex SNC, acrylate copolymers such as Carbopol Aqua SF-1, Acryloyldimethylammonium taurate/steareth-25 methacrylate crosspolymerization substances such as Aristoflex HMS, ammonium acryloyldimethyl taurate such as Arisfoflex AVC, and xanthan gum such as Keltrol CG; Any polymer that further contributes to making it stable with respect to shelf life, and which contributes to clarity.
增稠剂优选选自缔合性增稠剂、多糖和(未)改性羧乙烯基聚合物如淀粉、黄原胶(xanthene gum)和卡波姆。The thickener is preferably selected from associative thickeners, polysaccharides and (un)modified carboxyvinyl polymers such as starch, xanthene gum and carbomer.
本发明的组合物的粘度不受特别限制。粘度可在25℃下用粘度计或流变仪(优选具有锥形平面(cone-plan)几何形状)进行测量。优选地,本发明的组合物在25℃和1s-1下的粘度可例如在1Pa.s至2000Pa.s,且优选1Pa.s至1000Pa.s范围内。The viscosity of the composition of the present invention is not particularly limited. Viscosity can be measured at 25°C with a viscometer or a rheometer, preferably with cone-plan geometry. Preferably, the viscosity of the composition of the invention at 25°C and 1 s −1 may for example be in the range of 1 Pa.s to 2000 Pa.s, and preferably 1 Pa.s to 1000 Pa.s.
相对于组合物的总重量,增稠剂可以在0.001重量%至10重量%,并优选0.01重量%至10重量%,且再更优选0.1重量%至5重量%范围内的量存在。The thickener may be present in an amount ranging from 0.001% to 10% by weight, and preferably from 0.01% to 10% by weight, and still more preferably from 0.1% to 5% by weight relative to the total weight of the composition.
1-5-6.活性剂1-5-6. Active agent
对于尤其用于护理皮肤或化妆皮肤的应用,本发明的组合物可包括至少一种活性剂。For applications, in particular for caring for the skin or making up the skin, the compositions according to the invention may comprise at least one active agent.
这些活性剂可选自保湿剂(moisturizer)、遮光/防晒剂(sunscreen/sunblockagent)、抗皱剂、维生素(例如B3、B8、B12和B9)、脱皮剂(desquamating agent)、脱色剂、抗氧化剂等。These active agents may be selected from moisturizers, sunscreen/sunblock agents, anti-wrinkle agents, vitamins (such as B3, B8, B12 and B9), desquamating agents, depigmenting agents, antioxidants, etc. .
例如,可特别提及的保湿剂(或湿润剂)包括山梨糖醇、多元醇,优选C2-C8,且更优选C3-C6的多元醇,优选例如甘油、丙二醇、1,3-丁二醇、戊二醇、己二醇、一缩二丙二醇、一缩二乙二醇和双甘油,及其混合物、甘油及其衍生物、二醇醚(尤其含有3至16个碳原子),如单丙二醇、一缩二丙二醇或二缩三丙二醇(C1-C4)烷基醚、单乙二醇、一缩二乙二醇或二缩三乙二醇(C1-C4)烷基醚、脲及其衍生物,尤其是由National Starch出售的Hydrovance(2-羟乙基脲)、乳酸、透明质酸、AHA、BHA、氧脯氨酸钠(sodium pidolate)、木糖醇、丝氨酸、乳酸钠、依克多因(ectoin)及其衍生物、壳聚糖及其衍生物、胶原、浮游生物、由Sederma公司以名称Moist24出售的Imperata cylindra的提取物、丙烯酸均聚物,例如来自NOF Corporation的β-葡聚糖且特别是来自Mibelle-AG-Biochemistry的羧甲基β-葡聚糖钠;由Nestle以名称出售的西番莲油、杏油(apriot oil)、玉米油和米糠油的混合物;C-糖苷衍生物,如在专利申请WO02/051 828中描述的那些,且特别是以在水/丙二醇混合物(60/40重量%)中含有30重量%活性材料的溶液形式的C-β-D-吡喃木糖苷-2-羟基丙烷,如由Chimex以商品名制造的产品;由Nestle出售的麝香玫瑰油;由Engelhard Lyon公司以名称Marine FillingSpheres出售的海洋来源的胶原和硫酸软骨素的球体(缺端胶原,Atelocollagen);透明质酸球体,如由Engelhard Lyon公司出售的那些;精氨酸、摩洛哥坚果油(arganoil)及其混合物。For example, humectants (or humectants) that may in particular be mentioned include sorbitol, polyols, preferably C 2 -C 8 , and more preferably C 3 -C 6 polyols, preferably eg glycerol, propylene glycol, 1,3 -Butanediol, pentanediol, hexanediol, dipropylene glycol, diethylene glycol and diglycerol, mixtures thereof, glycerol and its derivatives, glycol ethers (especially containing 3 to 16 carbon atoms) , such as monopropylene glycol, dipropylene glycol or tripropylene glycol (C 1 -C 4 ) alkyl ethers, monoethylene glycol, diethylene glycol or triethylene glycol (C 1 -C 4 ) Alkyl ethers, urea and its derivatives, especially Hydrovance (2-hydroxyethylurea), lactic acid, hyaluronic acid, AHA, BHA, sodium pidolate, xylitol sold by National Starch , serine, sodium lactate, ectoin and its derivatives, chitosan and its derivatives, collagen, plankton, extracts of Imperata cylindra sold under the name Moist24 by the company Sederma, acrylic acid homopolymers, e.g. From NOF Corporation Beta-glucan and especially sodium carboxymethyl beta-glucan from Mibelle-AG-Biochemistry; sold by Nestle under the name Mixtures of passionflower oil, apriot oil, corn oil and rice bran oil sold; C-glycoside derivatives, such as those described in patent application WO 02/051 828, and especially in water/propylene glycol mixtures C-β-D-xylopyranoside-2-hydroxypropane in the form of a solution containing 30% by weight of active material in (60/40% by weight), as sold by Chimex under the trade name Manufactured product; musk rose oil sold by Nestle; spheres of collagen and chondroitin sulfate of marine origin (Atelocollagen) sold under the name Marine FillingSpheres by the company Engelhard Lyon; hyaluronic acid spheres such as by the company Engelhard Lyon Those sold; arginine, argan oil, and mixtures thereof.
优选地,将使用选自如下的保湿剂:甘油、脲及其衍生物,尤其是由NationalStarch出售的C-糖苷衍生物,如在专利申请WO 02/051 828中描述的那些,且特别是以在水/丙二醇混合物(60/40重量%)中含有30重量%的活性材料的溶液形式的C-β-D-吡喃木糖苷-2-羟基丙烷,如由Chimex以商品名制造的产品;摩洛哥坚果油及其混合物。Preferably, a humectant selected from the group consisting of glycerin, urea and their derivatives, sold especially by National Starch will be used C-glycoside derivatives, such as those described in patent application WO 02/051 828, and in particular C- β-D-Xylopyranoside-2-hydroxypropane, as sold by Chimex under the tradename Manufactured products; Argan oil and mixtures thereof.
更优选将使用甘油。More preferably glycerol will be used.
相对于所述组合物的总重量,保湿剂可以在0.1重量%至15重量%,特别地0.5重量%至10重量%或甚至1重量%至6重量%范围内的量存在于组合物中。The humectant may be present in the composition in an amount ranging from 0.1% to 15% by weight, in particular from 0.5% to 10% by weight or even from 1% to 6% by weight, relative to the total weight of the composition.
遮光剂(或防晒剂)是用于防止光老化和皮肤癌的重要护肤产品。有两类遮光剂:UVA遮光剂,其通常阻挡在320至400nm波长范围内的UV辐射,和UVB遮光剂,其通常阻挡在290至320nm波长范围内的辐射。Sunscreens (or sunscreens) are important skin care products used to prevent photoaging and skin cancer. There are two classes of sunscreens: UVA sunscreens, which generally block UV radiation in the wavelength range of 320 to 400 nm, and UVB sunscreens, which generally block radiation in the wavelength range of 290 to 320 nm.
本发明的组合物包含在UVA和/或UVB区域中有活性的有机和/或无机UV遮光成分,其为亲水和/或亲油的。特别地,本发明的UV遮光成分可具有8.0至9.5的溶解度。此类UV遮光成分具有良好的增塑剂功能。The compositions of the invention comprise organic and/or inorganic UV sunscreen ingredients active in the UVA and/or UVB region, which are hydrophilic and/or lipophilic. In particular, the UV sunscreen composition of the present invention may have a solubility of 8.0 to 9.5. Such UV sunscreen ingredients have good plasticizer function.
有利地,本发明的UV遮光剂可具有150至500g/mol的分子量并含有疏水位点和苯核或与极性位点结合的电子共振基团。Advantageously, the UV sunscreens of the invention may have a molecular weight of 150 to 500 g/mol and contain hydrophobic sites and benzene nuclei or electron resonance groups bound to polar sites.
亲水性和/或亲油性有机UV遮光成分特别选自二苯甲酰甲烷衍生物;肉桂酸衍生物;水杨酸衍生物;二苯甲酮衍生物;β,β-二苯基丙烯酸酯衍生物;对氨基苯甲酸(PABA)衍生物;和它们的混合物。Hydrophilic and/or lipophilic organic UV sunscreen ingredients are selected especially from dibenzoylmethane derivatives; cinnamic acid derivatives; salicylic acid derivatives; benzophenone derivatives; derivatives; para-aminobenzoic acid (PABA) derivatives; and mixtures thereof.
作为有机UV遮光成分的实例,可提及以下以它们的INCI名称表示的那些:As examples of organic UV sunscreen ingredients, mention may be made of the following, indicated by their INCI names:
-对氨基苯甲酸衍生物:- p-aminobenzoic acid derivatives:
-PABA,-PABA,
-PABA乙酯,- PABA ethyl ester,
-二羟基丙基PABA乙酯,- dihydroxypropyl PABA ethyl ester,
-由ISP特别地以商标“Escalol 507”出售的二甲基PABA乙基己酯,- Ethylhexyl dimethyl PABA sold especially under the trademark "Escalol 507" by ISP,
-PABA甘油酯,- PABA glycerides,
-二苯甲酰甲烷衍生物:-Dibenzoylmethane derivatives:
-由Hoffmann-LaRoche特别地以商标“Parsol 1789”出售的丁基甲氧基二苯甲酰甲烷,- Butylmethoxydibenzoylmethane sold especially under the trademark "Parsol 1789" by Hoffmann-LaRoche,
-异丙基二苯甲酰甲烷,- Isopropyldibenzoylmethane,
-水杨酸衍生物:- Salicylic acid derivatives:
-由Rona/EM Industries以商标“Eusolex HMS”出售的胡莫柳酯(Homosalate),- Homosalate sold under the trademark "Eusolex HMS" by Rona/EM Industries,
-由Haarmann and Reimer以商标“Neo Heliopan OS”出售的水杨酸乙基己酯,- Ethylhexyl salicylate sold under the trademark "Neo Heliopan OS" by Haarmann and Reimer,
-由Scher以商标“Dipsal”出售的一缩二丙二醇水杨酸酯,- Dipropylene glycol salicylate sold under the trademark "Dipsal" by Scher,
-由Haarmann and Reimer以商标“Neo Heliopan TS”出售的TEA水杨酸盐,- TEA salicylate sold under the trademark "Neo Heliopan TS" by Haarmann and Reimer,
-肉桂酸衍生物:- Cinnamic acid derivatives:
-由Hoffmann-LaRoche特别地以商标“Parsol MCX”出售的甲氧基肉桂酸乙基己酯,- ethylhexyl methoxycinnamate sold especially under the trademark "Parsol MCX" by Hoffmann-LaRoche,
-甲氧基肉桂酸异丙酯,- Isopropyl methoxycinnamate,
-由Haarmann and Reimer以商标“Neo Heliopan E 1000”出售的甲氧基肉桂酸异戊酯,- Isoamyl methoxycinnamate sold under the trademark "Neo Heliopan E 1000" by Haarmann and Reimer,
-西诺沙酯(Cinoxate),- Cinoxate,
-DEA甲氧基肉桂酸盐,- DEA methoxycinnamate,
-甲基肉桂酸二异丙酯,- Diisopropyl methyl cinnamate,
-甘油基乙基己酸酯二甲氧基肉桂酸酯,- Glyceryl ethylhexanoate dimethoxycinnamate,
-β,β-二苯基丙烯酸酯衍生物:-β,β-Diphenylacrylate derivatives:
-由BASF特别地以商标“Uvinul N539”出售的奥克立林(octocrylene);- octocrylene sold by BASF especially under the trademark "Uvinul N539";
-由BASF特别地以商标“Uvinul N35”出售的依托立林(etocrylene),- etocrylene sold under the trademark "Uvinul N35" by BASF,
-二苯甲酮衍生物:- Benzophenone derivatives:
-由BASF以商标“Uvinul 400”出售的二苯甲酮-1,- Benzophenone-1 sold under the trademark "Uvinul 400" by BASF,
-由BASF以商标“Uvinul D50”出售的二苯甲酮-2,- Benzophenone-2 sold under the trademark "Uvinul D50" by BASF,
-由BASF以商标“Uvinul M40”出售的二苯甲酮-3或氧苯酮(oxybenzone),- Benzophenone-3 or oxybenzone sold under the trademark "Uvinul M40" by BASF,
-由BASF以商标“Uvinul MS40”出售的二苯甲酮-4,- Benzophenone-4 sold under the trademark "Uvinul MS40" by BASF,
-二苯甲酮-5,- Benzophenone-5,
-由Norquay以商标“Helisorb 11”出售的二苯甲酮-6,- Benzophenone-6 sold under the trademark "Helisorb 11" by Norquay,
和它们的混合物。and their mixtures.
优选的UV遮光成分选自肉桂酸衍生物、β,β-二苯基丙烯酸酯衍生物、水杨酸衍生物、和它们的混合物。Preferred UV sunscreen ingredients are selected from cinnamic acid derivatives, β,β-diphenylacrylate derivatives, salicylic acid derivatives, and mixtures thereof.
优选的UV遮光成分特别选自甲氧基肉桂酸乙基己酯、奥克立林和水杨酸乙基己酯、和它们的混合物。Preferred UV sunscreen ingredients are especially selected from ethylhexyl methoxycinnamate, octocrylene and ethylhexyl salicylate, and mixtures thereof.
可特别提及由BASF公司以商品名出售的甲氧基肉桂酸乙基己酯、由SYMRISE公司以商品名出售的水杨酸乙基己酯和由SYMRISE公司以商品名出售的奥克立林。Special mention may be made by BASF Corporation under the trade name Ethylhexyl methoxycinnamate sold under the trade name Ethylhexyl salicylate sold by the company SYMRISE under the trade name octocrylene for sale.
相对组合物的总重量,本发明的组合物可包含0.1重量%至30重量%,例如0.5重量%至20重量%,例如1重量%至15重量%并且例如至少1重量%的UV遮光成分。The composition of the invention may comprise from 0.1% to 30%, such as from 0.5% to 20%, such as from 1% to 15% and such as at least 1% by weight of UV sunscreen ingredients relative to the total weight of the composition.
抗皱剂:可提及抗坏血酸及其衍生物,如抗坏血酸磷酸酯镁和抗坏血酸葡糖苷;生育酚及其衍生物,如生育酚乙酸酯;烟酸及其前体,如烟酰胺;泛醌;谷胱甘肽及其前体,如L-2-氧代噻唑啉-4-羧酸;C-糖苷化合物及其衍生物,如尤其在下文中所描述的:植物提取物,且尤其是海茴香和橄榄叶的提取物;及还有植物蛋白及其水解产物,如大米或大豆蛋白水解产物;海藻提取物,且尤其是海带的提取物;细菌提取物;皂苷元(sapogenin),如薯蓣皂苷元和包含皂苷元的薯蓣属(Dioscorea)植物的提取物,尤其是野山药的提取物;α-羟基酸;β-羟基酸,如水杨酸和5-正辛酰水杨酸;低聚肽和假二肽及其酰基衍生物,尤其是{2-[乙酰基-(3-三氟甲基苯基)氨基]-3-甲基丁酰基氨基}乙酸和由Sederma公司以商品名Matrixyl500和Matrixyl 3000出售的脂肽;番茄红素;锰盐和镁盐,尤其是葡萄糖酸锰和葡萄糖酸镁;及其混合物;Anti-wrinkle agents: Mention may be made of ascorbic acid and its derivatives, such as magnesium ascorbyl phosphate and ascorbyl glucoside; tocopherol and its derivatives, such as tocopheryl acetate; niacin and its precursors, such as niacinamide; ubiquinone; Glutathione and its precursors, such as L-2-oxothiazoline-4-carboxylic acid; C-glycosidic compounds and their derivatives, as described inter alia in: Plant extracts, and especially sea fennel and olive leaf extracts; and also vegetable proteins and their hydrolysates, such as rice or soybean protein hydrolysates; seaweed extracts, and especially extracts of kelp; bacterial extracts; sapogenins, such as dioscin Dioscorea and extracts of plants of the genus Dioscorea containing sapogenins, especially wild yam; alpha-hydroxy acids; beta-hydroxy acids such as salicylic acid and 5-n-octanoyl salicylic acid; oligopeptides and pseudodipeptides and their acyl derivatives, especially {2-[acetyl-(3-trifluoromethylphenyl)amino]-3-methylbutyrylamino}acetic acid and Sederma under the trade names Matrixyl500 and Lipopeptide sold in Matrixyl 3000; lycopene; manganese and magnesium salts, especially manganese and magnesium gluconate; and mixtures thereof;
脱皮剂:可提及β-羟基酸,尤其是水杨酸及其除了5-正辛酰水杨酸外的衍生物;脲;乙醇酸、柠檬酸、乳酸、酒石酸、苹果酸或扁桃酸;4-(2-羟乙基)哌嗪-1-丙磺酸(HEPES);槐米(Saphora japonica)提取物;蜂蜜;N-乙酰氨基葡萄糖;甲基甘氨酸二乙酸钠、α-羟基酸(AHA)、β-羟基酸(BHA),及其混合物;Peeling agents: mention may be made of beta-hydroxy acids, especially salicylic acid and its derivatives other than 5-n-octanoylsalicylic acid; urea; glycolic, citric, lactic, tartaric, malic or mandelic acids; 4-(2-Hydroxyethyl)piperazine-1-propanesulfonic acid (HEPES); Saphora japonica extract; honey; N-acetylglucosamine; sodium methylglycine diacetate, alpha-hydroxy acid ( AHA), beta-hydroxy acids (BHA), and mixtures thereof;
脱色剂:可提及神经酰胺、维生素C及其衍生物,特别是维生素CG、维生素CP和3-O乙基维生素C;α-和β-熊果苷;阿魏酸;曲酸;间苯二酚及其衍生物;D-泛酰巯基乙胺磺酸钙;硫辛酸;鞣花酸;维生素B3;苯乙基间苯二酚,例如来自Symrise公司的由Gattefosse出售的奇异果(猕猴桃,Actinidiachinensis)汁,牡丹(Paeonia suffructicosa)根提取物,如由Ichimaru Pharcos公司以名称出售的产品,红糖(甘蔗,Saccharum officinarum)提取物,如由Taiyo Kagaku公司以名称Molasses Liquid出售的糖蜜提取物、十一烯酸和十一碳烯酰基苯基丙氨酸的混合物,如来自Seppic的 Depigmenting agents: mention may be made of ceramides, vitamin C and its derivatives, especially vitamin CG, vitamin CP and 3-O ethyl vitamin C; alpha- and beta-arbutin; ferulic acid; kojic acid; m-benzene Diphenols and their derivatives; calcium D-pantetheinate; lipoic acid; ellagic acid; vitamin B3; phenylethylresorcinol, e.g. from the company Symrise Kiwifruit (Actinidia chinensis) juice sold by Gattefosse, peony (Paeonia suffructicosa) root extract as sold by the company Ichimaru Pharcos under the name Products sold, brown sugar (Sugar cane, Saccharum officinarum) extract, such as molasses extract sold under the name Molasses Liquid by the company Taiyo Kagaku, a mixture of undecylenic acid and undecylenoylphenylalanine, such as from Seppic of
抗氧化剂:可更特别地提及生育酚及其酯,尤其生育酚乙酸酯;EDTA;抗坏血酸及其衍生物,尤其抗坏血酸磷酸酯镁和抗坏血酸葡糖苷;螯合剂,如BHT、BHA、N,N’-双(3,4,5-三甲氧基苄基)乙二胺及其盐;及其混合物。Antioxidants: Mention may be made more particularly of tocopherol and its esters, especially tocopheryl acetate; EDTA; ascorbic acid and its derivatives, especially magnesium ascorbyl phosphate and ascorbyl glucoside; chelating agents such as BHT, BHA, N, N'-bis(3,4,5-trimethoxybenzyl)ethylenediamine and its salts; and mixtures thereof.
相对组合物的总重量,这些活性剂可以在0.001重量%至20重量%,优选0.01重量%至10重量%,并且更优选0.01重量%至5重量%范围内的量存在于组合物中。These active agents may be present in the composition in an amount ranging from 0.001% to 20% by weight, preferably from 0.01% to 10% by weight, and more preferably from 0.01% to 5% by weight, relative to the total weight of the composition.
1-6.组合物的制备和性质1-6. Preparation and Properties of Compositions
本发明的组合物可通过按照常规方法混合上述成分来制备。常规方法包括用高压均质器混合(高能量方法)。供选地,组合物可通过低能量方法诸如相变型温度方法(PIT)、相变型浓度(PIC)、自乳化等来制备。优选地,组合物通过低能量方法来制备。The composition of the present invention can be prepared by mixing the above-mentioned ingredients according to a conventional method. Conventional methods include mixing with a high pressure homogenizer (high energy method). Alternatively, the composition can be prepared by low energy methods such as phase change temperature method (PIT), phase change concentration (PIC), self-emulsification, and the like. Preferably, the compositions are prepared by low energy methods.
非离子表面活性剂与油的比率可为0.25至6,优选0.3至3,且更优选0.4至1.5。The ratio of nonionic surfactant to oil may be from 0.25 to 6, preferably from 0.3 to 3, and more preferably from 0.4 to 1.5.
本发明的组合物是纳米乳液或微乳液形式。可以两种方式(即以较广泛的意义和以较狭窄的意义)提及“微乳液”。也就是说,存在其中微乳液是指包含具有油性组分、水性组分和表面活性剂的三种成分的三元体系的热力学稳定的各向同性单一液相的一种情况(“狭义上的微乳液”),和存在其中,在热力学不稳定的典型的乳液体系中,微乳液另外包括由于它们的较小的粒径而呈现出透明或半透明外观的那些此类乳液的另一种情况(“广义上的微乳液”)(Satoshi Tomomasa等人,Oil Chemistry,第37卷,第11号(1988),第48-53页)。如本文所用的“微乳液”是指“狭义上的微乳液”,即热力学稳定的各向同性单一液相。The compositions of the invention are in the form of nanoemulsions or microemulsions. "Microemulsion" can be referred to in two ways, namely in a broader sense and in a narrower sense. That is, there is a case where a microemulsion refers to a thermodynamically stable isotropic single liquid phase comprising a ternary system having three components of an oily component, an aqueous component, and a surfactant ("in the narrow sense Microemulsions"), and another case where, in typical emulsion systems that are thermodynamically unstable, microemulsions additionally include those such emulsions that, due to their smaller particle size, exhibit a transparent or translucent appearance ("Microemulsion in a broad sense") (Satoshi Tomomasa et al., Oil Chemistry, Vol. 37, No. 11 (1988), pp. 48-53). "Microemulsion" as used herein refers to a "microemulsion in the narrow sense", ie a thermodynamically stable isotropic single liquid phase.
微乳液是指其中油通过胶束溶解的O/W(水包油)型微乳液、其中水通过反胶束溶解的W/O型(油包水)型微乳液、或其中表面活性剂分子的缔合体(associations)数量成为极大的使得水相和油相二者都具有连续结构的双连续微乳液中的任一种状态。Microemulsion refers to an O/W (oil-in-water) type microemulsion in which oil is dissolved through micelles, a W/O type (water-in-oil) type microemulsion in which water is dissolved through reverse micelles, or a surfactant molecule in which Any state in a bicontinuous microemulsion in which the number of associations becomes so large that both the water phase and the oil phase have a continuous structure.
所述微乳液可具有分散相,所述分散相具有通过激光粒度测定法测量的100nm或更小、优选50nm或更小、并且更优选20nm或更小的数均直径。The microemulsion may have a dispersed phase having a number average diameter measured by laser granulometry of 100 nm or less, preferably 50 nm or less, and more preferably 20 nm or less.
“纳米乳液”这里是指其特征在于具有小于350nm的尺寸的分散相的乳液,所述分散相通过在分散相/连续相界面处可任选形成层状类型的液晶相的非离子表面活性剂的冠(crown)来稳定。在不存在特定的不透明剂的情况下,纳米乳液的透明度源自于分散相的小尺寸,该小尺寸借助于使用机械能并且特别是高压均质器获得。"Nanoemulsion" here means an emulsion characterized by a dispersed phase having a size of less than 350 nm, which is passed through a non-ionic surfactant which may optionally form a lamellar-type liquid crystal phase at the dispersed phase/continuous phase interface The crown (crown) to stabilize. In the absence of specific opacifying agents, the transparency of nanoemulsions results from the small size of the dispersed phase, which is obtained by means of the use of mechanical energy and in particular a high-pressure homogenizer.
纳米乳液可与微乳液通过它们的结构区分开。具体地,微乳液是热力学稳定的分散体,其由例如充满油的非离子表面活性剂胶束形成。此外,微乳液不需要大量的机械能来制备。Nanoemulsions can be distinguished from microemulsions by their structure. In particular, microemulsions are thermodynamically stable dispersions formed, for example, of oil-filled micelles of nonionic surfactants. Furthermore, microemulsions do not require large amounts of mechanical energy to prepare.
微乳液可具有分散相,所述分散相具有通过激光粒度测定法测量的300nm或更小、优选200nm或更小、且更优选150nm或更小的数均直径。The microemulsion may have a dispersed phase having a number average diameter measured by laser granulometry of 300 nm or less, preferably 200 nm or less, and more preferably 150 nm or less.
本发明的组合物可为O/W纳米乳液或微乳液、W/O纳米乳液或微乳液或双连续乳液形式。优选地,本发明的组合物是O/W纳米乳液或微乳液形式。The composition of the invention may be in the form of an O/W nano- or micro-emulsion, a W/O nano- or micro-emulsion or a bicontinuous emulsion. Preferably, the composition of the invention is in the form of an O/W nanoemulsion or microemulsion.
在优选的实施方案中,本发明的组合物可为O/W乳液形式。在这种情况下,油可为数均粒径为300nm或更小,优选10nm至200nm,且更优选20nm至150nm的液滴形式。In a preferred embodiment, the composition of the present invention may be in the form of an O/W emulsion. In this case, the oil may be in the form of droplets having a number average particle diameter of 300 nm or less, preferably 10 nm to 200 nm, and more preferably 20 nm to 150 nm.
使用Mastersizer 2000粒径仪(由Malvern Instruments出售)通过光衍射测定油相液滴的平均尺寸。这些测定在1%SDS(十二烷基硫酸钠)在水中的溶液中稀释的乳液上进行。计算机程序使得可能获得按体积的平均直径D[4.3](μm)(参见操作者指南,Malvern Instruments,1998年12月,第61至67页)。The average size of the oil phase droplets was determined by light diffraction using a Mastersizer 2000 particle sizer (sold by Malvern Instruments). These assays were performed on emulsions diluted in a solution of 1% SDS (sodium dodecyl sulfate) in water. A computer program makes it possible to obtain the mean diameter D[4.3] (μm) by volume (see Operator's Guide, Malvern Instruments, December 1998, pp. 61-67).
本发明的组合物的油相的液滴的平均尺寸D[4.3](μm)在10nm至150nm,且更优选20nm至140nm范围内。The average size D[4.3] (μm) of the droplets of the oil phase of the composition of the invention is in the range of 10 nm to 150 nm, and more preferably 20 nm to 140 nm.
本发明的组合物是特别稳定的,特别在室温且甚至在37℃或45℃、大气压下2个月期间,并且它们呈现出最佳的化妆性质。事实上,本发明的组合物呈现出适当的流动性:它们易于处理,且还易于施用和铺展到皮肤上。The compositions of the invention are particularly stable, especially during 2 months at room temperature and even at 37°C or 45°C, atmospheric pressure, and they exhibit optimal cosmetic properties. In fact, the compositions of the invention exhibit suitable fluidity: they are easy to handle and also easy to apply and spread on the skin.
这些组合物也呈现出化妆用途所需的质地:它们不是粘性的、触感柔软并且赋予有弹性的感觉。因此,本发明的组合物还具有满足消费者在化妆性如较低粘度和更好的润肤性方面的期望的优点。These compositions also exhibit the desired texture for cosmetic use: they are not sticky, soft to the touch and impart a bouncy feel. Thus, the compositions of the present invention also have the advantage of meeting consumer expectations in terms of cosmetic properties such as lower viscosity and better emolliency.
本发明的组合物可为“变色组合物”。术语“变色组合物”指这样的组合物:其中施用前的颜色与施用后的颜色不同,该不同对于肉眼可见。The compositions of the present invention may be "color changing compositions". The term "color changing composition" refers to a composition in which the color before application differs from the color after application, the difference being visible to the naked eye.
尤其,该变色组合物可与根据CIE实验室系统1976(施用前/施用后ΔE)值的色差ΔE相关联。通过方程式限定ΔE:In particular, the color-changing composition can be associated with a color difference ΔE according to the CIE Laboratory System 1976 (ΔE before/after application) value. ΔE is defined by the equation:
[Math.1][Math.1]
其中L1、a1、b1为第一颜色(施用前的组合物)的色度空间中的参数,且L2、a2、b2为第二颜色(在施用到角蛋白材料上且在角蛋白材料上均匀化后的组合物)的参数。可通过分光光度计或利用色球(Chromasphere)(用于施用到皮肤上的组合物)测定这些值。本发明的变色组合物可被表征为具有大于1、尤其大于或等于2、优选地大于或等于3的施用前/施用后ΔE。where L 1 , a 1 , b 1 are parameters in the chromaticity space of the first color (the composition before application), and L 2 , a 2 , b 2 are the second color (after application to the keratin material and Composition after homogenization on keratin material) parameters. These values can be determined spectrophotometrically or using a Chromasphere (for compositions applied to the skin). The color changing composition of the invention may be characterized as having a pre-application/post-application ΔE greater than 1, especially greater than or equal to 2, preferably greater than or equal to 3.
本发明的组合物可具有透明或稍微半透明的外观,优选透明的外观。换句话说,本发明组合物在透明介质中包括包含可释放的着色剂的微胶囊。The compositions of the invention may have a transparent or slightly translucent appearance, preferably a transparent appearance. In other words, the compositions of the present invention comprise microcapsules comprising a releasable colorant in a transparent medium.
透明度可通过用吸收分光计测定可见区中的透射率来测定(例如,用具有2mm宽的池的V-550(JASCO)测定作为可见光透射率(在400和800nm之间)的平均的透明度)。所述测定在未稀释的组合物上进行。空白用蒸馏水来确定。Transparency can be measured by measuring transmittance in the visible region with an absorption spectrometer (for example, transmittance as an average of visible light transmittance (between 400 and 800 nm) is measured with a V-550 (JASCO) having a 2 mm wide cell) . The assays are performed on undiluted compositions. Blanks were determined with distilled water.
本发明的组合物可优选具有大于50%、优选大于60%、更优选大于70%、并且甚至更优选大于75%的透明度。The compositions of the invention may preferably have a transparency of greater than 50%, preferably greater than 60%, more preferably greater than 70%, and even more preferably greater than 75%.
在优选的实施方案中,本发明的组合物包含微胶囊;优选未着色的微胶囊,外层是白色或透明的,且当外层为透明的时,可见的内层是白色的。出于本发明的目的,术语“透明的组合物”指透过波长750nm的光的至少40%而不散射光的组合物,即其中光的散射角小于50°且更好地约5°的组合物。透明组合物可透过波长750nm的光的至少50%、尤其至少60%且尤其至少70%。In a preferred embodiment, the composition of the invention comprises microcapsules; preferably unpigmented microcapsules, the outer layer is white or transparent, and when the outer layer is transparent, the visible inner layer is white. For the purposes of the present invention, the term "transparent composition" refers to a composition which transmits at least 40% of light having a wavelength of 750 nm without scattering light, i.e. wherein the light is scattered at an angle of less than 50° and better about 5° combination. The transparent composition transmits at least 50%, especially at least 60% and especially at least 70% of light having a wavelength of 750 nm.
根据下列方案,利用来自Varian公司的Cary 300扫描UV-可见分光光度计进行光透射测定:Light transmission measurements were performed using a Cary 300 scanning UV-visible spectrophotometer from Varian according to the following protocol:
-将组合物倒入边长10mm的方形(square-sided)分光光度计小池中;- Pour the composition into a square-sided spectrophotometer cuvette with a side length of 10 mm;
-然后,在恒温调节室内在20℃下,保持组合物样品24小时;-then, keep the composition sample in a thermostatic chamber at 20°C for 24 hours;
-然后,在分光光度计上,通过扫描在700nm至800nm范围内的波长,测定透过组合物样品的光,以透射模式进行该测定;- then, on a spectrophotometer, the light transmitted through the sample of the composition is measured by scanning wavelengths in the range from 700 nm to 800 nm, this determination being carried out in transmission mode;
-然后,确定在750nm的波长处透过组合物样品的光的百分比。- Then, determine the percentage of light transmitted through the sample of the composition at a wavelength of 750 nm.
透明组合物,当它们被放置在一张白纸上绘制的直径2mm粗的黑线的前方0.01m时,允许该线被看到;相反,不透明组合物,即非透明组合物,不允许该线被看到。Transparent compositions, when they are placed 0.01m in front of a black line with a diameter of 2mm thick drawn on a white paper, allow the line to be seen; line is seen.
本发明的组合物(优选化妆粉底或皮肤着色产品)提供强烈的保湿感觉、霜状质地,具有在施用过程中的非常舒适的感觉和在施用后的完全自然的化妆结果。最后,所有这些特征帮助提供护肤功效感知(乳脂状和保湿)以及化妆功效(合适的覆盖率和自然的光亮)的非常良好的平衡。此外,本发明的组合物可呈现出遮光效果。有利地,在水相的存在下,微胶囊是可变形的。有利地,在组合物内部的微胶囊在施用到角蛋白材料上的压力下是可破裂的。The compositions of the invention, preferably cosmetic foundations or skin coloring products, provide an intense moisturizing feel, a creamy texture with a very pleasant feel during application and a completely natural cosmetic result after application. In the end, all these characteristics help to provide a very good balance of skin care efficacy perception (creaminess and moisturizing) and cosmetic efficacy (decent coverage and natural shine). In addition, the compositions of the present invention can exhibit a light-shielding effect. Advantageously, the microcapsules are deformable in the presence of an aqueous phase. Advantageously, the microcapsules inside the composition are breakable under the pressure applied to the keratin material.
2.方法和用途2. Methods and uses
本发明还涉及将上文中所述的组合物施用到皮肤、头发、粘膜、指甲、睫毛、眉毛或头皮上的化妆方法。The present invention also relates to a cosmetic method of applying the composition described above to the skin, hair, mucous membranes, nails, eyelashes, eyebrows or scalp.
本发明还涉及上文中所述的组合物用作或用于身体和/或面部皮肤和/或粘膜和/或头皮和/或头发和/或指甲和/或睫毛和/或眉毛的护理产品和/或清洗产品和/或化妆产品和/或卸妆产品的用途。The present invention also relates to the composition described hereinbefore as or for use as a care product for body and/or face skin and/or mucous membranes and/or scalp and/or hair and/or nails and/or eyelashes and/or eyebrows and and/or use of cleansing products and/or makeup products and/or makeup removers.
换句话说,本发明的组合物可作为以上产品原样使用。或者,本发明的组合物可作为以上产品的成分(element)使用。例如,本发明的组合物可添加到任何其它成分中或与任何其它成分组合以形成以上产品。In other words, the composition of the present invention can be used as the above products as they are. Alternatively, the composition of the present invention may be used as an element of the above products. For example, the compositions of the present invention may be added to or combined with any other ingredients to form the above products.
根据常规方法制备这些组合物。这种类型的组合物可为面部和/或身体护理或化妆产品的形式,和可被调制为例如置于罐中的乳霜或置于管或泵动瓶中的流体的形式。These compositions are prepared according to conventional methods. Compositions of this type may be in the form of face and/or body care or cosmetic products, and may be formulated, for example, as a cream in a jar or as a fluid in a tube or pump bottle.
在特定实施方案中,该组合物包含至少一种中和的2-丙烯酰胺基-2-甲基丙磺酸聚合物和共聚物及一种多糖生物聚合物。In particular embodiments, the composition comprises at least one neutralized 2-acrylamido-2-methylpropanesulfonic acid polymer and copolymer and a polysaccharide biopolymer.
表述“透明的含水介质”意指允许光通过而不通过折射或反射引起偏差的介质。含水介质的透明度可使用浊度计测定。例如可使用来自HACH公司的便携式Model来测定组合物的透明度范围。当浊度测定值在0和250NTU之间时,认为组合物是透明的,并且对于浊度值为250至1000NTU,认为组合物是半透明的。The expression "transparent aqueous medium" means a medium which allows light to pass through without causing deviations by refraction or reflection. The clarity of aqueous media can be determined using a nephelometer. For example a portable Model to determine the transparency range of the composition. The composition is considered transparent when the turbidity measurement is between 0 and 250 NTU, and translucent for turbidity values between 250 and 1000 NTU.
当放置在白纸上绘制的直径为2mm的0.01m粗的黑线前面时,该组合物显露该黑线,这与不透明组合物相反,也就是说,不透明组合物将不显露黑线。本发明的组合物优选包含水和包含可释放的着色剂的多层微胶囊。在优选的实施方案中,本发明的组合物包含至少一种亲水性或亲油性凝胶剂和至少一种水溶性润肤剂和/或具有极性部分的脂质。在优选的实施方案中,本发明的组合物包含至少两种类型的包含可释放的着色剂的不同多层微胶囊。When placed in front of a 0.01 m thick black line of 2mm diameter drawn on white paper, this composition reveals the black line, in contrast to the opaque composition, that is to say the opaque composition will not reveal the black line. The compositions of the invention preferably comprise water and multilayered microcapsules comprising a releasable colourant. In a preferred embodiment, the composition according to the invention comprises at least one hydrophilic or lipophilic gelling agent and at least one water-soluble emollient and/or lipid with polar moieties. In a preferred embodiment, the composition of the invention comprises at least two types of different multilayered microcapsules comprising a releasable colorant.
微胶囊可在最后步骤中伴随轻轻搅拌引入而没有在制备凝胶后破坏微胶囊。The microcapsules can be introduced with gentle agitation in the final step without destroying the microcapsules after preparation of the gel.
如此获得的具有微胶囊的透明组合物呈现纯粹且干净的外观,在-20/20℃(5次循环)、室温(25℃,2个月)、37℃(2个月)和45℃(2个月)、大气压下具有完美的稳定性。在施用过程中微胶囊释放颜料而没有感觉到任何颗粒。在施用后提供完美且均匀的化妆结果。The transparent composition with microcapsules thus obtained exhibited a pure and clean appearance at -20/20°C (5 cycles), room temperature (25°C, 2 months), 37°C (2 months) and 45°C ( 2 months), perfect stability at atmospheric pressure. The microcapsules release the pigment without feeling any particles during application. Provides a flawless and even makeup result after application.
本发明的组合物优选是透明的,并且也可为稍微着色的。在这种情况下,本发明的组合物包含至少一种非包埋的着色剂,优选基于全部组合物的总重量,其量少于1重量%。The compositions of the invention are preferably clear, and may also be slightly colored. In this case, the composition according to the invention comprises at least one non-entrapped colorant, preferably in an amount of less than 1% by weight, based on the total weight of the entire composition.
本发明的组合物也可为包含油和表面活性剂的凝胶乳霜或乳化凝胶的形式。The compositions of the invention may also be in the form of gel creams or emulsifying gels comprising oils and surfactants.
在另一实施方案中,本发明涉及包含一种以上定义的产品和涂抹器的试剂盒。所述涂抹器可选自常规使用的涂抹器。In another embodiment, the invention relates to a kit comprising one of the above defined products and an applicator. The applicator may be selected from conventionally used applicators.
本发明的组合物可例如通过手指或使用涂抹器施用。容器优选与包括配置以施用所述组合物至角蛋白物质的至少一种施用组件的涂抹器组合使用。Compositions of the invention can be applied, for example, with the fingers or using an applicator. The container is preferably used in combination with an applicator comprising at least one application component configured to apply said composition to keratinous substances.
该组合物主要包含水、至少一种非挥发性油、至少一种O/W乳化剂和微胶囊。The composition mainly comprises water, at least one fixed oil, at least one O/W emulsifier and microcapsules.
在整个说明书(包括权利要求书)中,术语“包含一”和“包括一”应理解为分别与“包含至少一”和“包括至少一”同义,除非另外提到。Throughout the specification (including the claims), the terms "comprising a" and "comprising a" are to be understood as being synonymous with "comprising at least one" and "comprising at least one", respectively, unless mentioned otherwise.
术语“...和...之间”和“从...至...”应理解为包括上下限,除非另外详细说明。The terms "between" and "from to" are to be understood as including upper and lower limits unless specified otherwise.
通过下述实施例更详细地示例说明本发明。除非另外提到,指示的量表示为活性材料的质量百分比。The invention is illustrated in more detail by the following examples. Unless mentioned otherwise, the indicated amounts are expressed as mass percent of active material.
实施例Example
将通过实施例更详细地描述本发明,然而,所述实施例不应解释为限制本发明的范围。The present invention will be described in more detail by way of examples, however, the examples should not be construed as limiting the scope of the present invention.
配方实施例recipe example
1:SUNSOFT A-121E(由Taiyo Kagaku提供)1: SUNSOFT A-121E (provided by Taiyo Kagaku)
2:MAGIC30-BW0105(由KPT提供)2: MAGIC30-BW0105 (provided by KPT)
(1)组合物的制备(1) Preparation of the composition
根据以下方法配制实施例1和对比实施例1:Preparation Example 1 and Comparative Example 1 according to the following methods:
制备油相(棕榈酸乙基己酯+聚甘油-5月桂酸酯+防腐剂的混合物),并将油相加热至约75℃。接下来,制备水相(水+甲基硬脂酰基牛磺酸钠+甘油+丁二醇),并将水相加热至约75℃。然后,将水相添加到油相中。在完成乳化后,向混合物中添加增稠剂相(丙烯酸酯/C10-30烷基丙烯酸酯交联聚合物)。然后,将混合物冷却至室温。对于实施例1,在室温下向混合物中添加MAGIC30-BW0105。Prepare the oil phase (mixture of ethylhexyl palmitate + polyglyceryl-5 laurate + preservatives) and heat the oil phase to about 75°C. Next, an aqueous phase (water+sodium methylstearyl taurate+glycerin+butylene glycol) was prepared, and the aqueous phase was heated to about 75°C. Then, add the water phase to the oil phase. After complete emulsification, the thickener phase (Acrylates/C10-30 Alkyl Acrylate Crosspolymer) was added to the mixture. Then, the mixture was cooled to room temperature. For Example 1, MAGIC30-BW0105 was added to the mixture at room temperature.
根据以下方法配制对比实施例2:Comparative Example 2 was prepared according to the following method:
制备水相(水+甘油+丁二醇),并将水相加热至约75℃。向混合物中添加增稠剂相(丙烯酸酯/C10-30烷基丙烯酸酯交联聚合物)。然后将混合物冷却至室温。在室温下向混合物中添加MAGIC30-BW0105。Prepare the aqueous phase (water+glycerin+butanediol) and heat the aqueous phase to about 75°C. Add the thickener phase (Acrylates/C10-30 Alkyl Acrylate Crosspolymer) to the mixture. The mixture was then cooled to room temperature. Add MAGIC30-BW0105 to the mixture at room temperature.
(2)技术效果的评价(2) Evaluation of technical effects
(i)观察(外观)(i) Observation (appearance)
通过视觉观察评价外观。Appearance was evaluated by visual observation.
(ii)没有MAGIC30-BW0105的主体的透明度(ii) Transparency of bodies without MAGIC30-BW0105
使用具有2mm宽的池的V-550(JASCO)测定透明度。透明度=可见光透射率(400和800nm之间)的平均。Transparency was measured using a V-550 (JASCO) with a 2 mm wide cell. Transparency = average of visible light transmission (between 400 and 800 nm).
(iii)粒径(iii) Particle size
使用VASCO-2(CORDOUAN TECHNOLOGIES)在未稀释条件下测定粒径。计算机程序使得可能通过指定强度获得平均直径。The particle size was measured under undiluted conditions using VASCO-2 (CORDOUAN TECHNOLOGIES). A computer program makes it possible to obtain the mean diameter by specifying the intensity.
(iv)覆盖率(iv) Coverage
在黑色上在1mg/cm3浓度(thickness)下测定施用颜色。该值通过ΔL*显示。ΔL*值越低,实现越大的覆盖率。in black Applied color was determined at 1 mg/cm 3 thickness (thickness). This value is displayed by ΔL*. The lower the ΔL* value, the greater coverage is achieved.
(v)感官测试(v) Sensory test
为了评价化妆性,由5名专家小组成员进行感官测试。专家小组成员就润肤性和湿度而言以5个等级评价各组合物。In order to evaluate cosmetic properties, a sensory test was conducted by 5 panelists. Panelists rated each composition on a 5-point scale for emolliency and moisture.
润肤性Emollient
5:非常润肤5: very emollient
4:相当润肤4: Quite emollient
3:较润肤3: Moisturizing
2:不润肤2: Non-emollient
1:非常不润肤(皮肤感觉相当硬)1: Very non-emollient (skin feels rather hard)
湿度humidity
5:非常湿5: very wet
4:相当湿4: fairly wet
3:较湿3: wet
2:不湿2: not wet
1:非常不湿1: very dry
表1Table 1
施用至角蛋白材料的模式具有观察到的技术效果Modes of application to keratin materials have observed technical effects
正如从以上结果清楚的是,发现根据本发明的O/W乳液形式的化妆品组合物具有较小的油滴,且因此,在微胶囊存在下提供具有较好透明度的外观。As is clear from the above results, the cosmetic composition in the form of an O/W emulsion according to the present invention was found to have smaller oil droplets, and thus, provided an appearance with better transparency in the presence of microcapsules.
对比实施例1是用于与实施例1比较的配方,在于对比实施例1没有微胶囊。由实施例1和对比实施例1之间的比较可归纳出根据本发明的实施例1在微胶囊的存在下获得透明凝胶,且透明度等同于没有微胶囊的配方。实施例1的粒径为150nm以下,且组合物为纳米乳液。Comparative Example 1 is a formulation for comparison with Example 1, in that Comparative Example 1 has no microcapsules. From the comparison between Example 1 and Comparative Example 1, it can be concluded that Example 1 according to the present invention obtains a transparent gel in the presence of microcapsules, and the transparency is equivalent to the formulation without microcapsules. The particle size of Example 1 is below 150nm, and the composition is a nanoemulsion.
对比实施例2是含水透明凝胶的配方。这意味着实施例1(透明纳米乳液凝胶)在覆盖率和感官性质(润肤性和湿度)方面超过对比实施例2(透明含水凝胶)。Comparative Example 2 is a formulation containing an aqueous clear gel. This means that Example 1 (clear nanoemulsion gel) outperforms Comparative Example 2 (clear aqueous gel) in terms of coverage and sensory properties (emollient and wetness).
Claims (22)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013268856A JP2015124168A (en) | 2013-12-26 | 2013-12-26 | Transparent composition containing oil and microcapsules |
JP2013-268856 | 2013-12-26 | ||
PCT/JP2014/084756 WO2015099198A1 (en) | 2013-12-26 | 2014-12-24 | Transparent composition containing oil and microcapsules |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105848626A true CN105848626A (en) | 2016-08-10 |
Family
ID=52392175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480070567.4A Pending CN105848626A (en) | 2013-12-26 | 2014-12-24 | Transparent composition containing oil and microcapsules |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2015124168A (en) |
KR (1) | KR20160101913A (en) |
CN (1) | CN105848626A (en) |
WO (1) | WO2015099198A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481739A (en) * | 2018-12-12 | 2019-03-19 | 四川大学华西医院 | Bone joint lubricant and preparation method thereof |
CN110917094A (en) * | 2019-12-18 | 2020-03-27 | 成都潮蛹科技有限公司 | Foundation make-up solution with blue light resistance and color change resistance and preparation method thereof |
CN111093598A (en) * | 2017-08-29 | 2020-05-01 | 莱雅公司 | Oil-in-water emulsion composition comprising ether oil |
CN111246833A (en) * | 2017-12-18 | 2020-06-05 | Lvmh研究公司 | Liquid cosmetic with agar shell capsule |
CN111356441A (en) * | 2017-11-16 | 2020-06-30 | 欧莱雅 | Makeup removing micelle emulsion |
CN112451394A (en) * | 2020-12-02 | 2021-03-09 | 广东柏俐臣生物科技有限公司 | Mild makeup remover |
CN116407456A (en) * | 2023-04-06 | 2023-07-11 | 株式会社资生堂 | cosmetic composition |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015189764A (en) * | 2014-03-31 | 2015-11-02 | ロレアル | Composition with optical effect |
JP6510177B2 (en) | 2014-04-01 | 2019-05-08 | ロレアル | Compositions in the form of nano or microemulsions |
JP6537788B2 (en) | 2014-06-25 | 2019-07-03 | ロレアル | Composition in the form of a nanoemulsion or microemulsion or having a lamellar structure |
KR101762416B1 (en) * | 2015-12-17 | 2017-07-28 | 강희철 | Micelle composition for cosmetic |
WO2017179041A1 (en) * | 2016-04-11 | 2017-10-19 | Tagra Biotechnologies Ltd. | Microcapsules encapsulating silicone materials |
KR101808834B1 (en) * | 2016-04-28 | 2017-12-13 | (주)바이오제닉스 | Color changing cosmetic composition of fusion antioxidant ability for make-up |
FR3058050B1 (en) * | 2016-10-28 | 2019-01-25 | L'oreal | COMPOSITION COMPRISING AT LEAST TWO ESTERS OF FATTY ACID AND (POLY) GLYCEROL, AND USE THEREOF IN COSMETICS |
US10980732B2 (en) * | 2017-02-28 | 2021-04-20 | L'oreal | Hair care compositions comprising polysaccharides and polyol |
KR102020781B1 (en) * | 2017-12-14 | 2019-09-11 | (주)바이오제닉스 | Horse fat capsule for moisturizing and manufacturing method thereof |
US11602582B2 (en) * | 2018-04-10 | 2023-03-14 | Chemsil Silicones, Inc. | Intimate care lubricant compositions and methods for making same |
KR102067094B1 (en) | 2018-04-17 | 2020-01-15 | 김철환 | A surfactant-free type oil-water dispersion composition, surfactant-free type water-oil dispersion composition and the manufacturing method thereof |
KR101914051B1 (en) * | 2018-07-13 | 2018-12-28 | (주)바이오제닉스 | Double capsule composition for containing charcoal and manufacturing method for the same |
KR102151803B1 (en) * | 2020-01-08 | 2020-09-03 | 에이스틴 주식회사 | A surfactant-free type oil-water dispersion composition, surfactant-free type water-oil dispersion composition and the manufacturing method thereof |
KR102151802B1 (en) * | 2020-01-08 | 2020-09-03 | 에이스틴 주식회사 | A surfactant-free type oil-water dispersion composition, surfactant-free type water-oil dispersion composition and the manufacturing method thereof |
KR102151804B1 (en) * | 2020-01-08 | 2020-09-03 | 에이스틴 주식회사 | A surfactant-free type oil-water dispersion composition, surfactant-free type water-oil dispersion composition and the manufacturing method thereof |
KR102225152B1 (en) * | 2020-09-08 | 2021-03-09 | 박진목 | Color changing soap composition |
KR102451153B1 (en) * | 2022-04-08 | 2022-10-06 | 송지원 | Cosmetic composition for eyebrow tattoo with improved coloration |
US12042550B2 (en) * | 2022-09-29 | 2024-07-23 | L'oreal | Leave-on hair treatment compositions |
CN115970602B (en) * | 2022-10-26 | 2024-12-06 | 中国科学院深圳先进技术研究院 | Preparation and application of oil-dispersible titanium dioxide nano-sustained release microcapsules |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101005818A (en) * | 2004-06-15 | 2007-07-25 | 西巴特殊化学制品控股公司 | Shatter resistant encapsulated colorants for natural skin appearance. |
CN101282710A (en) * | 2005-02-03 | 2008-10-08 | 宝洁公司 | Cosmetic composition comprising encapsulated colorant |
CN101472551A (en) * | 2006-06-07 | 2009-07-01 | 宝洁公司 | Bleed-resistant colored microparticles and skin care compositions comprising them |
JP2011079804A (en) * | 2009-10-09 | 2011-04-21 | Daito Kasei Kogyo Kk | Pigment-encapsulating microcapsule and cosmetic obtained by formulating the same |
KR20110059396A (en) * | 2009-11-27 | 2011-06-02 | (주)케이피티 | Highly moisturizing pellets containing oil and method for producing same |
CN102088946A (en) * | 2008-05-12 | 2011-06-08 | 塔格拉生物科技有限公司 | Compositions for topical application comprising microencapsulated colorants |
EP2474299A2 (en) * | 2009-09-02 | 2012-07-11 | Biogenics, Inc. | Colored capsule composition for cosmetics, method for manufacturing same, and cosmetic agent using the composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2528378A (en) | 1947-09-20 | 1950-10-31 | John J Mccabe Jr | Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same |
US2781354A (en) | 1956-03-26 | 1957-02-12 | John J Mccabe Jr | Imidazoline derivatives and process |
US5364633A (en) | 1994-03-14 | 1994-11-15 | Dow Corning Corporation | Silicone vesicles and entrapment |
JP3489703B2 (en) | 1995-10-23 | 2004-01-26 | 株式会社ノエビア | Fine emulsion composition |
JP3667046B2 (en) | 1997-08-27 | 2005-07-06 | 株式会社ノエビア | Fine emulsion composition |
FR2818547B1 (en) | 2000-12-22 | 2006-11-17 | Oreal | NOVEL C-GLYCOSIDE DERIVATIVES AND USE |
FR2841155B1 (en) | 2002-06-20 | 2008-06-27 | Bionatec | METHOD FOR MANUFACTURING A COSMETIC PRODUCT, COSMETIC PRODUCT AND USE |
BRPI0512035B1 (en) * | 2004-06-15 | 2015-06-23 | Ciba Sc Holding Ag | Microparticles, solid or liquid cosmetic or personal care composition and method for cosmetic treatment of a body |
FR2914860B1 (en) | 2007-04-12 | 2009-05-22 | Ile D Inventeurs Apis Spheromo | MULTILAYER SPHEROIDS WITH ANTIPALUDITIC ACTION IN WHICH ONE OF THE LAYERS CONTAINS ARTESUNATE |
WO2013107000A1 (en) * | 2012-01-17 | 2013-07-25 | L'oreal | Colour changing composition |
WO2013106998A1 (en) * | 2012-01-17 | 2013-07-25 | L'oreal | Colour changing composition in o/w emulsion form |
EP2774597A1 (en) * | 2013-03-06 | 2014-09-10 | L'Oréal | Colour changing composition in emulsion form comprising a partially neutralized, crosslinked acrylic homopolymer or copolymer |
ES2750150T3 (en) * | 2013-07-12 | 2020-03-25 | Oreal | Color changing composition comprising pigments and a high amount of water |
-
2013
- 2013-12-26 JP JP2013268856A patent/JP2015124168A/en active Pending
-
2014
- 2014-12-24 CN CN201480070567.4A patent/CN105848626A/en active Pending
- 2014-12-24 WO PCT/JP2014/084756 patent/WO2015099198A1/en active Application Filing
- 2014-12-24 KR KR1020167015533A patent/KR20160101913A/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101005818A (en) * | 2004-06-15 | 2007-07-25 | 西巴特殊化学制品控股公司 | Shatter resistant encapsulated colorants for natural skin appearance. |
CN101282710A (en) * | 2005-02-03 | 2008-10-08 | 宝洁公司 | Cosmetic composition comprising encapsulated colorant |
CN101472551A (en) * | 2006-06-07 | 2009-07-01 | 宝洁公司 | Bleed-resistant colored microparticles and skin care compositions comprising them |
CN102088946A (en) * | 2008-05-12 | 2011-06-08 | 塔格拉生物科技有限公司 | Compositions for topical application comprising microencapsulated colorants |
EP2474299A2 (en) * | 2009-09-02 | 2012-07-11 | Biogenics, Inc. | Colored capsule composition for cosmetics, method for manufacturing same, and cosmetic agent using the composition |
JP2011079804A (en) * | 2009-10-09 | 2011-04-21 | Daito Kasei Kogyo Kk | Pigment-encapsulating microcapsule and cosmetic obtained by formulating the same |
KR20110059396A (en) * | 2009-11-27 | 2011-06-02 | (주)케이피티 | Highly moisturizing pellets containing oil and method for producing same |
Non-Patent Citations (1)
Title |
---|
帕索斯: "《食品工程的创新:新技术与新产品》", 31 January 2013, 中国轻工业出版社 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111093598A (en) * | 2017-08-29 | 2020-05-01 | 莱雅公司 | Oil-in-water emulsion composition comprising ether oil |
CN111093598B (en) * | 2017-08-29 | 2022-11-15 | 莱雅公司 | Oil-in-water emulsion compositions comprising ether oils |
CN111356441A (en) * | 2017-11-16 | 2020-06-30 | 欧莱雅 | Makeup removing micelle emulsion |
US11540982B2 (en) | 2017-11-16 | 2023-01-03 | L'oreal | Demake-up micellar milk |
CN111246833A (en) * | 2017-12-18 | 2020-06-05 | Lvmh研究公司 | Liquid cosmetic with agar shell capsule |
CN111246833B (en) * | 2017-12-18 | 2024-01-26 | Lvmh研究公司 | Liquid cosmetic with agar shell capsule |
CN109481739A (en) * | 2018-12-12 | 2019-03-19 | 四川大学华西医院 | Bone joint lubricant and preparation method thereof |
CN110917094A (en) * | 2019-12-18 | 2020-03-27 | 成都潮蛹科技有限公司 | Foundation make-up solution with blue light resistance and color change resistance and preparation method thereof |
CN112451394A (en) * | 2020-12-02 | 2021-03-09 | 广东柏俐臣生物科技有限公司 | Mild makeup remover |
CN112451394B (en) * | 2020-12-02 | 2022-11-18 | 广东柏俐臣生物科技有限公司 | Mild makeup remover |
CN116407456A (en) * | 2023-04-06 | 2023-07-11 | 株式会社资生堂 | cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
WO2015099198A1 (en) | 2015-07-02 |
JP2015124168A (en) | 2015-07-06 |
KR20160101913A (en) | 2016-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105848626A (en) | Transparent composition containing oil and microcapsules | |
JP6742247B2 (en) | Composition comprising microcapsules containing reflective particles | |
JP6734786B2 (en) | Composition comprising microcapsules containing particles with high wetting point | |
KR102052778B1 (en) | Colour changing composition with alcohol | |
JP2016500113A (en) | Discoloration composition | |
JP6591408B2 (en) | Color change cosmetic composition in the form of an O / W emulsion in the form of an oleosome | |
CN104168871A (en) | Changing-color composition in foam form | |
KR102020081B1 (en) | Colour changing composition with polyol | |
EP2823804B1 (en) | Color changing composition comprising pigments and a high amount of water | |
JP6509207B2 (en) | Color change composition in the form of an O / W emulsion comprising a gemini surfactant | |
CN104168873B (en) | Color-changing composition | |
CN104168874B (en) | Color changing composition with polyol | |
US9889073B2 (en) | Colour changing composition in emulsion form comprising a partially neutralized, crosslinked acrylic homopolymer or copolymer | |
JP6442420B2 (en) | Emulsion-type color changing composition containing emulsifiable hydrophilic gelling agent | |
CN104168960A (en) | Colour changing composition in o/w emulsion form | |
CN104168959B (en) | Color-changing composition with UV filtering agents | |
CN104203350B (en) | Color-changing composition with alcohol | |
JP2020079205A (en) | Liquid composition for makeup containing goniochromatic pigments and white pigments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160810 |
|
WD01 | Invention patent application deemed withdrawn after publication |